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Abstract 
Foot pain is a common musculoskeletal complaint, that is associated with significant functional 
limitations and is often accompanied by systemic co-morbidities. Pain on the medial aspect of the 
foot and ankle between the medial malleolus and navicular is often diagnosed as dysfunction of the 
tibialis posterior tendon. Tibialis posterior tendinopathy (TPT) is considered to constitute the early 
stages of a condition that progresses to an acquired flatfoot deformity. Surgical intervention is 
recommended when conservative approaches are unsuccessful, with invasive and costly procedures 
recommended when significant deformity and dysfunction are present. Effective management in the 
early stages when tendon signs and symptoms predominate is desirable in order to prevent or delay 
progression of the condition.  
The overarching objective of this thesis was to inform the future development of targeted 
interventions for TPT. Specific thesis aims were to systematically synthesise current evidence in 
relation to terminology, clinical presentation and management of TPT (Part A) and to address 
current gaps in the literature in relation to diagnosis, and to explore the presentation of TPT using 
the ICF framework (Part B).  
The first study is a systematic review of randomised controlled trials investigating the efficacy of 
exercise management for TPT. Findings highlight the paucity of high-quality research for the 
conservative management of TPT, the lack of exercise prescription parameters reported in clinical 
trials and recommended that clinicians be guided by presenting impairments when prescribing 
exercise for TPT. Study 2 is a comprehensive review of selection criteria used in all primary 
research papers investigating the condition. The evidence led us to recommend that TPT is the 
preferred terminology when there are signs of local tendon dysfunction, with pain and/or swelling 
along the tendon and pain or difficulty with inversion or single leg heel raise the key clinical signs 
and symptoms.  
Studies 3 and 4 were systematic reviews and meta-analyses of existing literature. Study 3 quantified 
differences in clinical impairments, pain and disability between individuals with TPT and controls 
and investigated the relative magnitude of deficits in muscle function, foot posture and motion, pain 
and disability. Evidence of impaired tibialis posterior capacity and lower arch height in individuals 
with TPT was accompanied by self-reported stiffness, difficulties caused by foot problems and 
social restrictions. While there was strong evidence for lower arch height in TPT, studies stipulated 
requirements for arch height in TPT and control groups for eligibility and as such further research 
was warranted. Study 4 investigated kinematic characteristics at the foot and ankle in TPT by 
comparison to controls and found that individuals with TPT had significantly greater forefoot 
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abduction, calcaneal eversion and lowering of the medial longitudinal arch during the stance phase 
of gait.  
Three studies were designed to address the gaps identified in Part A and make a significant and 
substantial contribution to the current understanding of TPT. In Study 5, the diagnostic utility of the 
clinical signs identified in Study 1 was evaluated. Participants with medial foot/ankle pain 
underwent assessment of 4 clinical index tests and ultrasound assessment for the presence of grey 
scale changes in the tibialis posterior tendon. Overall, the ability of the evaluated clinical tests for 
TPT to predict grey scale changes in the tibialis posterior tendon on ultrasound was poor. Pain or 
inability to perform a single leg heel raise had the greatest diagnostic utility to detect grey scale 
changes. 
In Study 6, foot posture, mobility and single leg heel raise capacity were investigated in individuals 
with TPT and compared to individuals with medial foot/ankle pain that was not attributable to TPT 
and controls. Consistent with the findings from Study 5, the selection criteria for TPT were the 
presence of medial foot/ankle pain and pain or inability to perform a single leg heel raise. In an 
attempt to ascertain whether arch height is a key feature of TPT, no selection criteria regarding foot 
posture were used. This study highlighted that more pronated foot posture, and not arch height, and 
bilaterally impaired single leg heel raise capacity may be useful in distinguishing TPT from medial 
foot/ankle pain that is not attributable to TPT. Foot-related function and quality of life were similar 
for all participants with medial foot/ankle pain and were significantly impaired compared to 
controls. 
Study 7 was an investigation of the impact of TPT using the International Classification of 
Functioning framework in order to address and incorporate impairments, limitations, and 
restrictions of the condition in order to understand TPT from a biopsychosocial perspective. 
Impairments were not limited to the symptomatic foot and ankle; bilateral deficits in hip extensor 
torque and single leg heel raise endurance and limitations ascending and descending stairs were 
demonstrated in individuals with TPT compared to controls. Clinical impairments were 
accompanied by poorer self-reported function and quality of life, particularly relating to 
independent living, mental health and pain. These findings suggest a biopsychosocial approach 
should be considered for TPT. 
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 Introduction 
The thesis begins with a brief introductory chapter, outlining the impact and significance of foot 
problems, and specifically tibialis posterior tendinopathy (TPT). How the condition is 
conceptualised, uncertainties surrounding terminology for the condition and the problems with 
research and clinical practice historically focussing on local impairments during assessment and 
management are highlighted. The introduction recognises the importance of considering TPT 
beyond a purely biomedical model and evaluating the impact of the condition from a psychosocial 
perspective. Finally, the introductory chapter outlines the thesis aims and objectives, and the 
research plan.  
 Introduction, thesis aims and objectives 
1.1.1 Introduction 
Musculoskeletal conditions are highly prevalent in the general population and can have a significant 
and profound impact on those affected. Studies estimate that up to two thirds of individuals over the 
age of 50 report recent musculoskeletal pain 1 2 and contribute a significant cost directly to the 
health care system. 3 4 Indirect costs to the economy, largely due to reduced workplace productivity, 
5 far outweigh direct health care costs of reduced musculoskeletal health.  
Persistent pain, activity limitations and functional restrictions are the most common sequelae of 
musculoskeletal disorders. 6 The International Classification of Functioning, Disability and Health 
(ICF) framework describes health and health related components of well-being pertaining to body 
structure, function, activity and participation. 7 The ICF serves to describe the overall functioning 
and disability of an individual by considering impairments in body structure and function, activity 
limitations and participation restrictions, relationships between the three domains, and personal and 
environmental factors that interact with these components (Figure 1-1). 7 
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Figure 1-1 ICF framework 
Research has investigated relationships between body structure and function in musculoskeletal 
disorders and participation. It has been shown that physical and functional impairments often affect 
self-perceived quality of life and mental well-being and as such, musculoskeletal disorders have a 
significant effect on the psychosocial status of those experiencing pain and dysfunction. 8 9 
Musculoskeletal pain has been found to be associated with poorer general health and co-
morbidities, 10-12 depression, 13 14 and anxiety. 15 Integration of psychological and social factors with 
physical factors of musculoskeletal pain conditions (i.e. the biopsychosocial approach) can help 
understand the overall functioning and disability of an individual. 16 
Foot and ankle problems form a significant proportion of all musculoskeletal complaints, 17 
accounting for nearly 10% of all musculoskeletal consultations with general practitioners. 18 Foot 
pain has a significant impact on the lives of older adults in the community, and has been identified 
as a risk factor for decreased mobility, 19 balance deficits and increased falls risk 9 20-22 and 
difficulties with activities of daily living. 21 23 Considering the associated pain and functional 
limitations, foot problems impose a significant detriment on health-related quality of life.8 24 
Small sample sizes, low response rates and lack of consistent definitions for frequency, duration and 
location of pain make interpreting foot pain data difficult, yet some key factors have been found to 
be associated with the development of generalised foot pain. 25 The prevalence of foot pain 
Health condition 
(disorder or disease) 
Body structure and 
functions 
Participation Activity 
Environmental  
Factors 
Personal  
Factors 
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increases with age, particularly in women, with a peak incidence around 50 – 65 years. 26-28 Female 
sex, 26 28-30 obesity 8 28 30 31 and chronic diseases 30 31 have repeatedly shown to be related to the 
development of foot pain.  
Foot and ankle pain also constitutes a significant burden on the healthcare system; surgical 
intervention is frequently sought-after to correct foot deformity and relieve pain, particularly in 
individuals over 55 years of age. 32 An Australian audit (1997 – 2006) has shown the annual cost of 
foot and ankle surgery in 2006 exceeded $14 million in surgical fees. 32  
Foot and ankle problems are particularly prevalent in the general population with up to one in five 
people reporting foot problems. 25 Foot pain, aching and stiffness are the most common complaints. 
26 28 33 A systematic review on the population prevalence of foot and ankle pain in middle and old 
age adults provided pooled prevalence estimates of 15% and 22% for frequent ankle and foot pain 
respectively. 25 In community-dwelling older people, 70% of respondents with disabling foot pain 
reported forefoot pain and 46% reported pain in the arch area. 24 Common foot and ankle conditions 
affecting older adults include symptomatic foot osteoarthritis (approximately 12% of the population 
over 50 years of age), 34 hallux valgus (37.5% of elderly people over 65 years), 35 plantar fasciitis 
(3.2% of older adults in the Framingham Foot Study cohort), 36 tendinopathies including Achilles 
tendinopathy (1.85 per 1000 persons presenting to general practice) 37 and symptomatic flatfoot.  
The term “flatfoot” (or pes planus) is commonly used to describe feet with an absent or abnormally 
low arch, often in association with eversion of the rearfoot. 38 It is estimated that approximately 3-
25% of the adult population have pes planus world-wide. 39 Pes planus in the adult population can 
present as either flexible or rigid and may be congenital or acquired. The condition in which flatfoot 
is acquired in adulthood is termed “adult acquired flatfoot deformity” (AAFD). A wide spectrum of 
aetiologies have been proposed for adult acquired flatfoot including neuropathic, arthritic and 
traumatic causes, 40 41 however dysfunction of the tibialis posterior (TP) tendon remains the most 
common. 42 
Posterior tibial tendon dysfunction (PTTD) or an adult acquired flatfoot are the likely diagnoses for 
medial ankle pain and difficulties with activities that load the TP tendon. 43 44 The condition is most 
frequently reported among overweight, middle aged women, affecting up to 10% of elderly females. 
45-48 While the terms PTTD and AAFD may indicate pathology of vastly different structures, they 
are used interchangeably by clinicians and in the literature. 42 49 50 PTTD/AAFD is reported to occur 
along a spectrum and is theoretically divided into four progressive stages, with primarily tendon-
related signs and symptoms in the early stages, progressing to a flatfoot deformity with associated 
failure of soft tissue structures. 42  
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The first classification system was proposed by Johnson & Strom who described a three-stage 
classification system detailing the progression of tendon dysfunction and structural deformity, the 
key signs and symptoms and surgical treatment options for each stage (Table 1-1). 51   
Table 1-1 Johnson & Strom classification 51 
 Stage 1 Stage 2 Stage 3 
Tendon condition Peritendinitis and/or 
tendon degeneration 
Elongation Elongation 
Hind foot 
 
Mobile, normal 
alignment 
Mobile, valgus 
position 
Fixed, valgus 
position 
Pain Medial: focal, mild 
to moderate 
Medial: along 
tendon, moderate 
Medial: possibly 
lateral, moderate 
Single-heel-rise test Mild weakness Marked weakness Marked weakness 
“Too-many-toes’’ 
sign with forefoot 
abduction 
Normal  Positive Positive 
Pathology Synovial 
proliferation, 
degeneration 
Marked 
degeneration 
Marked 
degeneration 
Treatment Conservative, 3 
months; surgical, 3 
months with 
synovectomy, 
tendon debridement, 
rest 
Transfer to flexor 
digitorum longus for 
posterior tibial 
tendon 
Subtalar arthrodesis 
 
Since Johnson & Strom’s initial classification system, several authors have made amendments and 
sub-categories in each stage for more specific delineation of presenting signs and symptoms which 
are often used to guide management (Table 1-1 and Table 1-2). 
Table 1-2 Myerson classification 48 
Stage Characteristics Non-operative 
management 
Operative management 
Tenosynovitis Acute medial pain 
and swelling, can 
perform heel-rise, 
seronegative 
inflammation, 
extensive tearing 
Anti-inflammatory 
medication, 
immobilization for 
6-8 wks; if 
symptoms improve, 
ankle stirrup-brace; 
if symptoms do not 
Tenosynovectomy, 
tenosynovectomy + 
calcaneal osteotomy, or 
tenosynovectomy + 
tenodesis of flexor 
digitorum longus to 
posterior tibial tendon 
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improve, operative 
treatment 
Stage I Medial pain and 
swelling, hindfoot 
flexible, can perform 
heel-rise 
Medial heel-and-sole 
shoe wedge, hinged 
ankle-foot orthosis, 
orthotic arch-
supports 
Debridement of posterior 
tibial tendon, flexor 
digitorum longus transfer, 
or flexor digitorum longus 
transfer + calcaneal 
osteotomy 
Stage II Valgus angulation of 
heel, lateral pain, 
hindfoot flexible, 
cannot perform heel-
rise 
Medial heel-and-sole 
shoe wedge, stiff 
orthotic support, 
hinged ankle-foot 
orthosis, injection of 
steroids into the 
sinus tarsi 
Flexor digitorum longus 
transfer + calcaneal 
osteotomy or flexor 
digitorum longus transfer 
+ bone-block arthrodesis at 
calcaneocuboid joint 
Stage III Valgus angulation of 
heel, lateral pain, 
hindfoot rigid, 
cannot perform heel-
rise 
Rigid ankle-foot 
orthosis 
Triple arthrodesis 
Stage IV Hindfoot rigid, 
valgus angulation of 
talus 
Rigid ankle-foot 
orthosis 
Tibiotalocalcaneal 
arthrodesis 
 
These classification systems recommend surgical intervention for PTTD/AAFD if non-operative 
management is unsuccessful, even in the early stages of the condition. Surgical management has 
historically been the mainstay of intervention, 52 with little evidence to support the efficacy of this 
approach. Surgical techniques range from synovectomy and tendon debridement in the early stages 
53 54 to tendon transfer, osteotomy and arthrodesis in the later stages. 55 56 The majority of published 
literature investigating the efficacy of surgical intervention is level IV evidence, particularly 
retrospective case series, and no randomised control trials exist. Outcomes assessed following these 
invasive, costly procedures focus at the level of body structure (i.e. the correction of the structural 
deformity), 57 rather than activity or participation and therefore do not consider the overall 
functioning of the individual. Furthermore, complications following surgery for PTTD/AAFD have 
been found to be frequent and include infection, 58 non-union, 59 60 wound healing problems, deep 
vein thrombosis, 61 neurological trauma 62 and under or overcorrection. 42  
To facilitate best outcomes with non-operative approaches, it is vital that non-operative approaches 
are targeted and efficacious. This is of particular importance when surgical intervention is 
recommended after an unsuccessful trial of conservative management. 63 Early signs of 
PTTD/AAFD (i.e. medial pain and swelling, weakness with heel rise) 48 51 are consistent with 
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tendinopathy of the TP tendon. 64 This thesis pertains to the presentation of TP tendinopathy (TPT) 
and as such, TPT will be used, except where systematic reviews of the literature use PTTD/AAFD 
terminology. As the condition is progressive in nature, it is important that conservative management 
is trialled early in the continuum, when tendon signs and symptoms are the primary complaint (i.e. 
when there is TPT) 48 51 and before osseoligamentous involvement relegates surgical management 
the preferable option (i.e. degeneration of mid- and rear-foot joints and a rigid AAFD).  
With the aim of preventing progression of symptoms and delaying, or negating, the need for costly 
and invasive surgical intervention, early, effective management of TPT requires a thorough 
understanding of the presenting condition. A number of steps are required to inform development of 
effective management approaches for TPT. Evaluation of the diagnostic utility of the clinical signs 
used to identify TPT 48 51 may assist with early, accurate identification of the condition. There is 
also a need for a clear understanding of the overall presentation of TPT, including the key signs and 
symptoms, physical impairments (both local and widespread) and the impact of the condition on 
function and quality of life, so that appropriate outcomes can be used to evaluate management. 
1.1.2 Thesis aims and objectives  
The overall aim of this thesis is to characterize TPT with regard to terminology, diagnosis, physical 
impairments, pain and disability which could inform effective management programs. This aim will 
be completed by fulfilling the following objectives: 
1. Systematically evaluating the literature to determine the efficacy of current conservative 
management approaches for the condition 
2. Systematically reviewing the PTTD and AAFD literature with regard to selection criteria 
used for inclusion in research studies in order to synthesize and provide recommendations 
for future research, particularly the early stages  
3. Systematically reviewing the literature with regard to clinical impairments, kinematics, pain 
and disability, using meta-analysis where possible, to establish how individuals with TPT 
differ from controls 
4. Determining the diagnostic utility of clinical tests in diagnosing TPT identified on 
ultrasound scan 
5. Identifying clinical and psychosocial features that may characterise TPT and assist 
differential diagnosis amongst other causes of medial foot and ankle pain 
6. Characterizing physical impairments, quality of life, physical activity levels, pain and 
functional limitations associated with TPT by comparison to age and sex matched controls 
using the ICF framework 
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PART A:  
Understanding TPT from the literature 
 
This section is comprised of four systematic reviews, critically appraising and evaluating the 
current literature for TPT.  
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 Management of tibialis posterior tendinopathy 
 Exercise for posterior tibial tendon dysfunction: a systematic review of 
randomized clinical trials and clinical guidelines 65 
Classification systems for PTTD/AAFD recommend surgical intervention when conservative 
approaches are unsuccessful. Effective management in the early stages of the condition, when there 
is TPT, may prevent or delay progression and help to avoid costly and invasive surgical 
procedures. The aim of this chapter (Study 1) was to critically appraise and evaluate the efficacy of 
exercise management for TPT by systematically reviewing randomized controlled trials and is an 
adaptation of the published paper below (Appendix 2). While local strengthening exercises may 
provide some benefit for those with TPT, optimal prescription parameters are unknown. As such, 
when managing individuals presenting with TPT, clinicians should be guided by presenting 
impairments.  
Ross MH, Smith MD, Mellor R, Vicenzino B. Exercise for posterior tibial tendon dysfunction: a 
systematic review of randomised clinical trials and clinical guidelines. BMJ open sport & exercise 
medicine. 2018;4(1):e000430. 
Contributor Statement of contribution 
Megan H Ross (Candidate) Conception and design (50%) 
Analysis and interpretation (55%) 
Drafting and production (55%) 
Dr Michelle D Smith Conception and design (20%) 
Analysis and interpretation (15%) 
Drafting and production (15%) 
Dr Rebecca Mellor Conception and design (10%) 
Analysis and interpretation (15%) 
Drafting and production (15%) 
Professor Bill Vicenzino Conception and design (20%) 
Analysis and interpretation (15%) 
Drafting and production (15%) 
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2.1.1 Introduction  
TPT is prevalent, with estimates of prevalence ranging between 3.3 and 10%, 47 but suspected to be 
much higher, as the condition is often not formally diagnosed until the later stages. 47 TPT is 
disabling and characterised by impaired mobility, 66 poor function 67 68 and often a range of 
comorbidities including hypertension and diabetes and higher body mass index (BMI).43 67 69  
Decisions regarding management vary according to the stage of the pathology, 51 with reports of 
surgery predominating, probably due to the condition more commonly presenting in later and more 
severe stages. 70 Surgery aims to correct deformity in the later stages of the condition (i.e. stages III 
and IV) 55 71 72 and, relatively recently, to prevent soft tissue and joint destruction in earlier stages (I-
II) that do not respond to conservative management. 53 54 73-77 
Conservative management is utilized in earlier stages (I-II) with a focus on local strengthening 
exercises for the tibialis posterior musculotendinous unit and use of an orthosis to brace the foot. 78-
80 The level of evidence in support of this approach is currently unevaluated and is the basis of this 
systematic review. In evaluating the level of evidence it is important to also evaluate the quality of 
reporting of the exercise prescription parameters due to the potential influence variations in these 
parameters may have on the effectiveness of the treatment, 81 and clinical practice.  
The aim of this systematic review of randomised clinical trials (RCTs) was to provide estimates of 
treatment effects of local strengthening exercises compared to other forms of conservative 
management for adults with TPT on outcomes relating to the ICF framework (impairments, activity 
limitations and participation restrictions) and to evaluate the completeness of exercise prescription 
descriptors. 
2.1.2 Methods 
This systematic review was performed using a pre-determined protocol in accordance with the 
preferred reporting items for systematic review and meta-analysis (PRISMA) statement. 82 It was 
registered with PROSPERO (CRD42017076156) and is available from: 
http://www.crd.york.ac.uk/PROSPERO/display_record.php?ID=CRD42017076156.  
Search strategy and data sources 
To answer the research question about the treatment effects of local strengthening exercises for 
TPT, four electronic databases (CINAHL, Cochrane, Embase and PubMed) were searched from 
inception to June 2018 for full-text papers published in peer-reviewed journals. A comprehensive 
search strategy was developed to capture variations in terminology used in the literature for TPT 
and key conservative interventions (Table 2-1). No further limits were applied to the initial search 
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strategy. Reference list checks and author searches were also performed to ensure all relevant 
literature was identified. 
Table 2-1 Search strategy showing terms and how terms were combined 
Search Number Keyword/s 
1 ‘posterior tibial tendon dysfunction’ 
2 ‘adult acquired flatfoot’  
3 ‘adult-acquired flatfoot’ 
4 orthotics 
5 orthoses  
6 orthosis 
7 nonoperative 
8 non-operative 
9 nonsurgical  
10 non-surgical 
11 exercise 
12 stretching 
13 conservative  
14 #1 OR #2 OR #3 
15 #4 OR #5 or #6 OR #7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13 
16 #14 AND #15 
 
Eligibility criteria 
Eligibility criteria were determined prospectively using the PICO framework. 83 Trials were eligible 
for inclusion if they investigated individuals with TPT or adult acquired flatfoot deformity due to 
TPT, if they were randomised, and if local strengthening was compared to other forms of 
conservative management with respect to pain, function and/or physical impairment outcome 
measures. Diagnosis of TPT was required to be made based on a minimal list of diagnostic criteria, 
84 with two or more of: tenderness on palpation of the posterior tibial tendon, pain and/or swelling 
along the posterior tibial tendon, medial foot pain, difficulty and/or pain with single leg heel raise, 
and inability to invert the calcaneus on double leg heel raise. Flatfoot deformity was not considered 
as a selection criterion and as such, all stages of TPT were included.  
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Trials were excluded if they compared surgical interventions for TPT, did not include a comparator 
group, and combined data for individuals diagnosed with conditions other than TPT. Reviews, case 
studies and trials for paediatric flatfoot, asymptomatic flatfoot, neurological conditions and 
rheumatoid arthritis were also excluded.  
Study selection 
The lead reviewer (MHR) performed the search and exported all retrieved records into Endnote X7 
(Thompson Reuters, Carlsbad, California, USA). Duplicates were removed and titles and abstracts 
were screened independently by two reviewers (MHR and RM), based on established eligibility 
criteria. Full texts were retrieved for all potentially eligible papers and reviewed for inclusion and 
exclusion criteria. Where there were uncertainties, at least one additional author (MDS or BV) was 
consulted to determine final eligibility.  
Data extraction 
Data extraction for each included trial was completed by two investigators (MHR, RM) using a 
predetermined spreadsheet. Where reference was made to protocol papers or supplementary 
materials, these sources were obtained and used for data extraction. For each trial, study design, 
sample size, participant characteristics/demographics, diagnostic criteria, methods, intervention 
details (type, frequency, duration), outcomes, follow-up and results (means and standard deviations 
(SDs)) for each time point were extracted.  
As reporting of parameters of exercise prescription are essential for the implementation of research 
findings in exercise therapy, this data was also extracted. The ‘Template for Intervention 
Description and Replication’ (TIDieR) checklist 85 (developed to facilitate reporting and replication 
of intervention studies) and guidelines developed by Toigo and Boutellier 86 specifically for 
resistance exercise prescription provide a framework appropriate for the appraisal of exercise 
prescription in intervention studies for musculoskeletal conditions. 87 As such, specific parameters 
(% repetition maximum, repetitions, time under tension, etc) were extracted to allow for analysis of 
mechanobiological descriptors of exercise prescription. 86 Data for the 12-item TIDieR checklist 85 
were also independently extracted by two reviewers and the completeness of reporting was 
evaluated by allocating 1 point for complete items (clear, unambiguous descriptions allowing 
replication), and 0 for incomplete items (partial or no description) as per Holden (2017). 87 Total 
scores were calculated for each checklist and two authors (MDS and BV) verified all extracted data 
for accuracy.  
Risk of bias  
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Risk of bias was assessed as recommended by The Cochrane Collaboration’s tool for assessing risk 
of bias in randomised trials.83 The tool assesses six potential sources of bias under five domains 
(selection bias, performance bias, detection bias, attrition bias and reporting bias) and considers 
each as being either ‘low risk’, ‘high risk’ or ‘unclear risk’ of bias. Two independent reviewers 
(MHR and RM) rated included trials and results were collated and examined for discrepancies. 
Inter-rater disagreements were discussed and where a consensus could not be met were taken to a 
third party (BV or MDS).  
Statistical analyses / Data synthesis 
Analyses were performed in Review Manager (RevMan) V5.3 (Copenhagen: The Nordic Cochrane 
Centre, The Cochrane Collaboration). For continuous measures of pain, function and/or physical 
impairment, individual study effect sizes were expressed as standardised mean differences (SMDs) 
using means and SDs. The mean change scores from pre-intervention to post-intervention were 
compared between two independent participant groups (i.e. strengthening vs no strengthening; type 
of strengthening comparison). Change scores (mean and SD) for each group were calculated as 
post-score minus pre-score with within group correlation assumed to be 0.5 83 and were used to 
estimate the SD of the mean change using t-distributions.  
The difference between each group was considered significant where 95% confidence intervals 
(CIs) did not contain zero. For pain and self-reported outcome measures, higher scores indicated 
worse outcomes, and as such, the inverse of effect size was reported so that positive effect sizes 
indicated a beneficial effect for the intervention group. Improvements in strength and function 
measures were indicated by higher scores and positive effect sizes. The strength of the effect size 
was interpreted based on Hopkins, as follows; < 0.2 trivial effect, 0.2 - 0.6 small effect, 0.61 – 1.2 
medium effect, > 1.2-2.0 large effect and 2.0 – 4.0 extremely large effect. 88 
Inter-rater reliability of methodological quality was calculated in Stata v13 (College Station, TX: 
StataCorp LP) using the ĸ-statistic (95% CI). The reliability of the quality ratings between the two 
assessors was interpreted as ĸ <0.00 poor agreement; 0.00 – 0.20 slight agreement, 0.21 – 0.40 fair 
agreement, 0.41 – 0.60 moderate agreement, 0.61 – 0.80 substantial agreement and 0.81 to 1.00 
almost perfect agreement. 89 
2.1.3 Results 
Study selection and design  
The electronic database search retrieved 347 studies. After removing duplicates, 242 titles and 
abstracts were screened and 16 potentially eligible full text trials were assessed for eligibility 
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(Figure 2-1). Three randomized controlled trials were included in qualitative and quantitative 
synthesis.  
 
Figure 2-1 PRISMA flow chart for selected trials included for the systematic review 
 
Risk of bias 
The inter-rater reliability for the risk of bias assessment was almost perfect (agreement on 16/18 
ratings, ĸ = 0.857 (0.47 to 1)). Risk of bias was variable across the six items, with insufficient 
information available to permit a judgement for two of three trials on four items (random sequence 
generation, allocation concealment, blinding of participants and personnel, blinding of outcome 
assessment; Table 2-2). Considering attrition, two trials were deemed to have low risk of bias as 
reasons were provided for missing data (drop-outs) which were unrelated to outcomes of the 
intervention, and drop-outs were balanced across groups. The third trial had an imbalance of 
missing data across groups (2 (29%) vs 0 (0%)) for all outcomes and due to the already small 
sample size (n = 14), it is plausible this was large enough to induce clinically relevant bias. 
Selective reporting overall had a high risk of bias. Of the two trials in which a judgement could be 
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made, there were outcomes specified in the trial protocol that were omitted from the final analyses 
and manuscript.  
Table 2-2 Risk of bias table: review authors' judgements about each risk of bias item presented for 
each included study 
Bias Houck90 Jeong91 Kulig92 
Random sequence generation (selection bias) Low  Unclear  Unclear  
Allocation concealment (selection bias) High  Unclear  Unclear  
Blinding of participants and personnel (performance 
bias) High  Unclear  Unclear  
Blinding of outcome assessment (detection bias) Unclear  Unclear  Low  
Incomplete outcome data (attrition bias) Low  High  Low  
Selective reporting (reporting bias) High  Unclear  High  
 
Participant characteristics 
A total of 93 individuals with TPT were enrolled across all trials, with individual sample sizes 
ranging from 14 to 40 participants (5 to 19 per group) (Table 2-3). Studies enrolled participants 
with a mean age from 52.9 91 to 57.5 90 years and body mass index (BMI) between 23.3 91 and 30.5 
90 kg/m2. All studies had a predominance of women, with percentage of females ranging from 77.7 
90 92 to 100%. 91 Two trials 91 92 included individuals with stage I or II TPT and one trial 90 included 
those with only stage II TPT.  
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Table 2-3 Included studies 
 
 
 
      Intervention Group Comparator Group 
Study 
Number 
screened 
Number 
enrolled^ Intervention Comparator Stage n 
Age* 
years 
BMI* 
kg/m 
Female 
(%) n 
Age* 
years 
BMI* 
kg/m 
Female 
(%) 
Houck 90  88 39 Orthoses + stretching + 
isotonic strengthening 
Orthoses + 
stretching 
II 19 57 (2) 30 (6) 15 (78.9) 17 58 (9) 31 (5) 13 (76.5) 
Jeong 91 NR 14 Stretching + isotonic 
ankle strengthening + 
balance training 
No 
intervention 
I or 
II 
7 52.57 
(16.13) 
22.6 
(2.37) 
7 (100) 5 53.2 
(12.61) 
24.02 
(3.63) 
5 (100) 
Kulig 92  126 40 Orthoses + stretching + 
concentric strengthening 
Orthoses + 
stretching 
I or 
II 
12 55.3 
(16.4) 
32 
(9.24) 
10 (83.3) 12 51.3 
(17.2) 
28.7 
(6.26) 
8 (66.7) 
Kulig 92 126 40 Orthoses + stretching + 
eccentric strengthening 
Orthoses + 
stretching 
I or 
II 
12 49.4 
(12.6) 
28.5 
(7.09) 
10 (83.3) 12 51.3 
(17.2) 
28.7 
(6.26) 
8 (66.7) 
Key: * = mean (SD), NR = not reported, italics = same comparator group, ^ = pre-randomisation (includes drop-outs) 
16 
 
Selection criteria 
In all trials, diagnosis of TPT was established based on physical examination findings performed by 
either physical therapists or foot and ankle physicians. The number of essential/compulsory 
diagnostic criteria ranged between two and six with pain along the posterior tibial tendon, 
tenderness on palpation of the posterior tibial tendon, medial foot pain and a correctable flatfoot 
deformity most frequently utilised (Table 2-4). Imaging was not utilised in any trial to confirm 
diagnosis or exclude other potential sources of pain. Only one trial 92 reported a minimum duration 
of symptoms and one reported restrictions in function (able to walk >15m) and age (>40 years) 90 as 
study selection criteria. 
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Table 2-4 Selection criteria as stated in each study 
 
 
Trial 
Medial 
foot/ankle 
pain  
Pain 
PTT 
Swelling 
of PTT 
TOP 
PTT 
Correctable 
flatfoot 
deformity 
Foot 
flattening 
Abducted 
midfoot 
Duration 
of 
symptoms Imaging 
Other inclusion 
criteria 
Houck 90 NR Either NR √ NR NR NR NR 
Able to walk >15m 
>40 years of age 
Jeong 91 √ √ NR √ NR NR NR NR NR NR 
Kulig 92 √ NR NR √ √ √ √ >3 months NR NR 
Key: √ = essential eligibility criteria for the study, Either = one finding from this group of tests/clinical findings was required, NR = not 
reported 
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Outcome measures 
The trials included in this review reported a range of outcome measures relating to physical 
impairment, pain and function. Two studies 91 92 used a Visual Analogue Scale (VAS) to measure 
pain immediately post 5 minute walk test (5MWT). The same two studies 91 92 also reported 
distance ambulated (m) during the 5MWT. Houck 90 reported tibialis posterior muscle torque with 
combined plantar flexion and inversion, whereas Jeong 91 reported ankle strength and range of 
motion in dorsiflexion, plantar flexion, inversion and eversion. A total of three patient-reported 
outcome measures were utilised, with two trials 90 92 reporting the Foot Function Index (FFI). The 
FFI consists of three domains (pain, disability and activity limitations) which are summed to 
provide an overall total score. Houck 90 also utilised the Short Musculoskeletal Function 
Assessment (SMFA) which consists of mobility, dysfunction and bother indexes. Jeong 91 reported 
the American Orthopaedic Foot and Ankle Society (AOFAS) score which combines both patient 
self-report and clinician physical examination findings into one aggregate score. 93 Reassessment of 
outcomes varied from 6 weeks 90 91 to 12 weeks. 90 92 
Interventions 
The exercise intervention protocol varied in each of the included trials. Local tibialis posterior 
exercises were compared with foot orthoses and stretching in two trials,90 92 however the type of 
exercise (concentric, eccentric or isotonic) varied. Participants in the Kulig 92 trial were randomly 
assigned to either an eccentric or concentric exercise group (combined with stretching and orthoses) 
or a stretching and orthoses only group (3 groups in total). Houck 90 used an isotonic strengthening 
regime combined with stretching and orthoses compared to stretching and orthoses only. 
Participants in the Jeong 91 trial were randomised to receive either a isotonic ankle strengthening, 
stretching and balance program or no intervention.  
Completeness of reporting  
Completeness of intervention reporting based on the TIDieR checklist is provided in Table 2-5. Of 
the 12 items, Jeong 91 provided adequate information for 4 items, Houck 90 for 11 items and Kulig 92 
for all 12 items. Houck 90 and Kulig 92 both included sufficient information in regards to adherence 
(both the plan for assessment of adherence and reports of actual adherence).  
 
Table 2-5 TIDieR Checklist for included trials 
 Houck 90 Jeong 91 Kulig 92 
1 Intervention name Yes Yes Yes 
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2 Why (rationale) Yes No Yes 
3 What (materials) Yes Yes Yes 
4 What (procedures) Yes Yes Yes 
5 Who provided Yes No Yes 
6 How Yes No Yes 
7 Where No No Yes 
8 When and how much Yes Yes Yes 
9 Tailoring Yes No Yes 
10 Modifications Yes No Yes 
11 How well (planned) Yes No Yes 
12 How well (actual) Yes No Yes 
TOTAL 11 4 12 
 
No trial provided complete reporting of interventions based on the Toigio and Boutellier (2006) 86 
exercise prescription descriptors (Table 2-6). Of the 13 items, Jeong 91 provided adequate 
information for 5 items, Houck 90 for 7 items and Kulig 92 for 11 items. Of the six classical 
descriptors, only number of sets and repetitions of the exercises and duration of the experimental 
period over which exercises were performed were consistently described for all exercises in all 
trials (Table 2-6). Load magnitude (% repetition maximum) was only described in one trial. 92 Of 
the seven remaining mechanobiological descriptors, range of motion and an anatomical definition 
of the exercise was described in the methodology of two trials, 90 92 and time under tension was 
described in one trial. 92  
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Table 2-6 Exercise descriptors (from Toigio and Boutellier86) for included trials 
 
 Houck 
90 Jeong 91 Kulig 92 
Exercise descriptors BLHR 
Theraband 
ADD/INV 
in PF 
SLHR 
Theraband 
PF, DF, 
INV, EV 
(wk 1-6) 
Seated 
HR (wk 
1-2) 
BLHR 
(wk 3-
4, 5-6) 
SLHR 
(wk 5-
6) 
ADD in PF 
(concentric) 
ADD in 
PF 
(eccentric) 
1 Load magnitude BW 
Increasing 
resistance 
BW 
Red → 
Blue → 
Black 
Partial 
BW 
BW → 
loaded 
BW 15RM 15RM 
2 Number of repetitions 
10 → 
30 
10 → 30 
10 → 
30 
20 20 15 15 15 15 
3 Number of sets 2 → 3 2 → 3 2 → 3 4 4 3 3 3 3 
4 Rest in-between sets (s or 
min) 
NR NR NR 30s 30s 30s 30s 1-2 min 1-2 min 
5 Number of exercise 
interventions (per day or 
wk) 
2x/day 2x/day 2x/day NR NR NR NR 2x/day 2x/day 
6 Duration of experimental 
period (days or wks) 
12 wks 12 wks 12 wks 6 wks 6 wks 6 wks 6 wks 12 wks 12 wks 
7 Fractional/temporal 
distribution of the 
contraction per repetition 
and duration (s) of one 
repetition 
Isotonic Isotonic Isotonic Isotonic Isotonic Isotonic Isotonic Concentric Eccentric 
8 Rest in-between 
repetitions (s or min) 
NR NR NR NR NR NR NR NR NR 
9 Time under tension (s) NR NR NR NR NR NR NR 5s 5s 
10 Volitional muscular 
failure 
No Yes No NR NR NR NR No No 
11 Range of motion Full Full Full NR NR NR NR 
Neutral → 
EOR 
EOR → 
Neutral 
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12 Recovery time in-
between exercise sessions 
(hrs or days) 
NR NR NR NR NR NR NR NR NR 
13 Anatomical definition of 
the exercise (exercise form) 
described 
Yes Yes Yes No No No No Yes Yes 
TOTAL 7 4 11 
Abbreviations: BLHR; bilateral heel raise, ADD; adduction, INV; inversion,  PF; plantar flexion, SLHR; single leg heel raise, DF; 
dorsiflexion, INV; inversion, EV; eversion, HR; heel raise, wk; week,  BW; body weight, RM; repetition maximum, s; seconds, min; 
minutes, NR; not reported, EOR; end of range , hrs; hours 
Key: Items 1 – 6 = classical set of descriptors, Items 7 – 13 (shaded) = new set of descriptors 
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Main findings  
Physical impairments 
Isotonic ankle strengthening, balance and stretching improved ankle dorsiflexion range at six weeks 
beyond that of no intervention (SMD (95% CI) 1.71 (0.29 to 3.12)) (Figure 2-2). Plantar flexion 
inversion torque was not different at six weeks following isotonic tibialis posterior strengthening 
exercise combined with stretching and orthoses compared to stretching and orthoses alone (SMD 
(95% CI) 0.59( -0.08 to 1.26)) (Figure 2-2). Isotonic ankle strengthening, balance and stretching 
did not improve ankle torque in any direction at six weeks beyond that of no intervention (Figure 
2-2). Local strengthening was not superior to control comparator for any other physical impairment 
outcomes at six weeks (Figure 2-2).  
 
Figure 2-2 Standardised mean differences (95% CI) for outcomes at 6 weeks 
 
Neither concentric nor eccentric tibialis posterior strengthening exercises combined with stretching 
and orthoses were significantly different to control for the distance covered during the 5MWT at 12 
weeks (SMD (95% CI) 0.51 (-0.34 to 1.36) and 0.25 (-0.57 to 1.07) respectively), 92 nor were there 
differences between eccentric and concentric strengthening groups (SMD (95% CI) -0.39 (-1.22 to 
0.44))(Figure 2-3). There was no difference between isotonic tibialis posterior strengthening and 
-4 -2 0 2 4 6
Outcome Study Comparison SMD (95% CI)
5MWT - Distance (m) Jeong Isotonic ankle v Control 0.78 (-0.43, 1.98)
Tibialis posterior strength (N/kg) Houck Isotonic v Control 0.59 (-0.08, 1.26)
Dorsiflexion ROM (deg) Jeong Isotonic ankle v Control 1.71 (0.29, 3.13)
Plantar flexion ROM (deg) Jeong Isotonic ankle v Control 0.08 (-1.06, 1.23)
Inversion ROM (deg) Jeong Isotonic ankle v Control 0.91 (-0.32, 2.14)
Eversion ROM (deg) Jeong Isotonic ankle v Control 0 (-1.15, 1.15)
Dorsiflexion torque (% BW) Jeong Isotonic ankle v Control 1.07 (-0.19, 2.33)
Plantar flexion torque (% BW) Jeong Isotonic ankle v Control 1.14 (-0.13, 2.42)
Inversion torque (% BW) Jeong Isotonic ankle v Control 0.76 (-0.44, 1.97)
Eversion torque (% BW) Jeong Isotonic ankle v Control 0.75 (-0.46, 1.95)
Pain - VAS Jeong Isotonic ankle v Control 2.39 (0.75, 4.02)
FFI - Pain Houck Isotonic v Control 0.21 (-0.44, 0.87)
FFI - Activity Houck Isotonic v Control 0.3 (-0.35, 0.96)
FFI - Disability Houck Isotonic v Control 0.7 (0.03, 1.38)
FFI - Total Houck Isotonic v Control 0.48 (-0.19, 1.14)
SMFA - Mobility Houck Isotonic v Control 1.1 (0.4, 1.81)
SMFA - Dysfunction Houck Isotonic v Control 0.87 (0.18, 1.55)
SMFA - Bother Houck Isotonic v Control 0.2 (-0.45, 0.86)
AOFAS Jeong Isotonic ankle v Control -1.12 (2.39, 0.15)
Abbreviations: 5MWT; 5-minute walk test, m; metres, N/kg; Newtons per kilogram, ROM; range of motion, deg; degrees, BW; 
body weight, VAS; visual analogue scale, FFI; foot function index, SMFA; short musculoskeletal functional assessment
Favours 
strengthening
Favours no 
strengthening
SMD 
(95% CI)
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the control group for tibialis posterior strength (isometric combined plantar flexion and inversion) at 
12 weeks (SMD (95% CI) 0.59 (-0.08 to 1.26)) (Figure 2-3). 90 
 
Figure 2-3 Standardised mean differences (95% CI) for outcomes at 12 weeks 
 
Patient reported outcomes 
Isotonic ankle strengthening, balance and stretching reduced pain on a VAS scale beyond that of no 
intervention with a large, significant effect size at six weeks (SMD (95% CI) -2.39 (-4.02, -0.75)) 
(Figure 2-2). 91 Isotonic strengthening moderately reduced scores for the mobility and dysfunction 
subscales of the SMFA at six weeks (SMD (95% CI) -1.10 (-1.81 to -0.4) and -0.87 (-1.55 to -0.18) 
respectively)(Figure 2-2), but not 12 weeks (SMD (95% CI) 0.32 (-0.98 to 0.34) and -0.41 (-1.07 to 
0.26) respectively) (Figure 2-3). 90 There were no differences between local strengthening and 
control groups for mean change on the FFI subscales or total score at six weeks (Figure 2-2) or the 
SMFA bother subscale at six or 12 weeks (Figure 2-3). 90 
Eccentric strengthening combined with stretching and orthoses reduced mean scores for FFI-pain, 
FFI-disability and FFI-total beyond that of concentric strengthening, stretching and orthoses 
combined, and stretching and orthoses alone at 12 weeks with moderate effect sizes (SMD (95% 
CI) -1.1 (-1.97 to -0.23), -0.97 (-1.82 to -0.11) and -0.96 (1.81 to -0.1) respectively) and (SMD 
-2 -1 0 1 2
Outcome Study Comparison SMD (95% CI)
5MWT - Distance (m) Kulig Concentric v Control 0.51 (-0.34, 1.36)
Kulig Eccentric v Control 0.25 (-0.57, 1.07)
Kulig Eccentric v Concentric -0.39 (-1.22, 0.44)
Tibialis posterior strength (N/kg) Houck Isotonic v Control 0.59 (-0.08, 1.26)
Pain - VAS Kulig Concentric v Control 0.54 (-0.32, 1.39)
Kulig Eccentric v Control 0.56 (-0.28, 1.39)
Kulig Eccentric v Concentric 0.24 (-0.58, 1.06)
FFI - Pain Houck Isotonic v Control 0.12 (-0.54, 0.77)
Kulig Concentric v Control 0.28 (-0.52, 1.09)
Kulig Eccentric v Control 1.1 (0.23, 1.97)
Kulig Eccentric v Concentric 0.88 (0.03, 1.72)
FFI - Activity Houck Isotonic v Control 0 (-0.65, 0.65)
Kulig Concentric v Control -0.21 (-1.01, 0.59)
Kulig Eccentric v Control 0.07 (-0.73, 0.87)
Kulig Eccentric v Concentric 0.39 (-0.41, 1.2)
FFI - Disability Houck Isotonic v Control 0.19 (-0.47, 0.84)
Kulig Concentric v Control 0.14 (-0.67, 0.94)
Kulig Eccentric v Control 0.96 (0.11, 1.81)
Kulig Eccentric v Concentric 0.97 (0.11, 1.82)
FFI - Total Houck Isotonic v Control 0.08 (-0.58, 0.73)
Kulig Concentric v Control 0.09 (-0.71, 0.89)
Kulig Eccentric v Control 0.85 (0.01, 1.69)
Kulig Eccentric v Concentric 0.96 (0.1, 1.81)
SMFA - Mobility Houck Isotonic v Control 0.32 (-0.34, 0.98)
SMFA - Dysfunction Houck Isotonic v Control 0.41 (-0.26, 1.07)
SMFA - Bother Houck Isotonic v Control -0.17 (-0.82, 0.49)
Abbreviations: 5MWT; 5-minute walk test, m; metres, N/kg; Newtons per kilogram, ROM; range of motion, deg; degrees, BW; 
body weight, VAS; visual analogue scale, FFI; foot function index, SMFA; short musculoskeletal functional assessment
Favours 
strengthening
Favours no 
strengthening
SMD 
(95% CI)
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(95% CI) -1.1 (-1.97 to -0.23), -0.96 (-1.81 to -0.11) and -0.85 (-1.69 to -0.01) respectively) (Figure 
2-3). 92 Neither concentric nor isotonic tibialis posterior strengthening combined with stretching and 
orthoses were significantly different to stretching and orthoses alone for the 3 subscales of the FFI 
and FFI-total at 12 weeks (Figure 2-3). 90 92 
2.1.4 Discussion  
This systematic review evaluated pain and functional outcomes following local strengthening 
exercise in individuals with TPT. Two main findings emanate from this systematic review: the first 
is the lack of rigorous RCTs investigating the effects of non-surgical management on impairments, 
activity limitations and participation in adults with TPT and the second is that exercise parameters 
are poorly reported.  
Detailed reporting of exercise parameters for musculoskeletal interventions trialled in RCTs is 
essential for clinical replication and translation of research into practice. The implications of 
omitting important exercise parameters in reporting, however, extends beyond just clinical 
replication of exercise prescription. Exercise parameters such as time under tension, range of 
motion and rest or recovery time can be manipulated and are expected to influence both 
physiological response to and efficacy of the exercise prescription, 81 86 meaning that slight 
variations in prescription parameters may have vastly different physiological effects. Factors related 
to biophysical response to exercise were not sufficiently described in the included studies and 
strengthening interventions failed to improve strength related outcome measures at both 6 and 12 
weeks. Lack of detailed reporting becomes an important matter when a primary goal in 
rehabilitation of tendinopathies is to improve the load management capacity of the 
musculotendinous unit. 94 
Current literature implicates appropriate load management as the most important component of 
rehabilitation for tendinopathies. 94-96 The benefit of therapeutic exercise in the management of 
lateral epicondylalgia and Achilles, patellar and rotator cuff tendinopathies has been established in 
previous systematic reviews. 97-100 While early literature has focussed on eccentric exercise for 
tendinopathies, 101-103 more recent approaches with good efficacy include patient education on load 
management strategies and individualised, progressive loading exercises. 104 Overall, effect sizes 
from this systematic review provide limited evidence to suggest that isotonic tibialis posterior 
strengthening, stretching and orthoses and general isotonic ankle strengthening, balance and 
stretching exercises similarly improve pain, mobility and dysfunction in TPT in the short term 
compared to no strengthening. Considering the specific type of strengthening protocol, data from 
this review suggests that eccentric strengthening may be marginally more effective than other types 
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of strengthening; with eccentric but not concentric exercise resulting in significant reductions in 
self-reported pain, disability and overall foot function compared to controls at 12 weeks. 
The mechanism of effect for improved outcomes in tendinopathy following strengthening exercise 
is understood to be related to load. It has been suggested that the load through the tendon during 
therapeutic exercises needs to be sufficiently high enough to elicit physiological changes within the 
tendon. While relationships between internal tendon structure and pain and function are currently 
unclear,96 heavy-slow resistance appears to be beneficial in managing Achilles and patellar 
tendinopathies.105 It has been suggested that the physiological response to therapeutic exercise may 
be greater with heavy-slow resistance and eccentric strengthening due to higher loads applied 
through the tendon during these exercises. The device used for strengthening exercise in the study 
by Kulig allowed for quantification of load and constant resistance throughout the exercise. 92 
Participants in the eccentric exercise group in their clinical trial achieved loads 3.3 times higher 
than those in the concentric group by the end of the 12 week intervention. 92 This raised the 
possibility that differences in outcomes were dependent on load rather than specific contraction 
type. Tolerance and ability to perform the exercise with good form were criteria for progressing 
load, which suggests that participants in the eccentric group were better able to tolerate higher loads 
during the exercise program, optimising tendon response, and leading to the reporting of greater 
improvements in pain, disability and overall foot function. Physical tests of function (distance 
covered during 5MWT) however, were not different between groups. This suggests that while 
participants felt more confident loading their tendon, physical capacity of the tendon might not have 
improved.  
Exercise prescription parameters can be manipulated depending on the desired physiological 
response to exercise stimulus for example, to improve skeletal muscle strength, endurance or power. 
Each of the three trials indicated that the intention of the prescribed exercises was to improve 
strength. On further examination of the exercise prescription parameters (Table 2-6) in reference to 
the current American College of Sports Medicine (ACSM) guidelines for muscular strength, 106 
some discrepancies were apparent. Considering load magnitude, the ACSM guidelines for strength 
recommend up to 12 repetition maximum, where Kulig 92 prescribed 15, fitting the ACSM 
guidelines for muscular endurance. 106 Similarly, papers prescribed between 15 and 30 repetitions 
which is above the recommendations for inducing strength adaptations (8-12) and falls into the 
recommended repetitions for improving muscular endurance. 106  
Adherence should be considered in calculating the exercise stimulus (load) actually delivered to the 
musculotendinous unit and any strength gains accrued. Adherence was not reported in Jeong, 91 but 
ranged between 29% to 126% (average 79%) in Houck 90 and 39% to 98% (average = 68%) in 
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Kulig. 92 Considering this, it is possible the actual load participants performed was not high enough 
to elicit adaptations in skeletal muscle that would subsequently result in clinical improvements in 
strength (Houck) or physical tests of function (Kulig). Houck (2015) examined tibialis posterior 
force production in plantar flexion and forefoot adduction at baseline and 6 and 12 weeks following 
isotonic tibialis posterior exercises against the heaviest Theraband® resistance that could be 
tolerated, in addition to bilateral and unilateral heel raises. 90 The strengthening group did not 
exhibit increases in tibialis posterior strength at 6 or 12 weeks which suggests that while the 
intention of the prescribed exercise program was to increase strength, with poor adherence taken 
into consideration, actual load may not have been appropriate to elicit changes in musculotendinous 
strength.  
It was common among included trials for the intervention protocol to include co-interventions such 
as stretching and orthoses in addition to specific local strengthening exercises. It is possible that the 
effect of the local strengthening intervention was affected by these co-interventions. As no 
randomised trial has looked at local strengthening in isolation (i.e. not combined with 
stretching/orthoses or balance and stretching exercises), it is difficult to ascertain to what degree 
improvements can be attributed to targeted exercises only. Two trials that investigated stretching, 
orthoses and local strengthening compared to stretching and orthoses alone showed similar 
improvement in pain and function in all groups. It is possible that orthoses and/or stretching play a 
role in reduction of pain. Future research is required to investigate strength interventions in isolation 
of other treatments to establish its efficacy in the management of TPT.  
Interestingly, stretching exercises were included in all intervention groups across the three included 
trials. Both gastrocnemius and soleus stretches were prescribed for 3-10 repetitions of 30 second 
duration, 2-4 times per day. This stretch is performed in maximal dorsiflexion, which increases the 
compressive as well as the tensile load on the posterior tibial tendon posterior to the medial 
malleolus, 107 the combination of which has been found to be most damaging to the tendon. 108 Load 
management for pain relief in tendinopathy rehabilitation is two-fold, incorporating the reduction of 
both compressive and tensile loads. 109 So while foot orthoses and activity modification may aid in 
altering tensile loads (supporting the medial longitudinal arch and reducing the torque required from 
the tibialis posterior during activities), accompanying these interventions with static stretches in full 
dorsiflexion may be counterproductive to pain management and rehabilitation.  
Pain with palpation, pain on tendon loading and impaired function are key features in the clinical 
presentation of tendinopathies. 110-113 Pain and difficulty during activities that load the medial aspect 
of the foot and the posterior tibial tendon, such as the single leg heel raise, are key clinical features 
of TPT. Results from this systematic review have highlighted that interventions that aim to modify 
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the load through the tendon and foot locally (i.e. via tibialis posterior strengthening and/or arch 
supporting devices such as foot orthoses) have limited ability to improve pain and functional 
outcomes in TPT. As such, alternative means of modifying load to improve clinical outcomes 
warrant further investigation. Hip function can affect motion at the foot during gait 114-116 and weak 
hip external rotators and abductors have been associated with increased femoral internal rotation 117 
118 and adduction, 119 increased knee valgus, 118 120 tibial internal rotation 120-122 and subtalar joint 
pronation, 121 123 which may impact on tibialis posterior. Increased rearfoot eversion 124-128 and hip 
abduction strength 66 deficits have been demonstrated in TPT, which suggests that some proximal 
changes may be evident in the condition. Further research investigating proximal muscle function 
and kinematics in TPT would provide further support for interventions targeting proximal hip motor 
control and strength.  
Limitations 
While this is the first systematic review to investigate the efficacy of exercise as a treatment for 
TPT, there are several limitations that must be acknowledged. The small number and variability of 
interventions and outcomes of included studies did not allow meta-analysis or pooling of results. 
Meta-analysis was prevented due to variability in selection criteria, methodological quality, 
interventions and outcome measures assessed among the three included studies. Small sample sizes 
of individual studies can influence the ability to detect true effects. With very few outcomes 
replicated between studies, meta-analysis was prohibited and effect sizes presented in this review 
should be interpreted with this in mind. These aspects of the literature limits the inferences that 
might be drawn from the findings. Notwithstanding, this review is a synthesis of all available 
evidence from randomised controlled trials relating to exercise management for TPT and 
highlighted the dearth of evidence on which to guide management. It must be acknowledged that 
studies included in this review related to stage I and/or II TPT only. This is an important 
consideration in terms of the clinical application of findings and the generalizability of results, 
given that patient presentation may vary as the condition progresses.  
2.1.5 Conclusion  
This is the first systematic review on exercise therapy for TPT. Based on the limited available 
literature, it appears that local strengthening exercises provide some benefit in TPT, and eccentric 
exercises may be superior for improving pain, disability and self-reported overall foot function than 
concentric exercises and foot orthoses and stretching alone. No recommendations can currently be 
made regarding optimal exercise prescription based on published clinical trials. Clinicians should be 
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guided by presenting impairments to prescribe exercise, which holds some promise in managing 
TPT.  
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 Clinical features of tibialis posterior tendinopathy 
 Reported selection criteria for adult acquired flatfoot deformity and 
posterior tibial tendon dysfunction: are they one and the same? A 
systematic review 84 
Findings from Chapter two suggest that clinicians should be guided by presenting impairments 
when prescribing exercise for TPT. In order to investigate the presentation of TPT, it is important 
to understand the selection criteria for TPT. This chapter is adapted from systematic synthesis of 
the selection criteria used in the literature for TPT and AAFD (Appendix 3). The term posterior 
tibial tendon dysfunction (PTTD) is used instead of TPT throughout this chapter to be consistent 
with terminology used in each original research article. Only 35% of papers investigating either 
PTTD or AAFD stated condition-specific inclusion or selection criteria. Of those that stated 
selection criteria, the majority required signs of both tendon dysfunction and structural deformity 
(84% for AAFD and 81% for PTTD). This systematic review also provided recommendations for 
the future use of terminology for the two conditions, and more specifically, recommended selection 
criteria for TPT (stage one and two PTTD) and AAFD.  
Ross MH, Smith MD, Vicenzino B. Reported selection criteria for adult acquired flatfoot deformity 
and posterior tibial tendon dysfunction: Are they one and the same? A systematic review. PLoS One 
2017;12(12):e0187201. doi: 10.1371/journal.pone.0187201 
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3.1.1 Introduction 
Presentation of a progressively flat foot with medial ankle pain is likely to be diagnosed as a PTTD 
or AAFD. 43 44 These terms seem to be used interchangeably in the literature, 42 49 50 even though 
they suggest possible dysfunction of different structures. The evolution of the terminology used for 
this condition began with emphasizing the tendon pathology; PTTD 46 51 129 and increasingly over 
recent times the focus has shifted to the foot deformity; AAFD. The characteristic flat foot 
deformity, and the notion that PTTD does not adequately describe the ligamentous failure and 
resultant joint destruction that ultimately occurs, 49 130 are possible reasons for the adoption of 
AAFD terminology. The problem with using the term AAFD is that in addition to being a result of 
PTTD, 46 131 it also results from other aetiologies, such as traumatic (injury to ligament or tendon), 
degenerative, arthritic and neuromuscular conditions. 40 41 45 132 This situation is potentially 
problematic in both clinical practice and research, because AAFD may not adequately represent the 
underlying pathology and consequently the diagnosis. One of the problems with this is that 
management decisions are likely to differ according to the diagnosis. This review will 
systematically synthesise the key signs and symptoms of PTTD and AAFD from the literature to 
ascertain if there is a difference in diagnostic criteria related to nomenclature and provide 
recommendations for selection criteria to be used in future research.  
3.1.2 Methods 
A systematic review of the literature reporting work on PTTD and AAFD was undertaken to test the 
hypothesis that there would be overlapping terminology for selection criteria used by investigators 
in PTTD and AAFD literature.  
Search strategy  
Electronic databases (CINAHL, Cochrane, Embase, PubMed and Web of Science) were 
comprehensively searched by one reviewer (MR) for all years available up to and including June 13 
2016. The search strategy was developed in consultation with an experienced academic librarian 
and was undertaken using a combination of keywords and MeSH terms. Keywords used in the 
search strategy aimed to capture all past and present variations in terminology for the condition: 
Flatfoot OR (posterior AND tibia* AND (tendon* OR tendin*)) OR “pes planus” OR “pes 
planovalgus”. No restrictions or second string limitations were used to further narrow the search. 
All search results were imported in Endnote X7 (Thompson Reuters, Philadelphia, PA, USA) and 
duplicates were removed.  This systematic review followed the Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses (PRISMA) guidelines and it was registered at 
http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42016046943. 
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Selection criteria 
Articles were included if they investigated PTTD or AAFD and clearly defined diagnostic or 
inclusion criteria. Articles were excluded if they did not investigate PTTD or AAFD, and did not 
detail specific inclusion or diagnostic criteria (i.e. reported that diagnosis was only made by a 
specified health professional or was only based on a PTTD or AAFD classification system without 
detailing specific clinical signs or symptoms). Asymptomatic flatfoot conditions were not 
considered for this review. Non-English publications, clinical reviews/narratives or single case 
reports, as well as paediatric, animal and cadaveric studies were also excluded. Assessment of study 
eligibility was performed by one investigator (MR) and uncertainties were resolved by two other 
reviewers (BV and MS).  
Data extraction and synthesis 
A custom data extraction table was developed. One reviewer (MR) extracted data from all included 
studies including condition (PTTD or AAFD), stage of condition (I – IV; based on classification 
systems) and individual inclusion or diagnostic criteria specified in the article. Studies included in 
this review staged the condition using the Johnson & Strom, 51 Myerson 48 and Bluman 133 
classification systems. The Johnson & Strom and Myerson classification systems are the same and 
hence forth referred to as the former. It consists of 4 progressive stages 48 51 defined as follows: I) 
tenosynovitis and mild to moderate pain and tenderness of the tibialis posterior tendon, with no 
signs of foot deformity; II) degeneration and elongation of the tendon and flexible hindfoot eversion 
with forefoot abduction; III) rigid hindfoot eversion with forefoot abduction; IV) the same as III) 
with valgus angulation of the talus and degeneration of the tibiotalar joint. 48 The classification 
system defined by Bluman maintains the existing outline of Johnson & Strom, except each stage is 
divided into sub-categories, which include reference to radiographic findings and more refined 
delineation of presenting signs and symptoms. 133 For example, Bluman’s Stage IIB refers to 
talonavicular uncovering on radiographs, as well as flexible hindfoot eversion with forefoot 
abduction. 133 In this review the specific classification system used in each paper is indicated by the 
format used (i.e IIB indicates Bluman classification system was used, whereas II indicates Johnson 
& Strom was used).  
All criteria presented in individual papers were initially recorded using the exact terminology from 
the study (Table 3-1) and then reduced to key terms for reporting (e.g., hindfoot valgus was used as 
a key term to represent heel valgus, calcaneal valgus, hindfoot eversion). These key terms formed 
the aggregate list of diagnostic/inclusion criteria against which all included studies were scored.  
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We sought to represent criteria used in each paper by categorising them as either being compulsory 
(mandatory signs or symptoms required for diagnosis or inclusion) or optional (one of a number of 
possible signs or symptoms required for diagnosis or inclusion). When signs and symptoms were 
listed with the conjunction “and”, all criteria were considered to be compulsory. Where criteria 
were listed with “or” as the conjunction, or “at least one of” preceding the criteria, each criteria was 
considered to be optional, but the group of optional criteria (with ‘or’ ‘at least one of’ operand) was 
considered as one compulsory criterion. The total number of criteria for each description of 
diagnostic/inclusion criteria was the total number of compulsory (single or grouped optional) 
criteria. 
Table 3-1 Classification table collapsed terms 
Headings Terms used in study inclusion and diagnostic criteria 
Pain along PTT Pain over the tendon 
Pain medial ankle/foot Posteromedial ankle pain, medial hindfoot pain, pain on medial 
aspect of arch of the foot, medial ankle pain 
Tender on palpation PTT Palpable tenderness, tenderness over the tendon, pain on palpation 
of the TP tendon, tenderness along TP tendon, tenderness to 
palpation, pain reproduced on palpation of the TP tendon 
Pain with resisted inversion - 
Pain with SLHR Pain with unilateral heel rise, pain when rising onto toes while 
weightbearing 
Swelling along PTT Localized oedema, swelling over the tendon, local swelling, 
swelling along the course of TP tendon, swelling over tendon 
sheath, enlargement over the TP tendon 
Swelling medial ankle/foot Medial hindfoot swelling, swelling posteromedial aspect of ankle, 
swelling on medial aspect of arch of the foot, enlargement of the 
medial retromalleolar region 
Inversion strength deficit Weakened inversion force, weakness of TP, positive resistance test 
results, reduced or absent power of inversion, clinical strength 
deficit when tested with the foot in inversion and plantar flexion, 
weak strength upon supination on manual testing, inability to bring 
the foot across the midline from an abducted position, diminished 
TP power  
Difficulty with SLHR Inability to perform SLHR, lack of active hindfoot inversion 
during SLHR, inability to do single-limb toe raises, difficulty 
lifting one foot 
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Decreased walking ability Difficulty ambulating, decreased ability to walk any distance, 
reduced walking distance 
Flatfoot deformity Acquired flatfoot deformity, planovalgus deformity, pes 
planovalgus 
Hindfoot valgus Heel valgus, rearfoot abduction, calcaneal valgus, hindfoot 
eversion, valgus angulation of the heel 
Medial arch collapse Flattening of medial longitudinal arch, midfoot collapse, loss of 
height in the arch, loss of longitudinal arch, loss in medial arch 
contour, arch collapse, flattened midfoot posture, fallen medial 
longitudinal arch 
Forefoot abduction  Too many toes sign, varus forefoot, first metatarsal abduction, 
lateral deviation of the forefoot 
Midfoot abduction Abduction at the transverse tarsal joint, abducted midfoot posture 
Forefoot supination  - 
Flexible deformity Passively correctable deformity, flatfoot deformity with a mobile 
hindfoot, hindfoot valgus passively correctable, flexible pes 
planovalgus, manually correctable valgus deformity, non-fixed 
hindfoot valgus deformity, supple deformity, absence of rigid foot 
deformity, mobile mid- and hind-foot 
Talar head prominence - 
 
3.1.3 Results 
The electronic database search yielded a total of 13 526 records. Figure 3-1 outlines studies 
excluded at each stage of the selection process. After screening of title and abstract of all retrieved 
articles, 354 full text articles investigating either PTTD or AAFD were examined for final inclusion. 
Following this final full text screening, 80 articles met all inclusion criteria and were included in the 
review. Diagnostic or inclusion criteria for PTTD or AAFD were specified 82 times in 80 papers 
(Table 3-2). One article (Kohls-Gatzoulis, 2009) detailed diagnostic criteria for stage I PTTD, stage 
II PTTD and AAFD. Sixty-nine of the 82 definitions in the articles were for PTTD and the 
remaining 13 defined AAFD.  
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Figure 3-1 Flow chart of study selection process 
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Initial database search strategy  
n = 13 526 
Duplicates excluded 
n = 6504 
Title and abstracts screened  
n = 7022 
Full text assessed for eligibility  
n = 354 
Records excluded based on title 
and abstract n = 6668 
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Not specifying criteria = 148 
• Use of specialist/surgeon 
diagnosis only = 121 
• Use of classification system only  
= 24 
• Use of imaging only = 3  
Not condition = 43 
Not primary research = 40 
Not English = 28 
Cadaver study = 10 
Paediatric flatfoot = 1  
Number included in review  
n = 80 
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Table 3-2 Selection criteria for posterior tibial tendon dysfunction (PTTD) and adult acquired flatfoot deformity (AAFD) for included studies.  
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PTTD 
Teasdall 77 1994 I   1 1      1           3 
Crates 53 1999 I    1   1         1     3 
Perry 134 2003 I    1 1 1             1  4 
Sharma 54 2003 I   1     1  1           3 
Rosenfeld 135 2005 I    1     1    1   1   1  5 
Cooper 136 2007 I 1     1              2 
Kohls-Gatzoulis 47 2009 I     1    1 1           4 
Rabbito 126 2011 I   1 1    1             3 
Chow 137 2015 I 1     1  1 1           4 
Hua 138 2015 I   1 1 1    1            4 
Chen 139 1997 II   1 1  1  1             4 
Hintermann 140 1999 II   1      1 1   1 1 1 1 1  1  9 
Toolan 141 1999 II   1      1     1  1   1  5 
Conti 60 2002 II   1      1 1 1 1 1 1 1   1  9 
Fayazi 142 2002 II   1      1  1 1 1 1 1   1  8 
Wacker 143 2002 II   1     1 1 1   1   1   1  7 
Viladot 144 2003 II   1       1   1   1   1  5 
Wacker 145 2003 II   1     1 1 1   1   1   1  7 
Brodsky 146 2004 II 1  1   1  1 1           5 
Myerson 147 2004 II 1  1     1 1    1  1 1  1  8 
Valderrabano 148 2004 II   1      1 1 1 1 1 1 1   1  9 
Needleman 149 2006 II        1    1      1  3 
Tome 127 2006 II                   1  3 
Knupp 150 2007 II   1      1 1 1  1    1 1  7 
Migues 151 2007 II 1  1      1    1  1 1 1 1  8 
Neville 68 2007 II                  1  3 
Houck 152 2008 II                   1  3 
Krause 153 2008 II 1   1     1   1   1   1  6 
Wukich 154 2008 II         1   1        2 
Brodsky 155 2009 II         1     1     1  3 
Houck 124 2009a II                   1  3 
Houck 156 2009b II                   1  3 
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Kohls-Gatzoulis 47 2009 II         1 1 1  1 1 1   1  7 
Neville 157 2009 II                  1  3 
Giorgini 158 2010 II 1   1 1    1    1 1 1   1 1 9 
Neville 125 2010 II                  1  3 
Parsons 159 2010 II   1      1 1   1      1  5 
Imai 160 2011 II                         5 
Brilhault 161 2012 II 1       1    1        3 
Kou 162 2012 II 1        1   1 1  1 1  1  7 
Neville 163 2012 II                   1  3 
Niki 164 2012 II   1     1 1 1   1   1   1  7 
Neville 165 2013 II                   1  3 
Chadwick 166 2015 II   1    1  1 1   1   1   1  7 
Houck 90 2015 II             1      1  3 
Neville 167 2016 II                   1  3 
Yoshioka 168 2016 II                 1   1           1   4 
Silva 169 2015 IIB   1       1   1   1   1  5 
Kulig 92 2009 I-II   1 1          1 1 1 1  1  7 
Kulig 78 2009 I-II   1 1     1            3 
Kulig 66 2011 I-II  1 1           1  1  1  5 
Kulig 170 2015 I-II  1 1           1  1  1  5 
Weil 171 1998 II-III 1  1 1 1 1  1    1   1   1  9 
DiDomenico 172 2011 II-III   1      1 1   1 1  1   1  7 
Funk 46 1986 NR    1  1    1      1     4 
Chao 173 1996 NR 1     1  1 1           4 
Groshar 174 1997 NR 1  1   1  1    1  1      6 
Hsu 175 1997 NR    1      1    1 1 1     5 
Kitaoka 176 1997 NR    1     1 1   1 1 1 1 1  1  9 
Lim 177 1997 NR 1 1       1   1   1     5 
Stroud 178 2000 NR   1     1  1   1        4 
Augustin 80 2003 NR      1    1    1  1     4 
Kohls-Gatzoulis 70 2004 NR         1 1    1 1 1     5 
Alvarez 79 2006 NR    1   1  1 1           4 
Bulstra 179 2006 NR   1 1 1  1              4 
Satomi 180 2008 NR  1     1     1 1 1 1     6 
Sanhudo 181 2014 NR 1 1                  3 
Arnoldner 182 2015 NR 1     1      1        3 
Lin 183 2015 NR 1 1          1        3 
AAFD 
Chimenti 67 2014 II                  1  3 
Spratley 184 2014 IIB         1    1 1 1   1  5 
Bolt 185 2007 I-II             1 1 1 1 1  1  6 
Jeng 186 2011 IV         1 1    1 1      4 
Harper 187 1999 NR   1           1  1     3 
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Thomas 59 2001 NR   1   1   1    1 1 1 1   1  8 
Greisberg 188 2003 NR   1          1        2 
Kang 189 2003 NR 1  1  1    1    1 1 1     7 
Greisberg 190 2005 NR   1          1        2 
Arangio 191 2006 NR          1    1 1 1  1   5 
Arangio 192 2006 NR               1 1     2 
Arangio 193 2009 NR   1       1    1 1 1  1   6 
Kohls-Gatzoulis 47 2009 NR              1 1 1     3 
 
Legend: Black cells represent compulsory criteria and white cells represent not applicable to the individual article. Dark grey is a group of criteria 
relating to tendon dysfunction and light grey is a group of criteria relating to structural deformity where individual criteria in shaded boxes are 
optional and at least one from the group is compulsory. 
Abbreviations: PTT: posterior tibial tendon; TOP: tender on palpation; res.: resisted; INV: inversion; SLHR: single leg heel raise; dec.: decreased; 
FF: forefoot; def.: deformity; HF: hindfoot; ABD: abduction; MF: midfoot; SUP: supination; Flex: flexible; NR: not reported.
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Twenty-four articles (24/82; 29.3%) did not report which stage of the condition the paper 
investigated (9 AAFD, 13 PTTD). Two articles (2/58; 3.4%) used Bluman’s classification system (1 
AAFD, 1 PTTD) and the remaining 56 (56/58; 96.6%) used the Johnson and Strom classification. 
Of the 58 that did report stage of condition, 65.5% (38/58 articles) investigated stage II (1 AAFD, 
37 PTTD). All articles investigating stage I dysfunction looked at PTTD (10/58; 17.2%). The 
remaining articles investigated stage I-II (5/58; 8.6%; 1 AAFD, 4 PTTD), IIB (2/58; 3.4%; 1 
AAFD, 1 PTTD), II-III (2/58; 3.4%; 2 PTTD) and stage IV (1/58; 1.7%; 1 AAFD).  
After collapsing variations in terminology (Table 3-1), a total of 18 criteria were extracted from the 
80 individual papers. The criteria were separated into two main groups; those pertaining to tendon 
dysfunction (10 criteria) and those relating to structural deformity (8 criteria). Those relating to 
dysfunction of the tibialis posterior tendon were further categorised into symptoms of pain and 
swelling (7 criteria), and signs of deficits in strength or function (3 criteria). Pain was delineated 
based on location (i.e. along the posterior tibial tendon and/or medial ankle/foot) and provocating 
activity (i.e. tenderness on palpation, with resisted inversion and/or with single leg heel raise). 
Swelling was also separated into two categories based on location (i.e. along the posterior tibial 
tendon or the medial ankle/foot). The three criteria relating to strength or functional deficit were 
resisted inversion strength deficit, difficulty with single leg heel raise, and compromised walking 
ability. The eight criteria for foot posture and structural deformity were: flatfoot deformity, hindfoot 
valgus, medial arch collapse, forefoot abduction, midfoot abduction, forefoot supination, a flexible 
deformity, and talar head prominence.  
Individual studies reported between 2 (5/82; 6.1%) and 9 (6/82; 7.32%) compulsory criteria for the 
diagnosis of PTTD or AAFD. The most frequently occurring number of compulsory criteria in any 
paper was 3 (25 articles; 30.49%), but specific criteria differed between articles.  
The papers that referred to PTTD contained 69 diagnostic/inclusion criteria in 68 articles, with one 
paper (Kohls-Gatzoulis, 2009) describing criteria for both stage I and II PTTD separately (Table 
3-3). Thirteen PTTD articles (18.8%) required symptoms of tendon dysfunction but not structural 
deformity; whereas, 56 articles (81.2%) required signs of both tendon dysfunction and structural 
deformity. Considering all listed signs and symptoms (n = 382), a flexible deformity (41; 10.7%), 
forefoot abduction (41; 10.7%) and difficulty with single leg heel raise (39; 10.2%) were the most 
frequently reported criteria (optional and compulsory) required for the diagnosis of PTTD. 
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Table 3-3 Frequency of criteria for diagnosis of PTTD and AAFD based on tendon symptoms, 
structural deformity and a combination of both.  
 
Tendon Structure Both Total 
AAFD 0 2 11 13 
PTTD 13 0 56 69 
Total 13 2 67 82 
 
Thirteen papers describe diagnostic criteria for AAFD (Table 3-3). Eleven articles (84.6%) required 
both signs of tendon dysfunction and structural deformity. Two (15.4%) papers required only signs 
of structural deformity, with no mention of tendon dysfunction. Considering all signs and symptoms 
(n = 60), forefoot abduction (10; 16.7%), medial arch collapse (10; 16.7%) and hindfoot valgus (10; 
16.7%) were most frequently reported criteria for the diagnosis of AAFD. 
Considering all criteria for both PTTD and AAFD combined (n = 442), the most commonly 
reported (optional and compulsory) were forefoot abduction (51; 11.5%), a flexible deformity (45; 
10.2%) and difficulty performing a single leg heel raise (44; 10.0%).  
Considering signs and symptoms listed in articles investigating stage I PTTD (n = 36), the most 
frequently reported (optional and compulsory) criteria were tenderness on palpation of the posterior 
tibial tendon (6; 16.7%) followed equally by pain in the medial foot/ankle, swelling along the 
posterior tibial tendon, inversion strength deficit, and difficulty performing a single leg heel raise 
(4; 11.1%). There were no articles reporting grade 1 AAFD.  
The most commonly reported criteria (n = 237) for stage II (including IIB) PTTD were the presence 
of a flexible deformity (33; 13.9%), forefoot abduction (28; 11.8%) and difficulty with single leg 
heel raise (43; 10.1%). There were 2 papers investigating stage II AAFD (including 2B) and the 
most frequently reported criteria were the presence of a flexible deformity, forefoot abduction, 
medial arch collapse and hindfoot valgus.  
Consistent with data from when all PTTD studies were combined, when criteria (n = 293) for the 
early stages of PTTD were combined (stage I, II, I-II and IIB) the most frequently reported criteria 
were the presence of a flexible deformity (38; 13.0%), forefoot abduction (31; 10.6%) and difficulty 
with a single leg heel raise (28; 9.6%). When articles investigating the early stages of AAFD were 
combined, the most frequently reported criteria (n = 18) were the presence of a flexible deformity 
(3; 16.7%), forefoot abduction (3; 16.7%), medial arch collapse (3; 16.7%) and hindfoot valgus (3; 
16.7%).  
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There were 2 articles describing stage II-III PTTD. Pain (either along the tendon, medial foot or 
with inversion or single leg heel raise), difficulty with resisted inversion, forefoot abduction and a 
flexible flatfoot deformity were reported in both studies. One article described diagnostic criteria for 
stage IV AAFD, which included difficulty with resisted inversion and single leg heel raise, hindfoot 
valgus and decreased medial longitudinal arch.  
3.1.4 Discussion 
It is apparent from this systematic synthesis of available literature that there is significant overlap in 
the key signs and symptoms used to include PTTD and AAFD in research studies. While the 
hypothesis was to identify selection criteria, a major finding was that within the body of PTTD and 
AAFD literature, over half did not report how the condition was diagnosed. Of 228 primary 
research articles, 148 (65%) did not specify the specific criteria used to diagnose the condition or 
determine inclusion into the study (Figure 3-1). These studies frequently reported that the condition 
was diagnosed by the clinician or based on a classification system, without stating the impairments 
(signs and symptoms) that led to the diagnosis. Specifying impairments that confirmed diagnosis 
and led to inclusion in the study would improve consistency between studies and better enable 
comparisons. In order to appropriately apply evidence based practice in the clinic it is important to 
closely align or match patients with those reported in the literature. To accomplish this, it is 
essential that inclusion/diagnostic criteria are firstly reported in all studies and secondly consistent 
between studies. Of the articles investigating PTTD and AAFD that did report eligibility criteria, 67 
(81%) included signs and symptoms relating to both tendon dysfunction and structural deformity. 
The exception to this was articles investigating early stage I PTTD where tendon signs (pain, 
swelling, weakness) were most prevalent (indicative of TPT). Although terminology for a tendon 
related condition was used (PTTD); the presence of signs and symptoms indicating an acquired 
flatfoot deformity were still required for a positive diagnosis and study inclusion for stage II and 
above PTTD. Similarly, articles using the terminology AAFD for the condition included signs and 
symptoms relating to dysfunction of the posterior tibial tendon (i.e., TPT), not just the acquired 
flatfoot deformity. This suggests, despite differing nomenclature, these articles are investigating the 
same condition, which is characterised by dysfunction of the tibialis posterior tendon and an 
acquired flatfoot deformity.  
When data for PTTD and AAFD were combined, the overarching diagnostic criteria were difficulty 
performing a single leg heel raise, the presence of a flexible deformity and forefoot abduction. This 
is consistent with early descriptions of PTTD and classification systems; in which the ‘too many 
toes’ sign (forefoot abduction), a flexible flatfoot deformity and difficulty inverting the calcaneus 
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while rising onto the toes were reported as indicative of dysfunction of the tibialis posterior tendon. 
46 51 
Presenting signs and symptoms understandably vary with the stage of the condition. The majority of 
articles reported in this review pertain to stage I and or II PTTD (i.e., TPT) and, consistent with the 
progressive nature of tendon dysfunction, there were clear differences between these stages. In 
stage I PTTD tenderness on palpation, pain and swelling around the tendon played a key role in 
diagnosis. These were not the most common diagnostic criteria for stage II PTTD. Tendon 
involvement was evidenced by impaired function (i.e. difficulty with single leg heel raise) rather 
than pain or inflammation, and diagnosis of this stage included signs of deformity (Figure 3-2). 
This suggests that in stage I the tendon is reactive, 107 whereas in stage II it has progressed to a 
dysfunctional state where it is no longer able to invert the calcaneus and support the medial 
longitudinal arch.  
 
 
Figure 3-2 Diagrammatic summary. Similarities and differences in selection criteria for Stage I 
and II PTTD and AAFD. 
There were commonalities in the criteria used to diagnose stage II PTTD and stage II AAFD. A 
flexible deformity and forefoot abduction were required for both diagnoses. Consistent with the 
Stage II PTTD Stage I PTTD 
AAFD 
Flexible deformity 
Forefoot 
abduction 
Medial arch collapse 
Hindfoot valgus 
Tendon pain 
and swelling 
Decreased 
inversion strength 
Difficulty 
with single 
leg heel 
raise 
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nomenclature, tendon related symptoms (e.g. difficulty with single leg heel raise) were also required 
for the diagnosis of PTTD, whereas additional symptoms of structural deformity (e.g. hindfoot 
valgus and medial arch collapse) were required for the diagnosis of AAFD. An important 
consideration is that in the early stages (I-II) of both PTTD and AAFD, flexibility of the deformity 
is a key sign.  
There were substantially less articles detailing diagnostic criteria for the later stages of PTTD and 
AAFD. Two articles described criteria for stage II-III PTTD. It is interesting that stage II and III 
were combined in these papers, as original classification systems have a clear delineation between 
stage II and III; being that the flatfoot deformity is flexible in stage II and rigid in stage III. 51 Both 
papers listed the presence of a flexible deformity as a key criteria, which suggests stage II was the 
condition being studied. 171 172 The remaining criteria for these papers were also consistent with the 
most commonly reported signs for stage II PTTD. The criteria in the one paper investigating stage 
IV AAFD suggest that pain and inflammation are no longer key (or present) and the structural 
deformity and lasting functional deficits (e.g. difficulty with inversion and single leg heel raise) is 
emphasised. Two key issues have become apparent on review of the literature that did identify 
selection/inclusion criteria for PTTD and/or AAFD. First, PTTD and AAFD are being used 
interchangeably to describe the same condition. Where there are clear signs of a dysfunctional 
tendon (pain, swelling, weakness), we suggest the condition be referred to as PTTD. To negate the 
confusion surrounding early stages of the condition in which a flatfoot deformity is not present, we 
suggest that PTTD is the preferred terminology for the condition. The acquired flatfoot deformity 
may be a sign that develops in the later stages of the condition. This aligns with the literature that 
considers PTTD to be only one of several potential causes of AAFD. 40 132 194  
Second, research studies use inconsistent inclusion criteria for participants with PTTD and AAFD. 
Based on data from studies included in this review, we recommended the following signs pertaining 
to tendon dysfunction form the inclusion criteria for studies investigating stage I PTTD (i.e., TPT): 
pain along the tendon, swelling and weakness with inversion and/or single leg heel raise. Suggested 
inclusion criteria for stage II include difficulty with single leg heel raise and a flexible flatfoot 
deformity; characterised by forefoot abduction, a lowered medial longitudinal arch and/or hindfoot 
eversion. Recommendations for stage III and IV are unable to be made as few studies investigated 
the later stages of the condition.   
As PTTD is only one potential cause of AAFD, it is important to differentiate AAFD that is 
predominantly related to PTTD from other causes. An adult acquired flatfoot due to rheumatoid 
arthritis may not present with the same impairments (pain, function and/or disability) as those with 
an adult acquired flatfoot due to PTTD, nor will they likely respond in the same manner to 
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conservation or surgical intervention. It is important to clearly characterise the key signs and 
symptoms of PTTD in isolation from other causes of AAFD in order to best guide effective 
treatment protocols. To avoid potential misunderstanding, it stands to reason that when AAFD is 
used in the literature as an umbrella term for acquired flatfoot deformities, the underlying aetiology 
of the AAFD should be reported. As there are considerable differences in the diagnostic criteria 
used in each stage of PTTD and AAFD, it is also important that the stage of the condition be 
indicated.  
There are some limitations that need to be considered for this review. First, due to resource 
implications, after the search strategy was developed, a single reviewer independently searched the 
literature and assessed eligibility. Secondly, a hand search was not employed due to the broad 
search terms used and the large number of references retrieved. Thirdly, we might have excluded 
some studies that only stated they used a classification system and did not list the specific selection 
criteria. We felt justified in doing this to avoiding ambiguity in matching our extracted data and that 
which was specifically reported in those papers. 
3.1.5 Conclusion  
In conclusion, it is recommended that TPT is the preferred terminology for the condition of a 
painful, dysfunctional tibialis posterior tendon, even in the later stages where an acquired flatfoot 
deformity has developed. This will remove ambiguity regarding other potential causes for AAFD. 
There is a need for more consistent and uniform reporting of inclusion/selection criteria for studies 
investigating TPT. This chapter has outlined suggested eligibility criteria for TPT (i.e. stages I and 
II PTTD that can be used in future research and will enhance the applicability of evidence based 
practice in the clinic.  
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 Review of clinical impairments 
 Self-reported social and activity restrictions accompany local postural and 
strength impairments in tibialis posterior tendinopathy: a systematic 
review 195 
Chapter two recommended that clinicians are guided by presenting impairments to manage TPT 
conservatively. In order to inform these approaches and develop targeted intervention strategies, it 
is important to identify clinical features which are characteristic of TPT. This chapter is adapted 
from a systematic review of the literature to identify clinical impairments, pain and disability in 
TPT compared to controls (Appendix 4). Where possible, meta-analyses were used to calculate 
pooled standardised differences between those with TPT and those without. Primary findings 
include significant effects for altered foot posture and reductions in local strength. Data also 
revealed that individuals with TPT demonstrate reduced global functioning and more pain, 
functional difficulties and activity limitations compared to controls. 
Ross MH, Smith M, Plinsinga ML, Vicenzino B. Self-reported social and activity restrictions 
accompany local impairments in posterior tibial tendon dysfunction: a systematic review. Journal of 
Foot and Ankle Research. 2018;11(1):49. 
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4.1.1 Introduction 
Diagnosis of TPT is most commonly made clinically, based on patient history (e.g., area of pain) 
and physical examination. 44 Chapter two highlights key features of the physical examination for 
TPT; swelling, pain on palpation, and/or pain with loading of the TP tendon (e.g., resisted plantar 
flexion inversion and heel raises) that may be accompanied by a flatfoot deformity. 48 51 133 
Historically, and as mentioned in chapter two, TPT has been considered as the ‘early stage’ of 
PTTD/AAFD (i.e. stage I and II), when tendon signs and symptoms are the predominant features.  
Non-operative management is usually advocated for TPT, and typically focuses on 
musculotendinous conditioning exercises and arch supporting devices (e.g., in-shoe foot orthoses, 
braces). 79 80 90 There is a lack of high quality evidence for these treatments, which relegates 
physical therapy treatment decisions to one that targets presenting impairments and are based 
largely on the clinical reasoning skills of the clinician.  
The objective of this study was to systematically review the literature on clinical impairments of 
TPT. The main research question for this systematic review was: Do individuals with TPT have 
quantifiable differences in clinical impairments, pain and disability compared to controls? The 
second research question was: What is the relative magnitude of deficits in muscle function, foot 
posture and motion, pain and disability?  
4.1.2 Methods 
The systematic review protocol was developed in accordance with the Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses (PRISMA) statement82 and registered online at 
http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42016046951. Literature 
search criteria and methods were specified and agreed on in advance to minimise selection bias.  
Identification and selection of studies 
An electronic database search was conducted across CINAHL, Cochrane, Embase, PubMed and 
Web of Science from database inception up to and including 13 June 2016, limited to the English 
language. The search strategy was broad to capture all relevant papers pertaining to past and present 
variations in terminology for the condition: Flatfoot OR (posterior AND tibia* AND (tendon* OR 
tendin*)) OR “pes planus” OR “pes planovalgus”. The terms flatfoot, pes planus and pes 
planovalgus were included only to capture articles using varying terminology to describe TPT; 
other causes of AAFD and asymptomatic flatfoot were not included in this review. Due to limited 
literature available on the condition, a ‘participant’ (condition) only search was performed where 
articles were manually excluded based on intervention, comparator and outcome specifications.  
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Two independent reviewers (MR and MP) performed the search separately and results were 
imported into Endnote X7 (Thompson Reuters, Carlsbad, California, USA) where duplicates were 
removed. Titles and abstracts were screened for relevance by two reviewers (MR and MP), with 
disagreements resolved by consensus with reference to a third reviewer (BV). Full text versions of 
remaining articles were obtained and screened against final eligibility criteria by two reviewers 
(MR and MP).  
Studies were eligible for inclusion if they were published in the English language and contained 
data on clinical impairments, pain or disability compared between participants diagnosed with TPT 
(or AAFD related to tendon dysfunction) and pain-free individuals (Table 4-1). Studies including 
participants who had undergone a specific intervention were included only if baseline or pre-
intervention data was reported and compared to control participants without the condition. Any 
post-intervention data was not included.  
Table 4-1 Inclusion criteria  
 
Studies were excluded if there was no comparison group or clinical measures of pain, function or 
disability; the study was published in a language other than English or the full text was not 
available. Review articles, single case reports, paediatric, cadaver and animal studies were 
excluded. Studies including participants with other conditions such as osteoarthritis or rheumatoid 
arthritis that did not include separate data for individuals with TPT or AAFD were also excluded.  
Assessment of characteristics of studies 
Quality: Methodological quality of included articles was evaluated using the Epidemiological 
Appraisal Instrument (EAI), which has been shown to be a valid and reliable tool for the assessment 
of observational studies. 196 Twenty-one items from the original EAI were used following removal 
of items that were not applicable to cross sectional and case control study designs. Removed items 
specifically related to interventions, randomization, follow-up period and environmental factors. 
Detailed criteria for each response were clarified a-priori to match the purpose of this review.  
Two independent assessors (MR and MP) rated all included articles. Where a consensus was not 
able to be reached, disagreements were resolved by a third investigator (BV). Each item was scored 
as either “Yes” (score = 1), “Partial” (score = 0.5), “No” (score = 0), “Unable to determine” (score 
 Peer reviewed papers in the English language 
 Adult participants with TPT or AAFD related to 
PTTD 
 Baseline measures of clinical impairments, pain 
and/or disability  
 Data compared to healthy control participants 
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= 0) or “Not Applicable” (item removed from scoring) and an overall score was derived as an 
average score across all applicable items (range = 0 to 1).  
Outcome measures: Where available, the following information was extracted from all eligible 
studies: study design, recruitment source, inclusion/exclusion criteria, sample size, stage of TPT, 48 
population characteristics and comparison group characteristics. Quantitative data relating to 
outcome measures for physical impairment, pain and disability, specifically mean SD for 
continuous outcomes, were extracted to enable calculation of effect size. Data extraction was 
performed by two independent reviewers (MR and MP) and recorded in a pre-determined 
spreadsheet. Corresponding authors were contacted for additional information when reported data 
was insufficient for analyses. A third reviewer (MS) verified data extraction prior to analysis. 
Data analysis 
Reliability of the methodological quality assessment was calculated in Stata v13 (College Station, 
TX: StataCorp LP). The ĸ statistic (95% CI) was used to report the inter-rater reliability of the 
quality ratings between the two assessors. The ĸ statistic was interpreted as <0.00 poor agreement; 
0.00 – 0.20 slight agreement, 0.21 – 0.40 fair agreement, 0.41 – 0.60 moderate agreement, 0.61 – 
0.80 substantial agreement and 0.81 to 1.00 almost perfect agreement. 89  
Standardized mean differences and 95% CIs were calculated for continuous variables in Review 
Manager (RevMan) V5.3 (Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration) 
using random effects models. SMDs were calculated as the difference between TPT and control 
group means, divided by the pooled SD. 197 Where 95% CIs did not contain zero, the difference 
between groups was considered statistically significant. For each outcome measure, a positive SMD 
reflected greater values in the TPT population and a negative SMD reflected greater values in the 
control population. Effect sizes were interpreted based on Hopkins, as follows; < 0.2 trivial effect, 
0.2 - 0.6 small effect, 0.61 – 1.2 medium effect > 1.2 large effect. 88 
Meta-analysis was performed where similar methodology and outcome measures (study 
homogeneity) allowed pooling of data. Chi-squared tests (P<0.1) and the I2 statistic were used to 
quantify study heterogeneity for pooled SMDs with ≥0.75 considered substantial heterogeneity. 198 
A summary of main findings and study conclusions were presented where data was not available to 
calculate SMD.  
4.1.3 Results  
Flow of studies through the review 
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The search strategy identified a total of 13 526 articles of which 6504 were removed as duplicates 
(Figure 4-1). The remaining 7022 articles were screened by title and abstract and 67 potentially 
eligible articles were identified. Full text screening of the 67 articles excluded 57 articles which did 
not meet the inclusion criteria (Figure 4-1). The 10 remaining articles underwent methodological 
quality assessment and data extraction. Four authors were contacted for additional data for five 
papers. Data from two studies was made available 68 125 but not from others 66 67 152 with reasons 
being that the data was not collected or not available. Papers that reported on the same population 
sample were only included once in the analysis. One author was contacted to clarify that two papers 
125 165 reported data from the same sample, and as no additional (unique) data was provided, the 
second paper was excluded. 165 
 
Figure 4-1 Flow of studies through the review 
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Initial database search strategy  
n = 15 526 
Duplicates excluded  
n = 7452 
Title and abstracts screened  
n = 8074 
Full text assessed for eligibility  
n = 73 
Records excluded based on title and 
abstract 
n = 8001 
Full text excluded  
n = 63 
No clinical measures of pain, function or 
disability n = 39 
Not PTTD/AAFD n = 8 
No control n = 10 
No baseline measures n = 3 
Paediatric flatfoot n = 1 
Unable to obtain full text n = 1 
Data reported elsewhere = 1 
Number in qualitative synthesis  
n = 10 
Number in quantitative synthesis 
n = 10 
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Quality: Overall agreement on methodological quality of included studies was almost perfect 
(absolute agreement = 98.64%, ĸ = 0.97, 95% CI 0.85 to 1). Agreement was reached on 215 out of 
220 EAI items in total. Consensus was obtained on the quality rating of the 5 remaining items. 
Overall EAI scores ranged from 0.5 to 0.682 out of a possible score of 1 (Table 1). The 
methodological quality assessment revealed that only 2 studies (20%) adequately reported the 
source of the participant population, 20% performed sample size calculations and 40% had a control 
group adequately comparable to the case group. The reliability and validity of outcome measures 
were reported by 30% and 10% of studies respectively. One study collected data on duration of 
symptoms yet no studies (0%) accounted for history of symptoms in analyses. Generalizability of 
results to other populations was low (0%); 6 studies reported samples of convenience and the 
remaining 4 studies reported data for participants seeking treatment for their condition (referral 
from clinics).  
Participants: The 10 included studies contained a total of 213 participants with TPT compared to 
144 healthy controls. Sample sizes ranged from 12 126 to 30 124 125 156 TPT participants (Table 4-2) 
and 10 68 127 to 20 170 controls. Mean (SD) age of TPT patients ranged from 30.3 (7.9) 126 to 61 (10) 
152 years and the proportion of females ranged from 63.3% 125 to 100%. 66 170 
Table 4-3 has details of the ‘stage’ (as reported in studies) and criteria by which participants with 
TPT were selected. In brief, one study investigated stage I TPT, 126 2 studies investigated stage I-II 
TPT 66 170 and the remaining 7 studies investigated stage II TPT only. 67 68 124 125 127 152 156 The 
method of diagnosis was by clinical assessment in all studies with 9 out of 10 studies requiring both 
signs of tendon pathology and flexible flatfoot deformity for a positive diagnosis. The one study 
investigating stage I TPT 126 required only signs of tendon pathology including mild swelling and/or 
tenderness posterior to the medial malleolus that had been present for at least 3 weeks and 
aggravated by recreational activity.  
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Table 4-2 Results from quality assessment of all included papers (n = 10) on the EAI 
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Q1. Hypothesis/aim/ objective clearly described 1 1 1 1 1 1 1 1 1 1 100 
Q2. Main outcomes clearly described 1 1 1 1 1 1 1 1 1 1 100 
Q3. Reported study design 1 1 0.5 0.5 1 1 1 1 1 1 80 
Q4. Source of participant population clearly described 1 1 0 0 0 0 0.5 0 0 0 20 
Q5. Reported eligibility criteria 1 1 1 1 1 1 1 1 1 1 100 
Q6. Characteristics of study participants described 1 1 1 1 1 1 1 1 1 1 100 
Q7. Important covariates and confounders described 1 1 1 1 1 1 1 1 1 1 100 
Q8. Statistical methods clearly described 1 1 1 1 1 1 1 1 1 1 100 
Q9. Main findings of the study clearly described 1 1 1 1 1 1 1 1 1 1 100 
Q10. Provides estimates of the random variability in the data  1 1 1 1 1 1 1 1 1 1 100 
Q11. Sample size calculations 1 1 0 0.5 0.5 0 0 0 0 0 20 
Q12. Comparability of case/control groups 0 1 1 1 1 0 0 0 0 0 40 
Q13. Recruitment period for case/control groups 0 0 0 0 0 0 0 0 0 0 0 
Q14. Blinding of assessors 0 0 0 0 0 0 0 0 0 0 0 
Q15. Reliability of outcome measures 1 0.5 1 1 0 0.5 0 0.5 0.5 0 30 
Q16. Validity of outcome measures 1 0 0 0 0 0 0 0 0 0 10 
Q17. Standardised assessment  1 1 1 1 1 1 1 1 1 1 100 
Q18. Assessment period of case/control groups 0 0 0 0 0 0 0 0 0 0 0 
Q19. History of disease/symptoms collected and included in analysis 0 0 0.5 0 0 0 0 0 0 0 0 
Q20. Adjusted for covariates 1 1 1 1 0.5 1 1 1 1 1 90 
Q21. Reported data for subgroups 0 0 1 0 0 1 0 0 0 0 20 
Q22. Generalibility of results to other populations 0.5 0.5 0.5 0.5 0.5 0 0.5 0 0 0 0 
Overall quality score (range 0 to 1) 0.70 0.68 0.66 0.61 0.57 0.57 0.55 0.52 0.52 0.50 0.59 
Black shading = "yes" (1), Grey shading = "Partial" (0.5), White (no shading) = "No" or "Unable to determine", NA = "not applicable"
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Table 4-3 Study design, TPT diagnosis, clinical impairments and participant characteristics (mean (SD) or count (percentage)) 
          TPT Control 
Study ID Study design Diagnosis Selection criteria for TPT Clinical 
Impairments 
n Female 
(%) 
Age 
years 
BMI 
kg/m 
n Female 
(%) 
Age 
years 
BMI 
kg/m 
Chimenti67 Cross-
sectional 
laboratory 
Stage II 
AAFD 
1 or more signs of tendinopathy 
(tenderness, swelling or pain with 
unilateral heel raise) and 1 or more signs 
of flexible flatfoot deformity (excessive 
non-fixed hindfoot eversion, excessive 
first metatarsal abduction or loss of 
medial longitudinal arch height) 
Function & 
strength, Foot 
posture, 
PROM 
20 14 (70) 57 
(11.3) 
30 
(5.2) 
15 11 (73) 56 
(5.3) 
26 
(4.4) 
Houck124 Cross-
sectional 
laboratory 
Unilateral 
stage II 
TPT 
1 or more signs of tendinopathy 
(tenderness, swelling or pain with 
unilateral heel raise) and 1 or more signs 
of flexible flatfoot deformity (excessive 
non-fixed hindfoot eversion, excessive 
first metatarsal abduction or loss of 
medial longitudinal arch height) 
Foot posture 30 22 (73) 59.3 
(10.8) 
29.6 
(4.8) 
15 14 (93) 56.5 
(7.7) 
30.5 
(3.6) 
Houck156 Cross-
sectional 
laboratory 
Unilateral 
stage II 
TPT 
1 or more signs of tendinopathy 
(tenderness, swelling or pain with 
unilateral heel raise) and 1 or more signs 
of flexible flatfoot deformity (excessive 
non-fixed hindfoot eversion, excessive 
first metatarsal abduction or loss of 
medial longitudinal arch height) 
Function & 
strength, Foot 
posture  
30 21 (70) 59.8 
(11.1) 
29.9 
(4.8) 
15 14 (93) 56.5 
(7.7) 
30.6 
(3.6) 
Houck152 Case-control Unilateral 
stage II 
TPT 
Signs of tendon pathology (pain and/or 
swelling along medial ankle) and 
flexible flatfoot deformity (hindfoot 
eversion, forefoot abduction or loss of 
medial longitudinal arch height) 
Function & 
strength, Foot 
posture 
24 18 (75) 61 (10) 30 
(5) 
15 13 (87) 55 (8) 28 
(5) 
Kulig66 Cross-
sectional 
laboratory 
Unilateral 
early 
stage 
Pain along medial ankle, tender on 
palpation posterior tibial tendon, 
lowered medial longitudinal arch, 
Function & 
Strength, 
17 17 
(100) 
52.1 
(7.5) 
29.5 
(6.3) 
17 17 
(100) 
50.7 
(5.5) 
26.9 
(5.9) 
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TPT (I or 
II) 
abducted midfoot, absence of rigid foot 
deformity 
Foot posture, 
PROM 
Kulig170 Case-control  Unilateral 
early 
stage 
TPT (I or 
II) 
Pain along medial ankle, tender on 
palpation posterior tibial tendon, 
lowered medial longitudinal arch, 
abducted midfoot, absence of rigid foot 
deformity 
Function & 
strength, Foot 
posture, 
Balance  
19 19 
(100) 
54.6 
(6.3) 
28.9 
(4.5) 
20 20 
(100) 
50.8 
(5.5) 
26.9 
(5.9) 
Neville125 Cross-
sectional 
Unilateral 
stage II 
TPT 
1 or more signs of tendinopathy 
(tenderness, swelling or pain with 
unilateral heel raise) and 1 or more signs 
of flexible flatfoot deformity (excessive 
non-fixed hindfoot eversion, excessive 
first metatarsal abduction or loss of 
medial longitudinal arch height) 
Function & 
strength, 
ROM, Foot 
posture  
30 19 (63) 58.1 
(10.5) 
30.6 
(5.4) 
15 14 (93) 56.5 
(7.7) 
30.6 
(3.6) 
Neville68 Case-control Unilateral 
stage II 
TPT 
1 or more signs of tendinopathy 
(tenderness, swelling or pain with 
unilateral heel raise) and 1 or more signs 
of flexible flatfoot deformity (excessive 
non-fixed hindfoot eversion, excessive 
first metatarsal abduction or loss of 
medial longitudinal arch height) 
Foot posture, 
PROM 
17 14 (82) 56.1 
(11.6) 
33.2 
(7.4) 
10 7 (70) 50.2 
(6.8) 
31.8 
(3.8) 
Rabbito126 Case-control Stage I 
TPT 
Mild swelling, tenderness, pain 
posterior to the medial malleolus, 
aggravated by recreational activity  
ROM, Foot 
posture 
12 9 (75) 30.3 
(7.9) 
23.2 
(3.4) 
12 9 (75) 28.5 
(8.6) 
23.7 
(2.8) 
Tome127 Case-control  Unilateral 
stage II 
TPT 
1 or more signs of tendinopathy 
(tenderness, swelling or pain with 
unilateral heel raise) and 1 or more signs 
of flexible flatfoot deformity (excessive 
non-fixed hindfoot eversion, excessive 
first metatarsal abduction or loss of 
medial longitudinal arch height) 
Foot posture 14 12 (85) 56.8 
(11.7) 
33.7 
(7.4) 
10 7 (70) 51.2 
(7.3) 
31.8 
(3.6) 
Abbreviations: AAFD; adult acquired flatfoot deformity, TPT; tibialis posterior tendinopathy, ROM; range of motion, PROM; patient reported outcome measure  
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Outcome measures: Outcome measures reported for clinical impairments included heel raise 
performance, 66 67 156 170 leg muscle strength, 125 152 ankle ROM, 125 126 hip muscle function, 66 foot 
posture, 66-68 124-127 152 156 170 single leg balance 170 and distance walked and pain experienced during 
the 6-minute walk test (6MWT). 66 Pain was reported as an outcome measure following the 6MWT. 
66 Patient reported outcome measures included the Foot Function Index-Revised (FFI-R) 66 67 and 
the Short Musculoskeletal Functional Assessment (SMFA). 68 Meta-analysis was able to be 
conducted for a total of 8 outcome measures. 
Main findings: 
Heel raise performance  
Two clinical measures of heel raise performance (maximum number completed and height) were 
reported across 4 studies. Two studies were pooled and found a large effect size for the number of 
single leg heel raises performed by individuals with TPT compared to controls (i.e. approximately 7 
v 20 respectively; Figure 4-2). 66 170 One study reported significantly lower height on single leg heel 
raise, 67 whereas another reported no differences for bilateral heel raise height between TPT and 
control groups (Figure 4-2). 156 
 
Figure 4-2 Standardised mean difference (95% CI) for function and strength outcomes in TPT vs 
controls.  
 
Leg muscle strength  
-3 -2 -1 0 1 2 3
Outcome Study TPT Control SMD [95% CI)
Mean SD Total Mean SD Total
Number of single leg heel raises
Kulig 7.4 3.9 17 20.1 10.3 17 -1.59 [-2.38, -0.81]
Kulig 7.4 4.6 19 18.2 9.1 20 -1.46 [-2.17, -0.74]
Pooled (I2 = 0%) 36 37 -1.52 [-2.05, -0.99]
Height of single leg heel raise Chimenti 40.7 8.1 20 55.8 6.4 15 -1.99 [-2.82, -1.15]
Height of bilateral heel raise Houck 54 10.4 30 59.3 8.2 15 -0.53 [-1.17, 0.10]
Forefoot adduction-inversion strength (flexion) Houck 0.7 0.24 24 0.99 0.24 15 -1.18 [-1.89, -0.48]
Neville 0.74 0.22 26 1 0.21 16 -1.20 [-1.88, -0.52]
Pooled (I2 = 0%) 50 31 -1.19 [-1.68, -0.71]
Forefoot adduction-inversion strength (extension) Rabbito 1 0.41 12 0.99 0.35 12 0.03 [-0.77, 0.83]
Isometric hip extensor torque Kulig 1.05 0.46 17 1.55 0.6 17 -0.91 [-1.62, -0.20]
Hip extension endurance Kulig 28.6 12.9 17 46.9 28.7 17 -0.80 [-1.51, -0.10]
Isometric hip abductor torque Kulig 0.74 0.3 17 1.03 0.59 17 -0.60 [-1.29, 0.08]
Hip abduction endurance Kulig 17.2 7.7 17 23.6 8.1 17 -0.79 [-1.49, -0.09]
Single leg anteroposterior displacement (mm) Kulig 14 7.4 19 8.4 1.3 20 1.05 [0.37, 1.72]
Single leg mediolateral displacement (mm) Kulig 8.3 4.5 19 6.1 1.2 20 0.66 [0.02, 1.31]
6-minute walk test distance (m) Kulig 497.1 89.6 17 571.5 72.3 17 -0.89 [-1.60, -0.18]
Pain following 6-minute walk test
Kulig 22.9 23.8 17 1.2 3.1 17 1.25 [0.51, 1.99]
Abbreviations: TPT: tibialis posterior tendinopathy, SMD; standardized mean difference, SD; 
standard deviation, CI; confidence interval
Greater in TPTLesser in TPT SMD (95% CI)
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Combined isometric forefoot adduction and subtalar inversion strength in plantar flexion was 
reported in three studies. 125 126 152 Pooled data from two studies that measured strength in 90 
degrees of knee flexion 125 152 revealed a moderate deficit (SMD) in TPT compared to controls (MD 
-0.27 N/kg) (Figure 4-2). The other study measured forefoot abduction and subtalar inversion 
strength in full knee extension 126 and showed no difference (MD 0.01 N/kg). It was excluded from 
the pooled analysis due to heterogeneity of testing position.   
Hip muscle function  
Hip extensor and abductor muscle strength and endurance in individuals with TPT were compared 
to controls in one study. 66 Large SMDs indicate that participants with TPT had significantly 
reduced hip extensor strength and endurance compared to controls (Figure 4-2). There was a small-
moderate effect for hip abductor muscle strength differences between TPT and control groups, 
which did not reach statistical significance. SMDs for hip abductor muscle endurance revealed a 
significant medium effect with control participants demonstrating greater hip abductor muscle 
endurance than TPT participants. 
Single leg balance 
Anteroposterior and mediolateral centre of pressure displacement during single leg stance was 
moderately greater in participants with TPT compared to control (Figure 4-2). 170 The same study 
reported that 47% (9/19) of participants with TPT were unable to maintain single leg balance for 10 
seconds compared with 15% of controls (3/20).170 
6-minute walk test  
One study measured distance walked in 6 minutes (6MWT) and pain experienced on a 100 mm 
visual analogue scale.66 Participants with TPT covered a significantly shorter distance 
(approximately 74 metres) and reported a significantly higher pain level (22mm on visual analogue 
scale) when compared to individuals without TPT (Figure 4-2).  
Foot posture  
Foot posture was examined in two studies by using the Arch Index (AI) 66 170 and in eight studies 
using the Arch Height Index (AHI). 67 68 124-127 152 156 Pooled SMDs for the two studies investigating 
AI, 66 170 revealed a significant large effect indicating that TPT participants demonstrated a flatter 
foot posture compared to controls. AHI in bilateral stance was substantially (large SMD) lower in 
individuals with TPT compared to controls (Figure 4-3). 67 68 124-127 152 156 There was a large SMD 
for AHI taken in a seated position, yet the Arch Rigidity Index (ratio of standing AHI to seated 
AHI) was not different between TPT and control groups (Figure 4-3). 126 
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Figure 4-3 Standardised mean difference (95% CI) for foot posture and range of motion outcomes 
in TPT vs controls. 
 
Hindfoot Range of Motion  
Two studies measured hindfoot eversion range of motion 125 126 and reported a large pooled point 
estimate of effect for more eversion in TPT compared to controls (mean difference (95% CI) 4.97 (-
1.4 to 11.34) degrees), but this was not statistically significant (confidence intervals contained 0) 
(Figure 4-3). 
Self-reported function 
Five studies investigated self-reported function compared to controls using the Foot Function 
Index-Revised (FFI-R) 66 67 and the Short Musculoskeletal Functional Assessment. 68 Pooled SMDs 
were calculated for the stiffness, difficulty and social subscales of the FFI-R with large effect sizes 
demonstrating significantly more self-reported stiffness, difficulty and social restrictions in 
individuals with TPT (Figure 4-4). As one study reported SD of 0 for the pain and function 
subscales, pooled SMDs were not able to be calculated. 67 Another paper 66 revealed that compared 
to controls, participants with TPT had significantly higher self-reported pain and activity limitations 
(Figure 4-4).  
 
-4 -3 -2 -1 0 1 2 3 4
Outcome Study TPT Control SMD [95% CI]
Mean SD Total Mean SD Total
Arch Height Index -
Standing
Chimenti 0.3 0.03 20 0.33 0.03 15 -0.98 [-1.69, -0.26]
Houck 0.31 0.03 24 0.35 0.03 15 -1.31 [-2.02, -0.59]
Houck 0.31 0.02 30 0.38 0.03 15 -2.90 [-3.78, -2.02]
Houck 0.314 0.026 30 0.376 0.026 15 -2.34 [-3.14, -1.54]
Neville 0.311 0.036 17 0.384 0.026 10 -2.16 [-3.16, -1.16]
Neville 0.33 0.02 30 0.376 0.03 15 -1.91 [-2.65, -1.16]
Rabbito 0.34 0.01 12 0.35 0.02 12 -0.61 [-1.43, 0.21]
Tome 0.306 0.038 14 0.381 0.027 10 -2.13 [-3.18, -1.09]
POOLED (I
2 
= 70%) 177 107 -1.76 [-2.29, -1.23]
Arch Height Index - Seated Rabbito 0.36 0.01 12 0.38 0.02 12 -1.22 [-2.11, -0.34]
Arch Index Kulig 0.16 0.03 19 0.221 0.042 20 -1.63 [-2.36, -0.90]
Kulig 0.158 0.027 17 0.22 0.04 17 -1.77 [-2.58, -0.97]
POOLED (I
2 
= 0%) 36 37 -1.70 [-2.24, -1.15]
Arch Rigidity Index Rabbito 0.92 0.02 12 0.9 0.04 12 0.61 [-0.21, 1.43]
Hindfoot Eversion Neville 9.8 4.2 30 1.6 1.7 15 2.25 [1.46, 3.04]
Rabbito 6.5 3.1 12 4.8 2 15 0.65 [-0.13, 1.43]
POOLED (I
2 
= 87%) 42 30 1.45 [-0.12, 3.02]
SMD (95% CI)Less in TPT Greater in TPT
Abbreviations: TPT; tibialis posterior tendinopathy, SMD; standardized mean difference, SD; 
standard deviation, CI; confidence interval
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Figure 4-4 Standardised mean difference (95% CI) for patient reported outcome measures.  
 
Participants with TPT demonstrated significantly more self-reported mobility difficulties (Figure 
4-4) than controls on the Short Musculoskeletal Functional Assessment. 125 No significant 
differences between groups were found for functional limitations or the bothersome index (Figure 
4-4). Levels of self-reported physical activity were not significantly different between individuals 
with TPT and controls (Figure 4-4). 66 
4.1.4 Discussion 
This is the first review to systematically evaluate and synthesise results of research investigating 
clinical impairments and self-reported pain and disability associated with TPT. Data from the meta-
analysis indicate strong evidence for lower arch height and a lesser capacity to perform repeated 
unilateral heel rise in individuals with TPT. These deficits align with the function of tibialis 
posterior muscle, which is governed by its orientation and attachments. A large effect size for a 
deficit in single leg heel rise height and a medium effect for combined isometric forefoot adductor 
and subtalar invertor muscle strength in plantar flexion from individual studies further supports 
impaired musculotendinous function in TPT.  
-2 -1 0 1 2 3 4
Outcome Study TPT Control SMD [95% CI)
Mean SD Total Mean SD Total
FFI-R Stiffness Chimenti 33.8 14.5 20 17.2 1.9 15 1.46 [0.70, 2.23]
Kulig 16.4 6.8 17 9.1 1.7 17 1.44 [0.67, 2.20]
POOLED (I2 = 0%) 37 32 1.45 [0.91, 1.99]
FFI-R Difficulty Chimenti 37.7 18.4 20 10.4 1 15 1.91 [1.09, 2.73]
Kulig 16 10.3 17 8.6 1.4 17 0.98 [0.27, 1.70]
POOLED (I2 = 64%) 37 32 1.42 [0.52, 2.33]
FFI-R Social Chimenti 29.9 22.2 20 16.7 0.5 15 0.77 [0.07, 1.46]
Kulig 42.1 16.4 17 20.4 3.1 17 1.80 [0.98, 2.61]
POOLED (I2 = 72%) 37 32 1.26 [0.25, 2.27]
FFI-R Activity Chimenti 33.2 20.3 20 16.7 0 15 Not estimable
Kulig 44.8 16.4 17 20.5 1.2 17 2.04 [1.19, 2.89]
FFI-R Pain Chimenti 33 14.8 20 16.7 0 15 Not estimable
Kulig 25.4 7.8 17 11.8 2.3 17 2.31 [1.42, 3.20]
SMFA Mobility Neville 26.2 16.4 15 9.9 13.1 7 1.01 [0.06, 1.97]
SMFA Functional Neville 18.8 13.0 15 7.2 9.4 7 0.92 [-0.02, 1.87]
SMFA Bothersome Neville 17.8 12.2 9 9.1 13.6 6 0.65 [-0.42, 1.71]
Physical Activity Kulig 42.2 13.8 17 48.9 11.2 17 -0.52 [-1.21, 0.16]
Abbreviations: TPT; tibialis posterior tendinopathy, SMD; standardised mean 
difference, SD; standard deviation, CI; confidence interval, FFI-R; Foot Function 
Index-Revised, SMFA; Short Musculoskeletal Functional Assessment
SMD (95% CI) Greater in TPTLess in TPT
57 
While meta-analysis revealed strong evidence for lower arch height in individuals with TPT 
compared to controls. The magnitude of this effect must be interpreted with caution because control 
participants in five studies were only included if they had normal AHI and visually assessed normal 
foot posture. 68 124 125 127 156 A requirement for pain-free individuals to demonstrate normal AHI and 
foot posture may have potentially magnified the effect seen between TPT and controls. A finding 
that mitigates against this over-estimate of effect is that there was a large effect size of lower foot 
arch height in two studies that did not require controls to demonstrate normal foot posture. This 
suggests that key features of TPT are likely a combination of both tendon pathology (as discussed 
above) and postural deformity.  
Impairments demonstrated in TPT compared to controls were not limited to the level of body 
structure and function; lower self-reported function and greater pain also appear to be characteristic 
of TPT. Meta-analyses of FFI-R data suggest that stiffness, functional difficulties and social 
limitations are key features of TPT, with individual study SMDs also showing large effects for pain 
and activity limitations. Activity limitations were also not limited to self-report measures; poorer 
balance and mobility were demonstrated in TPT compared to controls with a moderate effect. The 
deficit in physical capacity (heel raise number and height and plantar flexion inversion weakness) 
and concomitant self-report concerns in functional, social and activity limitations as well as pain 
ought to be considered in the management of the condition. 
Clinical impairments in TPT are not limited locally to the foot and ankle. Medium effects were 
found for deficits in hip extension strength and endurance and hip abduction endurance in 
individuals with TPT. 66 Hip abduction strength deficits did not reach statistical significance (SMD 
(95% CI) -0.6 (-1.29, 0.08)) yet sample size was small and this may reflect a type II error. While 
further research is needed to determine true effects, these results are consistent with findings of 
impaired hip muscle function in other distal joint pathologies of the lower limb including knee 
osteoarthritis, 199 patellofemoral pain 200-202 and midportion achilles tendinopathy.203 These data 
suggest the need to assess and consider addressing any potential deficits in hip muscle capacity in 
the management of patients with TPT. 
All papers included within this review pertained to either stage I (n of papers =1), II (n=6) or I-II 
(n=2) TPT with data combined for analysis. Data for stage I and II TPT were pooled for two meta-
analyses; hindfoot eversion and AHI. Considering hindfoot eversion, one paper investigating stage 
II TPT found strong evidence for increased hindfoot eversion ROM, 125 whereas differences 
between individuals with stage I TPT and controls were less prominent (Figure 4-3). 126 Similarly, 
7 of the 8 papers investigating AHI found significant medium to large effects for lower AHI in 
stage II TPT compared to controls, whereas AHI in stage I TPT 126 did not appear to be different 
58 
when compared to controls.  When data for these outcomes were pooled, there was substantial 
heterogeneity (I2 = 87% and 70% respectively) and wide 95% confidence intervals which makes it 
difficult to draw conclusions about the true effects. The variability observed may be a result of 
underlying differences between stage I and II TPT and as such, the results must be interpreted with 
caution. 
Variations in participant characteristics, including age, BMI and physical activity participation, 
between studies investigating stage I and II TPT need to be considered in terms of contribution to 
some of the differences observed in the outcomes reported in this systematic review. Participants in 
the study that investigated stage I TPT were younger 126 and had a markedly lower BMI 126 than 
those in the studies that investigated stage II TPT (Table 4-3). Age and BMI for participants in two 
studies investigating stage I-II TPT 66 170 sat between those reported for stage I and stage II 
separately. All participants in the study investigating stage I TPT were undertaking running and 
running-related activities for at least 30 minutes three times per week. 126 While physical activity 
participation was not reported in most stage II studies, individuals with stage II TPT were found to 
have significant activity limitations compared to controls based on the FFI-R activity subscale. 
As TPT is considered a progressive condition,48 younger, active individuals with stage I TPT may 
not yet have progressed to a point where they present with certain signs of the condition, such as 
flatfoot deformity or an everted hindfoot, that may be more apparent in stage II TPT. In line with 
classification systems 48 51 133 and consistent with other studies, 204 this suggests that changes in foot 
posture may not be a key feature of stage I TPT. Differences between stage I and II TPT also appear 
to relate to tendon function. In stage I TPT, no difference was found for ankle inverter strength 
compared to controls. 126 This is in direct contrast to results from stage II studies which found 
strong evidence for decreased isometric forefoot adduction and subtalar inversion strength in 
individuals with stage II TPT compared to controls. This suggests that despite early signs of tendon 
reactivity, 107 the TP tendon may still be functionally competent in stage I of the condition.  
There are a number of factors to consider when interpreting results of this systematic review. While 
no restrictions were made regarding the stage of condition, these results apply to only stage I and II 
TPT as no data was available for stage III or IV (when foot deformity. Without quantifiable 
methods for staging the condition, 205 delineation between stages must be interpreted with caution. 
While all papers reported eligibility criteria relating to stage I or II TPT (100% on the quality 
appraisal), assessment of stage was based on classification systems that have not been validated. 205 
Clinical differentiation between stage II and III TPT has been based on the widely accepted notion 
that stage II is a flexible deformity, whereas in stage III the deformity is fixed. 48 The problem with 
this is that the method used to determine flexibility of the deformity is not reported. Perhaps this is 
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an omission in reporting, but it is more likely due to the lack of a valid clinical method of 
quantifying flexibility. Future research investigating clinical tools that may be able to provide a 
valid and reliable method of determining the stage of the condition would be beneficial for 
clinicians and academics. 
Another consideration is that this review was limited to 10 papers with relatively small sample 
sizes. The outcome with the strongest effect was based on a sample of 177 individuals with TPT 
and 107 controls. The majority of outcomes had a sample size much smaller than this and were 
calculated from individual papers. Small sample sizes and heterogeneity among included studies 
suggests effect estimates should be interpreted with caution. While SMDs were calculated in this 
review where possible to overcome small sample sizes, the current small body of TPT literature 
would benefit from larger, well-designed studies.  
4.1.5 Conclusion  
This review has appraised the existing literature and shows that TPT is characterised by 
impairments related to both local tendon dysfunction and foot posture as expected. However, the 
condition is also associated with changes in hip strength, walking, balance and global measures of 
self-reported function. These results highlight the need to consider both local impairments and 
measures of overall function when assessing the presentation and impact of the condition clinically, 
the effectiveness of TPT management, and when designing future studies
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 Gait characteristics in tibialis posterior tendinopathy 
 Foot and ankle kinematics during gait in tibialis posterior tendinopathy: a 
systematic review 
Chapter four identified clinical features of TPT that appear to be characteristic of the condition 
including impairments in foot posture, walking and self-reported function. To further investigate the 
presentation of TPT, this chapter systematically synthesises the literature exploring the kinematic 
gait characteristics in TPT compared to controls. In order to increase the confidence in findings, 
meta-analytic methods were used to pool data where homogeneity of methods and outcomes 
allowed.  
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5.1.1 Introduction 
Tibialis posterior tendinopathy (TPT) is characterised by pain on the medial aspect of the foot and 
ankle and difficulties with activities that load the tibialis posterior (TP). 195 Dysfunction is 
considered to occur along a spectrum where clinical signs of tendinopathy are predominant in the 
early stages, with pain and difficulty during activities that load the tendon primary complaints, 64 84 
195 which may be accompanied by an acquired flatfoot deformity. 42 130 
The TP tendon is a key dynamic support for the medial longitudinal arch and contributes to ankle 
plantar flexion, forefoot adduction and hindfoot inversion during stance. 206 207 The important role 
the TP tendon plays in stabilisation of the arch is evident when there is dysfunction of the tendon. 
Individuals with TPT have significant difficulty with activities that involve plantar flexion at the 
ankle and inversion at the subtalar joint. Large deficits have been demonstrated in single leg heel 
raise height and repetitions, in addition to forefoot adduction/inversion strength. 195 Furthermore, 
there is evidence for alterations in static foot posture, with large effects for lower arch height in TPT 
compared to health controls. 195 Asymptomatic flatfoot has been associated with altered lower limb 
kinematics during gait when compared to individuals with normal foot posture, 208 yet there has 
been no synthesis of available literature for lower limb kinematics in individuals with TPT 
compared to controls.  
Any pain related issues of the TP and accompanying clinical features are likely to affect lower limb 
kinematics during locomotion. It is therefore important to explore existing literature that has 
investigated foot kinematics during gait when there is pain and dysfunction of the TP. The aim of 
this systematic review was to synthesise the literature investigating kinematics of the foot and ankle 
in individuals with TPT compared to controls.  
5.1.2 Methods 
The protocol for the systematic review was developed in accordance with guidelines contained in 
the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement and 
registered online at: 
http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42016051527.  
Search Strategy  
A comprehensive literature search across electronic databases (CINAHL, Cochrane, Web of 
Science, Embase and PubMed) was performed up to and including 17 October 2018. The search 
strategy was broad to account for variations in terminology and ensure all relevant literature was 
captured (Flatfoot OR (posterior AND tibia* AND (tendon* OR tendin*)) OR “pes planus” OR 
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“pes planovalgus”). Reference lists of included papers were hand searched for potentially eligible 
articles.  
Two independent reviewers (MR and MP) performed the search and results were imported into 
Endnote X7 (Thompson Reuters, Carlsbad, California, USA). Duplicates were removed prior to 
screening titles and abstracts. Full text screening of potentially relevant articles against final 
eligibility criteria was performed by two reviewers (MR and MP). Where disagreements could not 
be resolved, a third reviewer (BV or MS) was consulted.  
Eligibility criteria  
Studies were included if: i) participants in each study were described as having clinical signs of 
TPT (and detailed eligibility criteria consistent with tendinopathy of tibialis posterior); ii) kinematic 
variables of the foot and ankle were evaluated in individuals with TPT and compared to healthy 
controls during gait (treadmill or over ground); iii) kinematic data were recorded from the foot and 
ankle, collected using three-dimensional (3D) multi-segment foot models; and iv) written in 
English.  
Reviews, single case reports, paediatric studies, studies investigating participants with rheumatoid 
arthritis or other conditions in addition to TPT and cadaver or animal studies were excluded. Where 
TPT data could not be separated from participants with other foot/ankle conditions or when there 
were no clinical signs of tendinopathy (i.e., other reasons for AAFD), studies were also excluded.  
Quality evaluation 
Methodological quality evaluation of included studies was performed via two methods. First, a 
modified version of the Epidemiological Appraisal Instrument (EAI)196 was used to evaluate 
methodological quality. As intervention/exposure outcomes were not the aim for this systematic 
review, some items were removed leaving only those relevant to cross-sectional studies. Each item 
was recorded as “Yes” (score = 1), “Partial” (score = 0.5), “No” (score = 0), “Unable to determine” 
(score = 0) or “Not Applicable” (item removed from scoring). The mean score across all applicable 
items was calculated to give the final overall score (range = 0 to 1).  
In addition to the EAI, an appraisal tool was used to assess the methodological quality specific to 
3D kinematic gait analysis. This 7-item tool was developed by Buldt, 208 based on a series of 
reviews addressing the issues associated with motion capture. 209-212 Each item was recorded as 
“Yes” (score = 1) or “No” (score = 0) for each article with a maximum score of 7 (i.e., highest 
methodological quality).  
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Two reviewers (MR and MP) rated the methodological quality of each included study against both 
appraisal tools. Inter-rater agreement was calculated for each scale prior to disagreements being 
discussed, and where a consensus could not be reached, a third reviewer (MS) was approached.  
Data extraction 
One reviewer extracted the following data in a predetermined spreadsheet: (i) participant 
characteristics – population source, sample size, sex, age, body mass index (BMI) and selection 
criteria (including for the diagnosis of TPT), (ii) details about 3D motion capture methods – 
including segments, planes, and (iii) main outcomes reported for each study. Means and standard 
deviations (SD) were extracted for all continuous kinematic and spatiotemporal data to allow 
standardised mean differences (SMDs) to be calculated for each included study. Where there was 
not sufficient information provided in the article to calculate ES (i.e. no mean or SD) for kinematic 
variables, the original authors were contacted for additional information. Kinematic data were 
extracted for the stance phase of gait only. When terminology/timing of each sub-phase (i.e. initial 
contact, loading response, mid-stance, terminal stance, pre-swing) varied between studies, data were 
categorised according to the following: initial contact; 0-10%, loading response; 0-20%, mid-
stance; 30-50%, terminal stance; 50-80%; pre-swing 90-100%. Prior to analysis, data extraction was 
verified by two additional reviewers (MS and BV).  
Statistical analyses 
Inter-rater agreement for reliability of the methodological quality assessment was calculated in Stata 
v14. The Cohen’s Kappa (ĸ) statistic (95% confidence interval (CI)) was interpreted as poor 
agreement (<0.00), slight agreement (0.00 – 0.20), fair agreement (0.21 – 0.40), moderate 
agreement (0.41 – 0.60), substantial agreement (0.61 – 0.80) or almost perfect agreement (0.81 to 
1.00 ). 89 
SMDs were calculated in Review Manager (RevMan) v5.3 (Copenhagen: The Nordic Cochrane 
Centre, The Cochrane Collaboration) using random effects models for Hedge’s g and calculated as 
the difference between TPT and control group means, divided by the pooled SD. 197 SMDs and 95% 
CIs were calculated and interpreted as small (≤0.59), medium (0.6-1.19) or large (≥1.2) 213 effect 
size.  
Meta-analysis was performed where methodology and reporting of outcome measures allowed 
pooling of data. Chi-squared tests (P<0.1) and the I2 statistic were used to quantify between study 
heterogeneity for pooled SMDs with ≥0.75 considered substantial heterogeneity. 198  A descriptive 
summary of main findings and study conclusions were presented where data was not available to 
calculate SMD.  
64 
5.1.3 Results 
Search strategy  
The initial database search identified 16 538 potentially eligible articles (Figure 5-1). After removal 
of duplicates, 8718 articles were screened by title and abstract of which 8644 did not meet the 
eligibility criteria. A total of 74 full text articles were screened against the eligibility criteria with 7 
articles included in the qualitative synthesis. Additional data for effect size calculations were 
provided by authors for Rabbito et al 126 and Ness et al. 128 
 
Figure 5-1 PRISMA flowchart 
Methodological quality  
The methodological quality of included articles, scored on the EAI, is represented in Table 5-1. 
Agreement between quality assessors, calculated as weighted ĸ, was almost perfect (ĸ statistic (95% 
CI) 0.94 (0.88, 1.00)) for the EAI. Two raters agreed on a total of 170 out of a possible 176 EAI 
items. All studies (100%) clearly described the objectives, main outcomes and characteristics of the 
participants included in the study. All studies (100%) also performed a standardised assessment on 
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Initial database search strategy  
n = 16 539 
Duplicates excluded  
n = 7821 
Title and abstracts screened  
n = 8718 
Full text assessed for eligibility  
n = 74 
Records excluded based on title and 
abstract 
n = 8001 
Full text excluded  
n = 67 
No kinematic data n = 42 
Not TPT n = 8 
No control n = 10 
No baseline measures n = 3 
Not gait = 2 
Paediatric flatfoot n = 1 
Unable to obtain full text n = 1 
Number in qualitative synthesis  
n = 7 
Number in quantitative synthesis 
n = 7 
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all participants. Eligibility criteria, important covariates, statistical methods, main findings and 
estimates of random variability were clearly described in 8 out of 9 studies (88.9%). One study 
(11.1%) reported the reliability of outcome measures and no studies reported the validity. One study 
collected disease history but no studies accounted for duration of symptoms in analyses. Two 
studies (22.2%) reported results for subgroups of PTTD participants and 6 (66.7%) studies adjusted 
for covariates in analyses.  
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Table 5-1 Epidemiological appraisal instrument for included studies (n = 7) 
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Q1. Hypothesis/aim/ objective clearly described        100 
Q2. Main outcomes clearly described        100 
Q3. Reported study design        42.9 
Q4. Source of subject population clearly 
described 
       14.3 
Q5. Reported eligibility criteria        85.7 
Q6. Characteristics of study participants 
described 
       100 
Q7. Important covariates and confounders 
described 
       85.7 
Q8. Statistical methods clearly described        85.7 
Q9. Main findings of the study clearly described        85.7 
Q10. Provides estimates of the random variability 
in the data  
       85.7 
Q11. Sample size calculations        14.3 
Q12. Comparability of case/control groups        42.9 
Q13. Recruitment period for case/control groups        0.0 
Q14. Reliability of outcome measures        14.3 
Q15. Validity of outcome measures        0.0 
Q16. Standardised assessment         100 
Q17. History of disease/symptoms collected and 
included in analysis 
       0.0 
Q18. Adjusted for covariates        71.4 
Q19. Reported data for subgroups        28.6 
Q20. Generalibility of results to other populations        0.0 
Overall quality score (range 0 to 1) 0.58 0.40 0.73 0.75 0.43 0.58 0.68 0.59 
Black shading = "yes" (1), Grey shading = "Partial" (0.5), White (no shading) = "No" or "Unable to 
determine", NA = "not applicable" (0) 
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The assessment of 3D kinematic specific methodological quality for gait studies is presented in 
Table 5-2. Agreement between two independent raters, calculated as ĸ, was almost perfect (ĸ 
statistic (95% CI) 0.86 (0.72, 1.01)). The median score was 5 (range 2 to 6). Details of the assessors 
carrying out the 3D kinematic analysis were not given in any paper, and only 2 papers (28.6%) 
provided adequate information about the reliability, precision and accuracy of data capture 
equipment. All papers (100%) clearly and accurately described marker placement, modelling 
technique, segments, anatomical reference planes and motion between segments.  
 
Participants 
Population source, sample sizes and participant characteristics (sex, age, BMI) are included in 
Table 5-3. Included TPT were predominantly females (% female ranging from 63.3% 125 to 100% 
214), mean age (SD) ranging from 30.3 (7.9) 126 to 69 (7.0) 214 and BMI between 23.4 (3.4) 126 and 
33.7 (7.4). 127 
 
Details regarding methods specific to 3D motion capture are provided in Table 5-4. Kinematic 
characteristics during gait were captured during treadmill walking in one study, and overground 
walking in remaining studies. Data for the medial longitudinal arch were captured in four of seven 
studies, with most studies reporting data for ankle, hindfoot and forefoot segments (Table 5-4). 
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Table 5-2 Methodological assessment scores for items relating to 3D kinematic gait analysis (n = 8)  
Item 
Houck 
et al 124 
Ness 
et al 
128 
Neville 
et al 125 
Rabbito 
et al 126 
Ringleb 
et al 214 
Tome 
et al 
127 
Van 
de 
Velde 
215 
Studies 
scoring 
‘Yes’ 
(%) 
1. Were details of the assessors carrying out the 3D 
kinematic gait analysis provided? 
0 0 0 0 0 0 0 0 
2. Were spatiotemporal data and gait analysis 
procedure methodology described? 
1 0 1 1 0 1 1 71.4 
3. Were movement tasks clearly defined? 1 0 1 1 0 1 1 71.4 
4. Was marker placement clearly and accurately 
described and was the modelling technique 
described? 
1 1 1 1 1 1 1 100 
5. Was data capture equipment reported including 
the reporting of reliability, precision and accuracy 
of equipment? 
0 1 1 0 0 0 0 28.6 
6. Was a reference position reported? 1 1 1 1 0 1 0 71.4 
7. Were the segments, anatomical reference planes 
and motion between segments reported? 
1 1 1 1 1 1 0 85.7 
Total (/7) 5 4 6 5 2 5 3 5* 
Key: 1; yes, 0; no, *; median score across all studies 
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Table 5-3 Sample sizes and population characteristics for included studies (n = 7) 
 
 Sample size Sex (TPT 
group) 
Age (mean (SD)) BMI (mean (SD)) Diagnostic criteria 
Paper Source of 
participants 
TPT Control Female (%) TPT Control TPT Control Tendinopathy 
signs 
Flatfoot 
requirement 
Houck et al 124 Orthopaedic 
clinic 
30 15 22 (73.3) 59.3 (10.8) 56.5 (7.7) 29.6 (4.8) 30.5 (3.6) TOP, swelling, 
pain with 
SLHR 
Yes 
Ness et al 128 Orthopaedic 
clinic 
34 25 30 (88.2) 52.8 (9.5)* 41.3 (12.5) 32 (7.5)* 26.3 (3.8) Not reported NR 
Neville et al 125 General 
community 
30 15 19 (63.3) 58.1 (10.5) 56.5 (7.7) 30.6 (5.4) 30.6 (3.6) At least 1 of: 
TOP, swelling, 
pain with 
SLHR 
Yes 
Rabbito et al 
126 
Recreational 
running 
community 
12 12 9 (100) 30.3 (7.9) 28.5 (8.6) 23.2 (3.4) 23.7 (2.8) Swelling, pain 
or TOP  
No 
Ringleb et al 
214 
Podiatric 
clinic 
5 20 5 (85.7) 69.0 (7.0)* 46.0 (14.0) 29.0 (1.0) 25.0 (4.0) TOP, swelling, 
pain with 
SLHR 
NR 
Tome et al 127 Orthopaedic 
clinic 
14 10 12 (70.0) 56.8 (11.7) 51.2 (7.3) 33.7 (7.4)* 31.8 (3.6) TOP, swelling, 
pain with 
SLHR 
Yes 
Van de Velde 
215 
Orthopaedic 
clinic 
15 15 10 (66.7) 51 (12.2) 52 (10.1) 29 (3.9) 24 (3.7) TOP, difficulty 
performing 
SLHR 
Yes 
* indicates significant difference (p < 0.05) between groups, TPT; tibialis posterior tendinopathy, SD; standard deviation, TOP; tenderness on 
palpation, SLHR; single leg heel raise 
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Table 5-4 Population types, activities, variables and spatiotemporal characteristics 
Paper Activity Equipment 
Sampling 
rate 
Reference 
position 
Model Segments Planes 
Number 
of trials 
Spatiotemporal 
characteristics 
Houck et al 
124 
Walking IRED, 6-
camera 
Optitrack 
Motion 
Analysis 
System 
60 Hz Subtalar 
neutral 
NR 4: Tibia, hindfoot 
(calcaneus), first metatarsal, 
Sagittal, 
coronal 
5 Controlled (1 m/s) 
Ness et al 
128 
Walking 15-camera 
Vicon Motion 
Analysis 
System 
120 Hz Relaxed 
standing 
Milwaukee 
Foot 
Model 
4: Tibia, hindfoot 
(calcaneus), forefoot (1st - 
5th metatarsals), hallux 
Sagittal, 
coronal, 
transverse 
3 Uncontrolled (avg 
0.79 m/s) 
Neville et 
al 125 
Walking IRED, 6-
camera 
Optitrack 
Motion 
Analysis 
System 
60 Hz Subtalar 
neutral 
NR 5: Tibia, hindfoot 
(calcaneus), medial forefoot 
(1st metatarsal), lateral 
forefoot (2nd - 4th 
metatarsals) (navicular 
tuberosity) 
Coronal, 
transverse, 
MLA 
5 Controlled (1 m/s) 
Rabbito et 
al 126 
Treadmill 
walking 
8-camera Vicon 
Motion 
Analysis 
System 
120 Hz Subtalar 
neutral 
NR 3: Tibia, hindfoot 
(calcaneus), 1st metatarsal, 
hallux, (navicular 
tuberosity) 
Coronal, 
MLA 
10 Controlled (1.2 
m/s) 
Ringleb et 
al 214 
Walking 10-camera, 
Real-Time 
ExpertVision 
System 
120 Hz Relaxed 
standing 
Custom 3: Tibia, hindfoot 
(calcaneus), midfoot (1st & 
5th metatarsals) 
Sagittal, 
coronal, 
transverse 
NR Uncontrolled (avg 
1.1 m/s) 
Tome et al 
127 
Walking IRED, 6-
camera 
Optitrack 
Motion 
Analysis 
System 
60 Hz Relaxed 
standing 
NR 5: Tibia, hindfoot, medial 
forefoot (1st metatarsal), 
lateral forefoot (2nd - 4th 
metatarsals), hallux 
(navicular tuberosity) 
Coronal, 
transverse, 
MLA 
5 Uncontrolled (avg 
1.2 m/s) 
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Van de 
Velde 215 
Walking 10-camera 
Vicon Motion 
Analysis 
System 
100 Hz Subtalar 
neutral 
Rizzoli 5: Tibia, calcaneus, 
midfoot, metatarsals, hallux 
Sagittal, 
coronal, 
transverse, 
MLA 
3 Uncontrolled 
(Stage II avg 1.0 
m/s) 
Abbreviations: IRED; infra-red emitting diode, Hz; hertz, NR; not reported, m/s; metres per second, MLA; medial longitudinal arch angle 
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Outcomes measured 
Spatiotemporal gait characteristics and kinematics for the tibia, hindfoot, midfoot, forefoot and 
hallux in three planes (sagittal, coronal, transverse) were reported for varying time points during the 
stance phase of gait (Appendix 5). SMDs were calculated for peak angles (Table 5-6) and 
excursion (Table 5-7) for each joint where a minimum of two studies reported data (the ankle, 
hindfoot and forefoot in the sagittal, coronal and transverse planes, hallux in the sagittal plane and 
the medial longitudinal arch angle). Where SMDs could not be calculated for a specific stance 
phase, data are reported descriptively.  
Main findings 
Spatiotemporal characteristics 
When walking speed was self-selected (n of studies = 4), meta-analysis showed a large, significant 
effect for slower walking speed in individuals with TPT compared to controls (SMD (95% CI) -1.4 
(-2.2 to -1.0) (Table 5-5/Figure 5-2). Pooled SMDs from two studies showed that cadence was 
significantly lower in TPT compared to controls (SMD (95% CI) -1.3 (-2.3 to -0.3)). Individual 
SMDs showed large effects longer stance duration (% of gait) 128 and shorter stride length 128 in 
TPT compared to controls ((SMD 95% CI) 1.4 (0.8 to 2.0) and -2.1 (-2.8 to -1.5) respectively) 
(Table 5-5/Figure 5-2). Individual SMDs from one study showed large effects for longer stride 
time in TPT compared to controls (SMD (95% CI) 1.9 (1.0 to 2.9)), 215 but another found no 
difference between groups for stance time (SMD (95% CI) 0.7 (-0.2 to 1.5)) (Table 5-5/Figure 
5-2). 127  
Figure 5-2 Spatiotemporal characteristics for TPT compared to controls presented as SMD (95% 
CI) (-SMD indicates smaller values in TPT, +SMD indicates larger values in TPT). 
-4 -2 0 2 4
Ness 2008
Tome 2006
Ness 2008
Van de Velde 2017
POOLED
Ness 2008
Van de Velde 2017
POOLED
Van de Velde 2017
Ringleb 2007
Neville 2010
Ness 2008Walking speed
Cadence
Stride time
Stride length
Stance time
Stance duration
SMD (95% CI)
73 
Table 5-5 Extracted data (mean, SD, n) and calculated SMDs for spatiotemporal data 
  TPT Control   
Characteristic Study Mean SD n Mean  SD n Weight SMD [95% CI] 
Walking speed  
(m/s) Ness 128 0.79 0.18 34 1.12 0.1 25 28.40% -2.15 [-2.80, -1.49] 
 Neville 
125 1.19 0.22 17 1.34 0.22 10 25.90% -0.66 [-1.47, 0.14] 
 Ringleb 
214 1.1 0.2 5 1.2 0.1 20 22.50% -0.78 [-1.79, 0.22] 
 Tome 
127 1.2 0 14 1.3 0 10  Not estimable 
 Van de Velde 
215 1 0.2 11 1.3 0.1 15 23.20% -1.94 [-2.90, -0.97] 
          
 Total (95% CI)   81   80 100.00% -1.41 [-2.20, -0.61] 
 Heterogeneity: Tau² = 0.47; Chi² = 10.68, df = 3 (P = 0.01); I² = 72%         
 Test for overall effect: Z = 3.46 (P = 0.0005)         
          
Cadence  
(steps/min) Van de Velde 215 92.9 15.5 11 116.4 9.1 15 41.90% -1.87 [-2.82, -0.91] 
 Ness 
128 96.26 9.75 34 104.2 7.86 25 58.10% -0.87 [-1.41, -0.33] 
          
 Total (95% CI)   45   40 100.00% -1.29 [-2.25, -0.32] 
 Heterogeneity: Tau² = 0.34; Chi² = 3.18, df = 1 (P = 0.07); I² = 69%         
 Test for overall effect: Z = 2.62 (P = 0.009)         
          
Stride time (m/s) Van de Velde 215 1.2 0.1 11 1 0.1 15 100.00% 1.94 [0.97, 2.90] 
          
Stride length (m) Ness 128 0.98 0.17 34 1.29 0.1 25 100.00% -2.11 [-2.76, -1.46] 
          
Stance time (s) Tome 127 0.772 0.083 14 0.72 0.064 10 100.00% 0.66 [-0.17, 1.50] 
          
Stance duration  
(% of stride) Ness 128 65.79 2.33 34 62.26 2.61 25 100.00% 1.42 [0.84, 2.00] 
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Table 5-6 Extracted data (mean, SD, n) and calculated SMDs for peak values (in degrees)for each joint/segment during each phase of stance 
   TPT Control   
Joint/segment Phase of 
stance 
Study Mean SD n Mean SD n Weight SMD [95% CI] 
Ankle plantar 
flexion/ 
dorsiflexion 
Initial 
contact 
Houck 124 -1.8 5.3 30 5.9 2.4 15 38.40% -1.66 [-2.37, -0.94] 
Ness 128 6.1 10.16 34 19.7 12 25 61.60% -1.23 [-1.79, -0.66] 
         
Total (95% CI) 
  
64 
  
40 100.00% -1.39 [-1.83, -0.95] 
Heterogeneity: Tau² = 0.00; Chi² = 0.87, df = 1 
(P = 0.35); I² = 0% 
        
Test for overall effect: Z = 6.15 (P < 0.00001) 
        
          
Loading 
response 
Houck 124 -10.5 4.2 30 -2.1 2.5 15 33.20% -2.21 [-2.99, -1.43] 
Ness 128 7.97 9.85 34 22.52 11.7 25 39.20% -1.34 [-1.92, -0.77] 
Ringleb 214 -10 3 5 -8 3 20 27.50% -0.64 [-1.64, 0.35] 
         
Total (95% CI) 
  
69 
  
60 100.00% -1.44 [-2.23, -0.65] 
Heterogeneity: Tau² = 0.33; Chi² = 6.25, df = 2 
(P = 0.04); I² = 68% 
        
Test for overall effect: Z = 3.59 (P = 0.0003) 
        
          
Midstance Ness 128 14.94 11.11 34 28.02 11.9 25 100.00% -1.13 [-1.69, -0.57] 
          
Terminal 
stance 
Houck 124 8 5.4 30 14.8 3.2 15 32.40% -1.39 [-2.08, -0.70] 
Ness 128 19.79 13.63 34 31.53 11.8 25 52.20% -0.90 [-1.44, -0.36] 
Ringleb 214 5 3 5 7 3 20 15.40% -0.64 [-1.64, 0.35] 
         
Total (95% CI) 
  
69 
  
60 100.00% -1.02 [-1.41, -0.63] 
Heterogeneity: Tau² = 0.00; Chi² = 1.86, df = 2 
(P = 0.40); I² = 0% 
        
Test for overall effect: Z = 5.10 (P < 0.00001) 
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Preswing Houck 124 -7.5 8.6 30 -4.2 3.8 15 36.50% -0.44 [-1.07, 0.19] 
Ness 128 15.43 15.2 34 27.4 12.1 25 49.20% -0.85 [-1.39, -0.31] 
Ringleb 214 -12 3 5 -8 6 20 14.30% -0.69 [-1.69, 0.31] 
         
Total (95% CI) 
  
69 
  
60 100.00% -0.68 [-1.05, -0.30] 
Heterogeneity: Tau² = 0.00; Chi² = 0.93, df = 2 
(P = 0.63); I² = 0% 
        
Test for overall effect: Z = 3.49 (P = 0.0005) 
        
           
Hindfoot 
inversion 
/eversion 
Initial 
contact 
Houck 124 -3.4 4 30 -0.7 2.4 15 41.30% -0.75 [-1.39, -0.10] 
Ness 128 -4.48 10.34 34 3.64 10.1 25 58.70% -0.78 [-1.32, -0.25] 
         
Total (95% CI) 
  
64 
  
40 100.00% -0.77 [-1.18, -0.36] 
Heterogeneity: Tau² = 0.00; Chi² = 0.01, df = 1 
(P = 0.93); I² = 0% 
        
Test for overall effect: Z = 3.66 (P = 0.0003) 
        
          
Loading 
response 
Houck 124 -11.2 4.3 30 -6.1 2.2 15 22.60% -1.34 [-2.02, -0.65] 
Ness 128 -6.8 9.7 34 2.04 9.44 25 27.80% -0.91 [-1.45, -0.37] 
Neville 125 -12.3 5.9 16 -5.1 1.9 15 18.50% -1.58 [-2.40, -0.76] 
Ringleb 214 -4 3 5 -4 4 20 14.70% 0.00 [-0.98, 0.98] 
Tome 127 -9.6 4.7 14 -3.4 4.6 10 16.40% -1.28 [-2.19, -0.38] 
         
Total (95% CI) 
  
99 
  
85 100.00% -1.06 [-1.51, -0.60] 
Heterogeneity: Tau² = 0.12; Chi² = 7.19, df = 4 
(P = 0.13); I² = 44% 
        
Test for overall effect: Z = 4.54 (P < 0.00001) 
        
          
Midstance Ness 128 -8.81 9.94 34 0.21 9.58 25 44.00% -0.91 [-1.45, -0.37] 
Neville 125 -13.2 5 16 -5.5 2 15 28.20% -1.95 [-2.82, -1.07] 
76 
Tome 127 -10.4 4.5 14 -5.4 3.6 10 27.70% -1.16 [-2.05, -0.27] 
         
Total (95% CI) 
  
64 
  
50 100.00% -1.27 [-1.88, -0.66] 
Heterogeneity: Tau² = 0.14; Chi² = 3.89, df = 2 
(P = 0.14); I² = 49% 
        
Test for overall effect: Z = 4.10 (P < 0.0001) 
        
          
Terminal 
stance 
Houck 124 -9.8 4.3 30 -4.8 2.2 15 21.80% -1.31 [-1.99, -0.63] 
Ness 128 -10.53 10.19 34 -0.28 9.26 25 23.50% -1.03 [-1.58, -0.48] 
Neville 125 -11.5 4.8 16 -3.8 2.2 15 19.10% -1.99 [-2.87, -1.11] 
Ringleb 214 -2 3 5 -4 2 10 16.00% 0.80 [-0.32, 1.92] 
Tome 127 -9 3.9 14 -6.4 2.9 10 19.60% -0.71 [-1.55, 0.13] 
         
Total (95% CI) 
  
99 
  
75 100.00% -0.92 [-1.62, -0.22] 
Heterogeneity: Tau² = 0.46; Chi² = 15.90, df = 
4 (P = 0.003); I² = 75% 
        
Test for overall effect: Z = 2.58 (P = 0.010) 
        
          
Preswing Houck 124 -1.4 5 30 3.8 2.6 15 22.10% -1.17 [-1.84, -0.50] 
Ness 128 -10.51 9.34 34 2.85 6.42 25 23.50% -1.60 [-2.20, -1.00] 
Neville 125 -5.1 6 16 3.7 2.7 15 18.90% -1.82 [-2.68, -0.97] 
Ringleb 214 10 8 5 9 3 20 16.80% 0.22 [-0.76, 1.21] 
Tome 127 -3.2 4.7 14 1.1 3.5 10 18.70% -0.98 [-1.84, -0.11] 
         
Total (95% CI) 
  
99 
  
85 100.00% -1.12 [-1.73, -0.52] 
Heterogeneity: Tau² = 0.31; Chi² = 12.09, df = 
4 (P = 0.02); I² = 67% 
        
Test for overall effect: Z = 3.65 (P = 0.0003) 
        
           
Forefoot 
plantar 
Initial 
contact 
Houck 124 6.3 8.4 30 -1.7 3.5 15 48.10% 1.09 [0.43, 1.76] 
Ness 128 -27.69 11.49 34 -45.61 7.56 25 51.90% 1.76 [1.15, 2.38] 
         
77 
flexion/ 
dorsiflexion 
Total (95% CI) 
  
64 
  
40 100.00% 1.44 [0.79, 2.10] 
Heterogeneity: Tau² = 0.12; Chi² = 2.11, df = 1 
(P = 0.15); I² = 53% 
        
Test for overall effect: Z = 1.66 (P = 0.10) 
        
          
Loading 
response 
Houck 124 12.2 7.9 30 2.4 3.5 15 34.40% 1.42 [0.73, 2.11] 
 
Ness 128 -26.11 11.07 34 -43.24 8.63 25 35.70% 1.67 [1.07, 2.27] 
 
Ringleb 214 -0.2 5 5 1 3 20 29.90% -0.34 [-1.32, 0.65] 
          
 
Total (95% CI) 
  
69 
  
60 100.00% 0.98 [-0.07, 2.04] 
 
Heterogeneity: Tau² = 0.72; Chi² = 12.07, df = 
2 (P = 0.002); I² = 83% 
        
 
Test for overall effect: Z = 1.83 (P = 0.07) 
        
          
Midstance Ness 128 -26.49 9.48 34 -42.4 7.85 25 100.00% 1.78 [1.16, 2.39] 
          
          
Terminal 
stance 
Houck 124 16.4 8.5 30 7.3 4.2 15 34.20% 1.21 [0.54, 1.88] 
Ness 128 -22.65 9.34 34 -38.83 7.89 25 34.60% 1.82 [1.20, 2.44] 
Ringleb 214 -3 5 5 0 2 20 31.10% -1.05 [-2.08, -0.02] 
         
Total (95% CI) 
  
69 
  
60 100.00% 0.72 [-0.72, 2.16] 
Heterogeneity: Tau² = 1.46; Chi² = 22.07, df = 
2 (P < 0.0001); I² = 91% 
        
Test for overall effect: Z = 0.98 (P = 0.33) 
        
          
Preswing Houck 124 -0.3 9.9 30 -8.5 6 15 38.40% 0.91 [0.26, 1.56] 
Ness 128 -25.03 11.48 34 -42.14 7.85 25 42.00% 1.67 [1.07, 2.27] 
Ringleb 214 -8 7 5 -15 6 20 19.60% 1.09 [0.06, 2.13] 
         
Total (95% CI) 
  
69 
  
60 100.00% 1.27 [0.76, 1.78] 
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Heterogeneity: Tau² = 0.07; Chi² = 2.95, df = 2 
(P = 0.23); I² = 32% 
        
Test for overall effect: Z = 4.87 (P < 0.00001) 
        
           
Forefoot 
inversion 
/eversion 
Initial 
contact 
Ness 128 4.53 8.55 34 6.41 8.1 25 100.00% -0.22 [-0.74, 0.30] 
          
Loading 
response 
Ness 128 1.48 7.76 34 1.95 7.85 25 57.00% -0.06 [-0.58, 0.46] 
Ringleb 214 -6 3 5 -3 2 20 43.00% -1.31 [-2.37, -0.26] 
         
Total (95% CI) 
  
39 
  
45 100.00% -0.60 [-1.82, 0.62] 
Heterogeneity: Tau² = 0.61; Chi² = 4.37, df = 1 
(P = 0.04); I² = 77% 
        
Test for overall effect: Z = 0.96 (P = 0.34) 
        
          
Midstance Ness 128 0.86 6.14 34 2.59 6.73 25 100.00% -0.27 [-0.79, 0.25] 
          
Terminal 
stance 
Ness 128 1.1 6.23 34 4.67 6.77 25 77.60% -0.55 [-1.07, -0.02] 
Ringleb 214 3 1 5 3 2 20 22.40% 0.00 [-0.98, 0.98] 
         
Total (95% CI) 
  
39 
  
45 100.00% -0.42 [-0.89, 0.04] 
Heterogeneity: Tau² = 0.00; Chi² = 0.92, df = 1 
(P = 0.34); I² = 0% 
        
Test for overall effect: Z = 1.79 (P = 0.07) 
        
          
Preswing Ness 128 2.13 5.82 34 15.4 7.89 25 55.20% -1.93 [-2.56, -1.30] 
Ringleb 214 -4 5 5 -2 2 20 44.80% -0.70 [-1.70, 0.30] 
         
Total (95% CI) 
  
39 
  
45 100.00% -1.38 [-2.58, -0.18] 
Heterogeneity: Tau² = 0.58; Chi² = 4.18, df = 1 
(P = 0.04); I² = 76% 
        
Test for overall effect: Z = 2.25 (P = 0.02) 
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Forefoot 
abduction 
/adduction 
Initial 
contact 
Ness 128 2.61 10 34 16.44 7.66 25 100.00% -1.50 [-2.09, -0.91] 
          
Loading 
response 
Ness 128 -2.81 9.89 34 7.56 6.29 25 44.50% -1.20 [-1.76, -0.63] 
Neville 125 -6.2 4.8 16 -2.4 1.9 15 24.80% -1.00 [-1.75, -0.25] 
Ringleb 214 1 1 5 3 2 20 13.30% -1.04 [-2.07, -0.01] 
Tome 127 -9.1 3.7 14 -4.4 3.4 10 17.30% -1.27 [-2.17, -0.37] 
         
Total (95% CI) 
  
69 
  
70 100.00% -1.14 [-1.51, -0.76] 
Heterogeneity: Tau² = 0.00; Chi² = 0.28, df = 3 
(P = 0.96); I² = 0% 
        
Test for overall effect: Z = 5.95 (P < 0.00001) 
        
          
Midstance Ness 128 -4.68 10.46 34 3.97 5.11 25 52.30% -0.99 [-1.54, -0.44] 
Neville 125 -8.1 4.6 16 -5 2.2 15 28.90% -0.83 [-1.57, -0.09] 
Tome 127 -10.1 3.1 14 -5.7 3.1 10 18.80% -1.37 [-2.29, -0.45] 
         
Total (95% CI) 
  
64 
  
50 100.00% -1.01 [-1.41, -0.62] 
Heterogeneity: Tau² = 0.00; Chi² = 0.83, df = 2 
(P = 0.66); I² = 0% 
        
Test for overall effect: Z = 5.01 (P < 0.00001) 
        
          
Terminal 
stance 
Ness 128 -6.44 11.57 34 2.7 5.99 25 28.50% -0.94 [-1.48, -0.39] 
Neville 125 -10 4.7 16 -6.6 2.1 15 26.00% -0.90 [-1.64, -0.16] 
Ringleb 214 -1 1 5 -2 1 20 22.40% 0.97 [-0.06, 1.99] 
Tome 127 -11.4 2.8 14 -6.5 2.8 10 23.10% -1.69 [-2.66, -0.72] 
         
Total (95% CI) 
  
69 
  
70 100.00% -0.68 [-1.56, 0.21] 
Heterogeneity: Tau² = 0.64; Chi² = 15.04, df = 
3 (P = 0.002); I² = 80% 
        
Test for overall effect: Z = 1.49 (P = 0.14) 
        
          
Preswing Ness 128 -5.08 12.11 34 -0.78 8.73 25 29.60% -0.39 [-0.91, 0.13] 
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Neville 125 -7.3 5.5 16 1.2 2.9 15 25.20% -1.86 [-2.73, -1.00] 
Ringleb 214 3 2 5 9 3 20 21.20% -2.03 [-3.19, -0.88] 
Tome 127 -9.2 5.7 14 -0.9 3.8 10 24.00% -1.60 [-2.55, -0.65] 
         
Total (95% CI) 
  
69 
  
70 100.00% -1.40 [-2.29, -0.51] 
Heterogeneity: Tau² = 0.63; Chi² = 13.61, df = 
3 (P = 0.003); I² = 78% 
        
Test for overall effect: Z = 3.08 (P = 0.002) 
        
          
Medial 
longitudinal 
arch angle 
  
Loading 
response 
Neville 125 10.7 8.8 16 0.3 3.1 15 54.20% 1.52 [0.70, 2.33] 
Tome 127 8.2 8.7 14 0 3.3 10 45.80% 1.13 [0.25, 2.01] 
         
Total (95% CI) 
  
30 
  
25 100.00% 1.34 [0.74, 1.94] 
Heterogeneity: Tau² = 0.00; Chi² = 0.40, df = 1 
(P = 0.53); I² = 0% 
        
Test for overall effect: Z = 4.39 (P < 0.0001) 
        
          
Midstance Neville 125 12 8.4 16 2.2 2.9 15 54.30% 1.50 [0.69, 2.31] 
Tome 127 9.8 7.9 14 2.1 4.2 10 45.70% 1.12 [0.24, 2.00] 
         
Total (95% CI) 
  
30 
  
25 100.00% 1.33 [0.73, 1.92] 
Heterogeneity: Tau² = 0.00; Chi² = 0.38, df = 1 
(P = 0.53); I² = 0% 
        
Test for overall effect: Z = 4.35 (P < 0.0001) 
        
          
Terminal 
stance 
Neville 125 13 8.1 16 5.1 3 15 54.40% 1.24 [0.47, 2.02] 
Tome 127 12.2 6.9 14 7.2 4 10 45.60% 0.82 [-0.03, 1.67] 
         
Total (95% CI) 
  
30 
  
25 100.00% 1.05 [0.48, 1.62] 
Heterogeneity: Tau² = 0.00; Chi² = 0.52, df = 1 
(P = 0.47); I² = 0% 
        
Test for overall effect: Z = 3.59 (P = 0.0003) 
        
          
81 
Preswing 
  
Neville 125 12.5 8.2 16 1.8 4.7 15 55.70% 1.55 [0.73, 2.36] 
Tome 127 5.3 8.4 14 -4.7 4.4 10 44.30% 1.37 [0.46, 2.29] 
         
Total (95% CI) 
  
30 
  
25 100.00% 1.47 [0.86, 2.08] 
Heterogeneity: Tau² = 0.00; Chi² = 0.08, df = 1 
(P = 0.78); I² = 0% 
        
Test for overall effect: Z = 4.72 (P < 0.00001)                 
 
Table 5-7 Extracted data (mean, SD, n) and calculated SMDs for total excursion (degrees) at each joint/segment during each phase of stance 
   TPT Controls   
Joint/segment 
Phase of 
stance Study Mean SD n Mean  SD n Weight SMD [95% CI] 
Ankle plantar 
flexion/ 
dorsiflexion 
Initial 
contact 
Ness 128 6.10 10.16 34 19.70 11.96 25 100.00% -1.23 [-1.79, -0.66] 
          
Loading 
response 
Ness 128 4.92 1.52 34 6.86 1.89 25 51.70% -1.14 [-1.70, -0.58] 
Van de Velde 215 4.40 1.90 11 3.70 1.40 15 48.30% 0.42 [-0.37, 1.20] 
         
Total (95% CI) 
  
45 
  
40 100.00% -0.39 [-1.91, 1.14] 
Heterogeneity: Tau² = 1.09; Chi² = 9.99, df 
= 1 (P = 0.002); I² = 90% 
        
Test for overall effect: Z = 0.50 (P = 0.62) 
        
          
Midstance Ness 128 9.08 2.73 34 7.38 2.97 25 59.60% 0.59 [0.06, 1.12] 
Van de Velde 215 10.50 1.80 11 10.70 3.10 15 40.40% -0.07 [-0.85, 0.70] 
         
Total (95% CI) 
  
45 
  
40 100.00% 0.32 [-0.32, 0.96] 
Heterogeneity: Tau² = 0.11; Chi² = 1.92, df 
= 1 (P = 0.17); I² = 48% 
        
Test for overall effect: Z = 0.99 (P = 0.32) 
        
          
82 
Terminal 
stance 
Ness 128 7.36 4.12 34 6.45 3.47 25 100.00% 0.23 [-0.28, 0.75] 
          
Pre-swing Ness 128 8.81 5.34 34 12.10 5.02 25 63.20% -0.62 [-1.15, -0.09] 
Van de Velde 215 16.40 8.50 11 16.80 5.00 15 36.80% -0.06 [-0.84, 0.72] 
         
Total (95% CI) 
  
45 
  
40 100.00% -0.42 [-0.95, 0.12] 
Heterogeneity: Tau² = 0.04; Chi² = 1.39, df 
= 1 (P = 0.24); I² = 28% 
        
Test for overall effect: Z = 1.52 (P = 0.13) 
        
           
Hindfoot 
inversion 
/eversion 
Initial 
contact 
Ness 128 4.48 10.34 34 -3.64 10.10 25 100.00% 0.78 [0.25, 1.32] 
          
Loading 
response 
Ness 128 2.76 1.99 34 4.10 2.02 25 53.80% -0.66 [-1.19, -0.13] 
Van de Velde 215 4.40 1.90 11 3.70 1.40 15 46.20% 0.42 [-0.37, 1.20] 
         
Total (95% CI) 
  
45 
  
40 100.00% -0.16 [-1.22, 0.89] 
Heterogeneity: Tau² = 0.46; Chi² = 4.95, df 
= 1 (P = 0.03); I² = 80% 
        
Test for overall effect: Z = 0.30 (P = 0.76) 
        
          
Mid-stance Ness 128 2.90 1.14 34 5.10 2.77 25 53.80% -1.09 [-1.64, -0.53] 
Van de Velde 215 10.50 1.80 11 10.70 3.10 15 46.20% -0.07 [-0.85, 0.70] 
         
Total (95% CI) 
  
45 
  
40 100.00% -0.62 [-1.61, 0.37] 
Heterogeneity: Tau² = 0.40; Chi² = 4.33, df 
= 1 (P = 0.04); I² = 77% 
        
Test for overall effect: Z = 1.22 (P = 0.22) 
        
          
Terminal 
stance 
Ness 128 4.82 3.85 34 6.90 4.02 25 100.00% -0.52 [-1.05, 0.00] 
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Pre-swing Ness 128 6.66 5.28 34 6.22 3.75 25 51.90% 0.09 [-0.42, 0.61] 
Van de Velde 215 11.40 4.90 11 21.50 4.20 15 48.10% -2.17 [-3.18, -1.16] 
         
Total (95% CI) 
  
45 
  
40 100.00% -1.00 [-3.21, 1.22] 
Heterogeneity: Tau² = 2.40; Chi² = 15.35, df 
= 1 (P < 0.0001); I² = 93% 
        
Test for overall effect: Z = 0.88 (P = 0.38) 
        
           
Hindfoot 
abduction 
/adduction 
Initial 
contact 
Ness 128 4.88 8.56 34 -2.17 5.39 25 100.00% 0.94 [0.40, 1.49] 
          
Loading 
response 
Ness 128 2.57 1.17 34 5.35 2.81 25 52.00% -1.35 [-1.93, -0.78] 
Van de Velde 215 3.50 2.50 11 3.50 1.60 15 48.00% 0.00 [-0.78, 0.78] 
         
Total (95% CI) 
  
45 
  
40 100.00% -0.70 [-2.03, 0.62] 
Heterogeneity: Tau² = 0.79; Chi² = 7.52, df 
= 1 (P = 0.006); I² = 87% 
        
Test for overall effect: Z = 1.04 (P = 0.30) 
        
          
Mid-stance Ness 128 2.61 1.03 34 5.81 4.78 25 52.30% -0.99 [-1.53, -0.44] 
Van de Velde 215 3.70 2.50 11 2.90 1.80 15 47.70% 0.37 [-0.42, 1.15] 
         
Total (95% CI) 
  
45 
  
40 100.00% -0.34 [-1.66, 0.98] 
Heterogeneity: Tau² = 0.79; Chi² = 7.64, df 
= 1 (P = 0.006); I² = 87% 
        
Test for overall effect: Z = 0.50 (P = 0.61) 
        
          
Terminal 
stance 
Ness 128 5.70 4.77 34 6.50 2.55 25 100.00% -0.20 [-0.72, 0.32] 
          
Pre-swing Ness 128 5.45 2.86 34 5.73 3.08 25 51.80% -0.09 [-0.61, 0.43] 
Van de Velde 215 3.10 1.60 11 10.30 2.80 15 48.20% -2.94 [-4.10, -1.77] 
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Total (95% CI) 
  
45 
  
40 100.00% -1.46 [-4.25, 1.32] 
Heterogeneity: Tau² = 3.84; Chi² = 19.16, df 
= 1 (P < 0.0001); I² = 95% 
        
Test for overall effect: Z = 1.03 (P = 0.30) 
        
           
           
Forefoot 
plantar flexion 
/dorsiflexion 
Initial 
contact 
Ness 128 -27.69 11.49 34 -45.61 7.56 25 100.00% 1.76 [1.15, 2.38] 
          
Loading 
response 
Ness 128 3.70 4.37 34 4.55 2.34 25 69.30% -0.23 [-0.75, 0.29] 
Van de Velde 215 3.30 2.10 11 3.60 1.70 15 30.70% -0.15 [-0.93, 0.62] 
         
Total (95% CI) 
  
45 
  
40 100.00% -0.21 [-0.64, 0.22] 
Heterogeneity: Tau² = 0.00; Chi² = 0.02, df 
= 1 (P = 0.88); I² = 0% 
        
Test for overall effect: Z = 0.94 (P = 0.35) 
        
          
Mid-stance Ness 128 3.23 2.62 34 5.35 2.54 25 51.50% -0.81 [-1.35, -0.27] 
Van de Velde 215 5.40 3.10 11 2.90 1.30 15 48.50% 1.08 [0.24, 1.92] 
         
Total (95% CI) 
  
45 
  
40 100.00% 0.11 [-1.75, 1.96] 
Heterogeneity: Tau² = 1.66; Chi² = 13.81, df 
= 1 (P = 0.0002); I² = 93% 
        
Test for overall effect: Z = 0.11 (P = 0.91) 
        
          
Terminal 
stance 
Ness 128 5.53 2.99 34 11.03 4.87 25 100.00% 0.04 [-0.47, 0.56] 
          
Pre-swing Ness 128 7.79 8.36 34 8.73 3.57 25 69.40% -0.14 [-0.65, 0.38] 
Van de Velde 215 16.40 8.50 11 16.80 5.00 15 30.60% -0.06 [-0.84, 0.72] 
         
Total (95% CI) 
  
45 
  
40 100.00% -0.11 [-0.54, 0.32] 
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Heterogeneity: Tau² = 0.00; Chi² = 0.03, df 
= 1 (P = 0.87); I² = 0% 
        
Test for overall effect: Z = 0.51 (P = 0.61) 
        
           
Forefoot 
inversion 
/eversion 
Initial 
contact 
Ness 128 -4.53 8.55 34 -6.41 8.10 25 100.00% 0.22 [-0.30, 0.74] 
          
Loading 
response 
Ness 128 4.16 2.18 34 7.21 5.16 25 56.40% -0.80 [-1.34, -0.27] 
Van de Velde 215 2.20 1.70 11 2.20 1.50 15 43.60% 0.00 [-0.78, 0.78] 
         
Total (95% CI) 
  
45 
  
40 100.00% -0.45 [-1.24, 0.33] 
Heterogeneity: Tau² = 0.21; Chi² = 2.78, df 
= 1 (P = 0.10); I² = 64% 
        
Test for overall effect: Z = 1.14 (P = 0.26) 
        
          
Mid-stance Ness 128 2.71 1.30 34 6.10 4.58 25 57.90% -1.07 [-1.62, -0.51] 
Van de Velde 215 1.50 0.70 11 1.80 0.90 15 42.10% -0.35 [-1.14, 0.43] 
         
Total (95% CI) 
  
45 
  
40 100.00% -0.77 [-1.46, -0.08] 
Heterogeneity: Tau² = 0.14; Chi² = 2.13, df 
= 1 (P = 0.14); I² = 53% 
        
Test for overall effect: Z = 2.17 (P = 0.03) 
        
          
Terminal 
stance 
Ness 128 5.53 2.99 34 11.03 4.87 25 100.00% -1.39 [-1.97, -0.82] 
          
Pre-swing Ness 2008 8.39 5.59 34 12.91 5.08 25 59.10% -0.83 [-1.37, -0.29] 
Van de Velde 215 5.40 1.90 11 10.80 3.60 15 40.90% -1.74 [-2.67, -0.81] 
         
Total (95% CI) 
  
45 
  
40 100.00% -1.20 [-2.08, -0.32] 
Heterogeneity: Tau² = 0.26; Chi² = 2.74, df 
= 1 (P = 0.10); I² = 64% 
        
Test for overall effect: Z = 2.68 (P = 0.007) 
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Forefoot 
abduction 
/adduction 
Initial 
contact 
Ness 128 -2.61 10.00 34 -16.44 7.66 25 100.00% 1.50 [0.91, 2.09] 
          
Loading 
response 
Ness 128 5.94 1.91 34 9.91 6.24 25 68.70% -0.91 [-1.45, -0.37] 
Van de Velde 215 1.50 0.70 11 2.50 1.70 15 31.30% -0.70 [-1.51, 0.10] 
         
Total (95% CI) 
  
45 
  
40 100.00% -0.85 [-1.30, -0.40] 
Heterogeneity: Tau² = 0.00; Chi² = 0.17, df 
= 1 (P = 0.68); I² = 0% 
        
Test for overall effect: Z = 3.68 (P = 0.0002) 
        
          
Mid-stance Ness 128 3.29 2.21 34 5.92 2.84 25 51.60% -1.04 [-1.59, -0.49] 
Van de Velde 215 3.50 3.00 11 2.20 1.30 15 48.40% 0.58 [-0.22, 1.38] 
         
Total (95% CI) 
  
45 
  
40 100.00% -0.26 [-1.84, 1.33] 
Heterogeneity: Tau² = 1.19; Chi² = 10.72, df 
= 1 (P = 0.001); I² = 91% 
        
Test for overall effect: Z = 0.32 (P = 0.75) 
        
          
Terminal 
stance 
Ness 128 4.33 2.56 34 8.51 3.66 25 100.00% -1.34 [-1.92, -0.77] 
          
Pre-swing Ness 128 6.86 3.36 34 13.17 4.68 25 51.90% -1.57 [-2.16, -0.97] 
Van de Velde 215 7.20 5.30 11 8.20 2.90 15 48.10% -0.24 [-1.02, 0.54] 
         
Total (95% CI) 
  
45 
  
40 100.00% -0.93 [-2.23, 0.37] 
Heterogeneity: Tau² = 0.76; Chi² = 7.06, df 
= 1 (P = 0.008); I² = 86% 
        
Test for overall effect: Z = 1.40 (P = 0.16) 
        
           
Hallux plantar 
flexion 
/dorsiflexion 
Initial 
contact 
Ness 128 12.15 7.96 34 19.38 8.07 25 100.00% -0.89 [-1.43, -0.35] 
          
Ness 128 5.88 3.98 34 10.08 4.99 25 60.20% -0.94 [-1.48, -0.39] 
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Loading 
response 
Van de Velde 215 7.60 5.90 11 9.30 5.20 15 39.80% -0.30 [-1.08, 0.48] 
         
Total (95% CI) 
  
45 
  
40 100.00% -0.68 [-1.29, -0.07] 
Heterogeneity: Tau² = 0.08; Chi² = 1.71, df 
= 1 (P = 0.19); I² = 41% 
        
Test for overall effect: Z = 2.19 (P = 0.03) 
        
          
Mid-stance Ness 128 2.98 2.58 34 5.68 3.15 25 55.90% -0.94 [-1.49, -0.40] 
Van de Velde 215 7.80 6.00 11 8.40 4.20 15 44.10% -0.12 [-0.89, 0.66] 
         
Total (95% CI) 
  
45 
  
40 100.00% -0.58 [-1.38, 0.23] 
Heterogeneity: Tau² = 0.22; Chi² = 2.90, df 
= 1 (P = 0.09); I² = 66% 
        
Test for overall effect: Z = 1.41 (P = 0.16) 
        
          
Terminal 
stance 
Ness 128 14.15 9.03 34 23.03 8.10 25 100.00% -1.01 [-1.56, -0.46] 
          
Pre-swing Ness 128 15.52 9.38 34 25.55 10.67 25 68.80% -1.00 [-1.54, -0.45] 
Van de Velde 215 29.40 11.90 11 37.80 8.20 15 31.20% -0.82 [-1.64, -0.01] 
         
Total (95% CI) 
  
45 
  
40 100.00% -0.94 [-1.40, -0.49] 
Heterogeneity: Tau² = 0.00; Chi² = 0.12, df 
= 1 (P = 0.73); I² = 0% 
        
Test for overall effect: Z = 4.05 (P < 0.0001) 
        
           
Medial 
longitudinal 
arch angle 
  
Loading 
response 
Van de Velde 215 2.40 2.00 11 4.10 2.40 15 100.00% -0.73 [-1.54, 0.07] 
Mid-stance Van de Velde 215 4.10 2.70 11 6.70 2.20 15 100.00% -1.04 [-1.88, -0.20] 
Preswing Van de Velde 215 14.40 5.40 11 21.30 7.70 15 100.00% -0.98 [-1.81, -0.15] 
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Ankle joint 
The ankle joint movement was defined as the relative angle between the tibia and calcaneus for 
movement in the sagittal plane. Meta-analyses show large significant effects for greater ankle 
plantar flexion in TPT compared to controls at initial contact (n of studies = 2) (SMD (95% CI) -1.4 
(-1.8 to -1.0) and loading response (n of studies = 3) (SMD (95% CI) -1.4 (-2.2 to -0.7), and 
medium effects at terminal stance (n of studies = 3) (SMD (95% CI) -1.0 (01.4 to -0.6) and pre-
swing (n of studies = 3) (SMD (95% CI) -0.7 (-1.1 to -0.3)) (Table 5-6/Figure 5-3). Medium 
effects were also found in one study for greater plantar flexion during mid-stance in TPT compared 
to controls (SMD (95% CI) -1.1 (-1.7 to -0.6) (Table 5-6/Figure 5-3). There were no differences 
between groups for excursion except for during initial contact (n of studies = 1) where individuals 
with TPT had significantly less hindfoot sagittal plane excursion (SMD (95% CI) -1.2 (-1.8 to -0.7) 
(Table 5-7). 
Figure 5-3 SMD (95% CI) for ankle plantar flexion/dorsiflexion peak values in the sagittal plane (-
SMDs indicate greater plantarflexion in TPT compared to controls). 
 
Hindfoot 
For movement of the hindfoot relative to the tibia in the coronal plane, large significant effects were 
found for greater hindfoot eversion at mid-stance in TPT compared to controls (n of studies = 3) 
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(SMD (95% CI) -1.3 (-1.88 to -0.66) (Table 5-6/Figure 5-4). Medium effects were found for 
greater eversion at initial contact (n of studies = 2) (SMD (95% CI) -0.8 (-1.2 to -0.4), loading 
response (n of studies = 5) (SMD (95% CI) -1.1 (-1.5 to -0.6), terminal stance (n of studies = 5) 
(SMD (95% CI) -0.9 (-1.6 to -0.2) and pre-swing (n of studies = 5) (SMD (95% CI) -1.1 (-1.7 to -
0.5) in TPT compared to controls (Table 5-6/Figure 5-4).  
Figure 5-4 SMD (95% CI) for hindfoot eversion/inversion peak values in the coronal plane (-SMDs 
indicate greater eversion in TPT compared to controls). 
 
One study reported peak hindfoot eversion angle, time to peak eversion and total eversion excursion 
throughout the stance phase 126 and no differences were found between individuals with TPT and 
controls (Table 5-8). At initial contact, there was a medium effect for greater hindfoot eversion 
excursion in TPT compared to controls (n of studies = 1) (SMD (95% CI) 0.8 (0.3 to 1.3) and there 
were no other differences in hindfoot excursion between groups in the coronal or transverse planes 
(Table 5-7/Figure 5-5).
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Table 5-8 Findings for studies reporting kinematic variables unable to be included in forest 
plots/meta-analyses 
Study Gait parameter Event during 
gait 
Mean difference / significant 
findings between TPT and 
controls 
Effect size 
(95% CI) 
Houck  
124 
 
First metatarsal 
dorsiflexion (ref: 
calcaneus) 
Entire stance 
phase 
8.8 degrees (4.3 to 13.2) more dorsiflexion in 
TPT 
 Hindfoot (ref: global) Initial contact 4 degrees greater plantarflexion 
in TPT 
 
  15% stance 4.5 degrees greater 
plantarflexion in TPT 
 
 First metatarsal 
dorsiflexion (ref: 
global) 
Entire stance 
phase 
13.7 degrees (8.4 to 18.9) more dorsiflexion in 
TPT 
Neville 
125 
Hindfoot eversion Entire stance 
phase 
7.8 (4.1 to 11.5) degrees more 
everted in TPT 
1.45 (0.64 to 
2.25) 
Rabbito 
126 
Peak hindfoot eversion Entire stance 
phase 
3.1 ( 0.1 to 6.1) degrees more 
everted in TPT 
0.80 (-0.04 to 
1.64) 
 Hindfoot eversion 
excursion 
Entire stance 
phase 
0.7 (-1.15 to 2.55) degrees 
more eversion excursion in 
TPT 
0.29 (-0.51 to 
1.10) 
 Time to peak eversion % of stance 
phase 
7.7 (-0.92 to 16.32) % later in 
TPT  
0.69 (-0.14 to 
1.52) 
 Peak MLA Entire stance 
phase 
0.5 (-7.48 to 6.48) degrees 
lower in TPT 
-0.06 (-0.86 to 
0.75) 
Ringleb 
214 
Time to peak ankle 
plantarflexion 
% of stance 
phase 
3 (0.06 to 5.94) % earlier in 
TPT 
-0.97 (-1.99, 
0.06) 
 Time to peak forefoot 
dorsiflexion 
% of stance 
phase 
Earlier in TPT  
Abbreviations: TPT; tibialis posterior tendinopathy,CI; confidence interval,  ref; reference, MLA; 
medial longitudinal arch 
  
91 
 
Figure 5-5 SMD (95% CI) for hindfoot excursion in TPT compared to controls (+SMDs indicate 
greater excursion in TPT).  
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Forefoot 
For movement of the forefoot relative to the hindfoot (calcaneus) in the sagittal plane, pooled SMDs 
found a large significant effect for greater forefoot dorsiflexion at initial contact (n of studies = 2) 
(SMD (95% CI) 1.4 (0.8 to 2.1) and pre-swing (n of studies = 3) (SMD (95% CI) 1.3 (0.8 to 1.8) in 
TPT compared to controls (Table 5-6/Figure 5-6). No differences were found during loading 
response (n of studies = 3) (SMD (95% CI) 1.0 (-0.1 to 2.0)) or terminal stance (n of studies = 2) 
(SMD (95% CI) 0.7 (-0.7 to 2.2) in TPT compared to controls (Table 5-6/Figure 5-6). SMDs from 
one study showed a large effect for greater forefoot dorsiflexion in TPT compared to controls at 
mid-stance ((SMD (95% CI) 1.8 (1.2 to 2.4) (Table 5-6/Figure 5-6).  
 
Figure 5-6 SMD (95% CI) for forefoot plantar flexion/dorsiflexion in the sagittal plane (+SMDs 
indicate greater dorsiflexion in TPT compared to controls). 
 
Considering forefoot excursion in the sagittal plane, one study showed a large effect for greater 
excursion at initial contact in individuals with TPT compared to controls ((SMD (95% CI) 1.8 (1.2 
to 2.4) (Table 5-7/Figure 5-7). There were no other differences between TPT and controls for 
forefoot sagittal plane excursion (Table 5-7/Figure 5-7) or coronal plane peak angles during any 
stance phase (Table 5-6/Figure 5-8). Medium to large effects (SMD > 0.61) were found for less 
coronal plane excursion in TPT compared to controls in mid-stance (n of studies = 2) (SMD (95% 
CI) -0.8 (-1.5 to -0.1), terminal stance (n of studies = 1) (SMD (95% CI) -1.4 (-2.0 to -0.8) and pre-
swing (n of studies = 2) (SMD (95% CI) -1.2 (-2.1 to -0.3)) (Table 5-7/Figure 5-7).  
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Figure 5-7 SMD (95% CI) for forefoot excursion in TPT compared to controls (+SMDs indicate 
greater excursion in TPT).  
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Figure 5-8 SMD (95% CI) for forefoot eversion/inversion in the coronal plane (-SMDs indicate 
greater eversion in TPT compared to controls). 
 
In the transverse plane, pooled SMDs showed medium to large effects for greater forefoot 
abduction in TPT compared to controls throughout loading response (n of studies = 4) (SMD (95% 
CI) -1.1 (-1.5 to -0.8), mid-stance (n of studies = 3) (SMD (95% CI) -1.0 (-1.4 to -0.6) and pre-
swing (n of studies = 4) (SMD (95% CI)-1.4 (-2.3 to -0.5)) (Table 5-6/Figure 5-9). Although a 
medium effect for greater forefoot abduction was found at terminal stance (n of studies = 4), this 
did not reach statistical significance (SMD (95% CI) -0.7 (-1.6 to 0.2)) (Figure 5-9). During 
loading response, there was a large effect for greater forefoot abduction in TPT compared to 
controls from one study ((SMD (95% CI) -1.5 (-2.1 to -0.9) (Table 5-6/Figure 5-9). Medium to 
large effects for less forefoot excursion in the transverse plane in TPT compared to controls were 
found during loading response (n of studies = 2) (SMD (95% CI) -0.9 (-1.3 to -0.4) and terminal 
stance (n of studies = 1) (SMD (95% CI) -1.3 (-1.9 to -0.8). At initial contact, one study found 
greater forefoot excursion in the transverse plane in TPT compared to controls (SMD (95% CI) 1.5 
(0.9 to 2.1) (Table 5-7/Figure 5-7). 
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Figure 5-9 SMD (95% CI) for forefoot abduction/adduction in the transverse plane (-SMDs 
indicate greater abduction in TPT compared to controls). 
 
Medial longitudinal arch 
The medial longitudinal arch angle was generated from markers on the calcaneus, first metatarsal 
head and navicular tuberosity. Pooled SMDs from two studies showed large, significant effects for 
lower medial longitudinal arch height in TPT compared to controls at loading response (SMD (95% 
CI) 1.3 (0.7 to 1.9), mid-stance (SMD (95% CI) 1.3 (0.7 to 1.9) and pre-swing (SMD (95% CI) 1.5 
(0.9 to 2.1), and medium effects at terminal stance (SMD (95% CI) 1.1 (0.5 to 1.6) (Table 
5-6/Figure 5-10). One study reported peak medial longitudinal arch (i.e., lowest value) throughout 
the gait cycle but this was not different between groups ((SMD (95% CI) -0.06 (-0.86 to 0.75)) 
(Table 5-8). For medial longitudinal arch excursion, one study found medium effects at mid-stance 
(SMD (95% CI) -1.0 (-1.9 to -0.2) and pre-swing (SMD (95% CI) -1.0 (-1.8 to -0.2) for less medial 
longitudinal arch excursion in TPT compared to controls but no difference at loading response 
(SMD (95% CI) -0.7 (-1.5 to 0.1) Table 5-7/Figure 5-11). 
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Figure 5-10 SMD (95% CI) for medial longitudinal arch angle (+SMDs indicate lower medial 
longitudinal arch height (greater angle) in TPT compared to controls). 
 
Hallux 
Movement of the hallux relative to the forefoot was measured in two studies. 128 215 There were 
medium effects for less hallux excursion in the sagittal plane during initial contact (n of studies = 1) 
(SMD (95% CI) -0.9 (-1.4 to -0.4), loading response (n of studies = 2) (SMD (95% CI) -0.7 (-1.3 to 
-0.1) and terminal stance (n of studies = 1) (SMD (95% CI) -1.0 (-1.6 to -0.5) (Table 5-7/Figure 
5-11). 
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Figure 5-11 SMD (95% CI) for a) hallux plantar flexion/dorsiflexion and b) medial longitudinal 
arch excursion in TPT compared to controls (+SMDs indicate greater excursion in TPT). 
 
5.1.4 Discussion 
This systematic review provides a comprehensive synthesis of foot and ankle kinematic 
characteristics of individuals with TPT compared to controls during the stance phase of gait. It is 
clear that foot kinematics are different in individuals with TPT compared to controls during the 
stance phase of gait. Meta-analyses demonstrated large effects (SMD >1.2) for greater ankle plantar 
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flexion, hindfoot eversion, forefoot abduction and lower medial longitudinal arch height, 
particularly during the loading response and push-off phases of gait.  
Differences in kinematics between individuals with TPT and controls were most predominant 
during the phases of stance in which the TP muscle has the greatest activity in healthy populations. 
216 Anatomically, the TP muscle contracts eccentrically to limit hindfoot eversion at the subtalar 
joint, forefoot abduction, 146 and stabilise the medial longitudinal arch during loading response. 
Concentric contraction during mid-stance controls pronation and inverts and stabilises the hindfoot 
locking the midtarsal joint to allow effective propulsion by the plantar flexors during push-off. 216 
217 As such, greater hindfoot eversion and forefoot abduction during loading response, lower medial 
longitudinal arch height and reduced forefoot plantar flexion during push-off observed in 
individuals with TPT compared to controls are suggestive of an inefficient TP muscle-tendon unit.  
Impaired TP capacity has been demonstrated in studies investigating heel raise height, endurance 
and plantar flexion inversion force in individuals with TPT compared to controls. 195 Pain and 
difficulty performing a SLHR is a key clinical feature of TPT. 79 84 Five of the seven studies in this 
review included pain or difficulty with a SLHR in the selection criteria for the TPT group. 
Individuals with TPT have demonstrated lower heel height and ankle plantar flexion with greater 
forefoot forefoot dorsiflexion and subtalar eversion during a SLHR task compared to age-matched 
controls. 67 These findings are consistent with the foot and ankle kinematics found during the push-
off phase of gait in this systematic review. Previous research has identified that the biomechanical 
characteristics and TP muscle activity required during the push-off phase of gait are similar to those 
during a SLHR. 218  
Alterations in muscle activity and coordination occur in the presence of musculoskeletal pain 219-221 
and may be related to changes in movement patterns which occur when there is pain and 
dysfunction. Electromyographic (EMG) studies investigating muscle activity during walking in 
TPT are limited. One study has measured EMG simultaneously with kinematics in 5 individuals 
with TPT compared to 5 healthy controls and provides preliminary insight into TP muscle activity 
during gait. 214 There was greater TP EMG amplitude during the second half of stance and greater 
forefoot abduction in TPT during this phase. This suggests kinematic patterns indicative of a 
dysfunctional TP occur with greater muscle activity (motor recruitment) in individuals with TPT i.e. 
this increased motor recruitment strategy does not maintain normal kinematics. Greater EMG 
activity has previously been demonstrated in muscles of the lower limb when there is weakness. 222 
Ringleb et al 214 also found impaired plantar flexor power during push-off with a lower degree of 
ankle plantar flexion range. While these findings provide some insight into TP muscle activity and 
99 
foot and ankle kinematics in TPT, further EMG studies with larger sample sizes are required to 
investigate timing and amplitude of muscle activity in TPT during gait.  
Due to the role of the TP in supporting the medial longitudinal arch, alterations in arch height and 
foot posture have been frequently investigated in the literature. 195 There is strong evidence for 
lower arch height in individuals with TPT compared to controls. 195 Of the studies that investigated 
arch angle during gait, only one 126 did not find MLA to be lower in TPT compared to controls 
during gait, but it was the only one not to have flatfoot posture as an eligibility criteria. 
Furthermore, an association between foot posture and lower limb kinematics has been demonstrated 
in asymptomatic flatfoot populations. A systematic review has shown greater hindfoot eversion and 
forefoot abduction in low-arch foot posture compared to normal foot posture, and an association 
between increasing flatfoot posture and increased rearfoot eversion, and total range of motion. 208 
Therefore it is unclear whether alterations in kinematics of the foot found in this systematic are 
related to the condition or the foot posture.  
Whereas synthesis of the available evidence confirms the characteristic foot and ankle deformity 
and altered movement patterns proposed to be associated with TPT, the available evidence provides 
little insight into proximal movement patterns. Included papers did not collect or report kinematic 
characteristics of the hip or knee. One study was identified during full-text screening stage that 
reported hip and knee kinematics but was excluded from the review as it did not report foot/ankle 
data. Maeda (2018) found that individuals with TPT had increased knee internal rotation during the 
loading response of gait compared to controls. However, these findings are difficult to interpret with 
no foot/ankle data. 223 As alterations in movement patterns at the foot are likely to be accompanied 
by alterations proximally at the knee, femur, hip and/or pelvis, 114 116 120 224 future research should 
include kinematic analysis of the whole lower limb in TPT populations. 
A key finding of this systematic synthesis was the variability in methodology for collecting, 
analysing and reporting kinematic data. A number of different models, with varying marker 
placement, definition of segments, and definitions of joint axes were used. While careful 
consideration was made before pooling data to ensure accuracy and homogeneity, there was still 
substantial heterogeneity (>75%) for some pooled SMDs. This needs to be considered when 
interpreting results. Sample size and subsequent power issues also need to be considered in 
interpretation, as sample size for pooled SMDs ranged between 55 and 184. Some papers were not 
able to be pooled due to differences between studies in definitions of joints and movements, angles 
reported (i.e. peak versus average) and time points during stance phase of gait that were used. This 
limits the overall sample size of the meta-analysis. Standardised and consistent models, 
methodology and reporting in future studies would permit replication and increase overall 
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confidence in kinematic findings. Consistency would also increase robustness of future meta-
analyses as accuracy, measurement error and sample size are frequent limitations for individual 
kinematic studies.  
5.1.5 Conclusion 
Differences in foot and ankle kinematics between individuals with TPT and controls include greater 
ankle plantar flexion, hindfoot eversion, forefoot abduction and lower medial longitudinal arch 
height, particularly during the loading response and push-off phases of gait. Interventions aimed at 
supporting the medial longitudinal arch during loading activities and improving dynamic stability 
may assist with symptom modification. 
101 
 
 
 
 
 
 
 
 
 
PART B:  
Experiments to better understand TPT  
 
This section consists of three lab studies designed to contribute to the understanding of the clinical 
presentation of TPT by addressing gaps identified in Part A. 
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 Diagnostic utility of clinical tests for tibialis posterior 
tendinopathy 
 Diagnostic accuracy of clinical tests to diagnose ultrasound-confirmed 
tibialis posterior tendinopathy in patients presenting with medial foot/ankle 
pain 
Part A has critically appraised and evaluated the literature for TPT. Chapter three provided 
recommendations for selection criteria for stage I and II PTTD (i.e TPT). This chapter explores the 
diagnostic accuracy of four clinical tests (selected based on the findings in Chapter three) 
compared to ultrasound (US) confirmation of TP tendon pathology. The aim of this chapter is to 
determine how well commonly used clinical tests can identify grey scale changes within the TP 
tendon using US as the reference standard. Of all tests, single leg heel raise (SLHR) was most likely 
to identify grey scale changes within the TP tendon.  
Ross MH, Smith MD, Durbridge, G, Vicenzino B. The diagnostic accuracy of clinical tests to 
diagnose ultrasound-confirmed tibialis posterior tendinopathy in patients presenting with medial 
foot/ankle pain. Submitted to BJSM.  
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Analysis and interpretation (70%) 
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Dr Michelle D Smith Conception and design (15%) 
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6.1.1 Introduction 
Tibialis posterior tendinopathy (TPT) presents as pain on the medial side of the mid- to rear-foot 
and/or ankle and is associated with difficulties during activities that load the tibialis posterior 
tendon. 84 TPT is considered to occur on a continuum from disordered tendon to joint destruction, 48 
51 133 and is regarded to be the most common cause of acquired flatfoot deformities in adults. 45 129 
Current literature suggests that TPT is often misdiagnosed, or goes undiagnosed, until significant 
and prolonged symptoms severely interfere with function. 47 70  
The 2019 International Consensus Statement defined tendinopathy as persistent tendon pain and 
loss of function related to mechanical loading. 64 We recently conducted a systematic review of 
selection criteria for TPT in primary research papers. 84 Tenderness on palpation, swelling along the 
tendon, poor plantar flexion-inversion (PF/INV) strength and difficulties performing a single leg 
heel raise (SLHR) were identified as the most frequently reported clinical features of TPT used for 
study inclusion.84 These clinical signs are specifically thought to be indicative of TPT, but to date 
there is a lack of data supporting their validity.  
The diagnostic utility of clinical findings for identifying TPT when it is shown on imaging has not 
been tested. Diagnostic ultrasound (US) is commonly used to assess tendon changes. High-
resolution US is a cost effective, readily accessible and clinically available tool, 182 that has shown 
good sensitivity and specificity for diagnosing TPT when using MRI as the reference standard. 182 
225-227 It is a reliable method for assessing greyscale tendon changes (e.g. hypoechogencity, fibrillar 
disruption) 228-230 and can reliably measure tendon size. 231  
Determining clinical tests that are reliable and can assist clinicians to identify TPT in individuals 
presenting with medial ankle pain will assist appropriate diagnosis and management of the 
condition. The aim of this study was to determine the reliability and utility of clinical tests in 
detecting tibialis posterior tendon pathology on US in individuals presenting with medial foot/ankle 
pain.  
6.1.2 Methods 
Study design 
We conducted a diagnostic utility study in which individuals with medial foot/ankle pain underwent 
an US examination (reference standard) by a sonographer and a clinical examination (index tests) 
performed by physiotherapists. All examiners were blind to each other’s findings. 
Participants 
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Participants were recruited through local advertisements (social media, websites) within a 50 
kilometre radius of the Brisbane area between November 2017 and March 2019. Eligibility was 
determined via a preliminary online screening survey and subsequent phone screening. Participants 
were eligible if they were aged between 18 and 70 years and reported average medial ankle/foot 
pain greater than 2 out of 10 on an 11 point Numerical Rating Scale (NRS) (where 0 = no pain and 
10= worst pain imaginable) that had been present on most days for a minimum of 3 months and 
were able to attend both the clinical and US exam sessions. The presence of medial foot/ankle pain 
was determined based on the participant’s reporting of the location of their pain. Participants were 
excluded if self-reported (and clinician confirmed) location of pain was not on the medial aspect of 
the foot/ankle, if they had any known neurological disorders or other known medical conditions (i.e. 
gout, fibromyalgia, rheumatoid or psoriatic arthritis).  
Reference standard 
Diagnostic US imaging was used as the reference standard as it has been shown to be reliable for 
detecting echogenicity, fibrillar disruption, and changes in tendon size. 228-231 These US changes are 
considered to represent TPT.139 175 232 The US scans were performed by an experienced 
sonographer. Participants were recumbent during testing, with the ankle in neutral. The sonographer 
performed a standardised assessment of the tibialis posterior tendon in both longitudinal and 
transverse views using a Siemens/Acuson S3000 14MHz linear array ‘hockey stick’ probe (Figure 
6-1). Based on current literature, the standardised assessment included evaluation of the tendon for 
greyscale changes (including hypoechoic changes in the tendon, fibrillar disruption and tendon 
thickening) 233,234 which were rated as positive (present) or negative (absent). The reference 
standard was considered positive when there was at least one greyscale finding within the tendon 
present on US examination. 
To increase our confidence that these findings were clinically relevant, we surveyed health care 
professionals on their views of which US features were most important in diagnosing TPT 
(Appendix 6). The health care professionals ranked greyscale changes on US as being most 
important in diagnosing TPT.  
Measurements of the antero-posterior and transverse tendon diameters and hypoechoic areas were 
reported (where present) from longitudinal and transverse views both posterior to the medial 
malleolus (posterior to the most prominent aspect of the medial malleolus) and mid-way between 
the medial malleolus and navicular tuberosity (Figure 6-1).  
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Figure 6-1 Ultrasound measurements of the tibialis posterior tendon 
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We studied four index tests (palpation, observation, manual resisted contraction, weight bearing) 
that we found from a systematic review of the literature. 84 The index tests were rated as positive if 
there was: tenderness on palpation along the course of the tibialis posterior tendon (from the 
musculotendinous junction to insertion on the navicular tuberosity), palpable or visible swelling of 
the tendon sheath along the course of the tendon, pain or weakness on manually resisted isometric 
contraction of ankle PF/INV in neutral, and pain on or inability performing one SLHR. The SLHR 
test was performed barefoot, with light fingertip support from the examiner as required. Participants 
were asked to perform one SLHR to their maximum height in a controlled manner. We also tested a 
combination of palpation plus one of the two loading tests (PF/INV, SLHR) in order to replicate 
what seems to be common clinical practice of using palpation and loading in diagnosing 
tendinopathy. 64 
Procedure 
Participants were invited to attend a testing session during which two physiotherapists (minimum 7 
years clinical experience) independently screened for eligibility and assessed the index tests for 
TPT (based on the criteria above). US imaging was conducted within 2 weeks of the clinical 
examination (assessment of index tests) with sonographer and physiotherapists blind to each other’s 
findings. 
Analysis 
Sample characteristics 
Participant characteristics between those with and without US defined TPT or the combined clinical 
tests (palpation plus a loading test) were analysed with independent t-tests for continuous data and 
the chi-square statistic for categorical data. Pairwise comparisons were used to evaluate group 
differences and expressed as mean differences (MDs) and standardised mean differences (SMDs) 
with 95% CIs. Effect sizes were interpreted as: < 0.2 trivial effect, 0.2 - 0.6 small effect, 0.61 – 1.2 
moderate effect, and > 1.2 large effect. 88  
Reliability of the index tests 
Statistical analysis was performed using IBM SPSS V24 (SPSS Chicago, Illinois, USA). Inter-rater 
agreement for the reliability of each index test (positive, negative) was calculated using the -
statistic (95% confidence interval (CI)). A  of < 0.00 was interpreted as poor agreement, 0.00-0.20 
slight agreement, 0.21 – 0.40 fair agreement, 0.41 – 0.60 moderate agreement, 0.61 – 0.80 
substantial agreement or 0.81 to 1.00 almost perfect agreement. 89 
Diagnostic utility analyses 
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A series of 2x2 contingency tables were constructed to cross-tabulate the positive and negative 
results of the index tests (including the clinical diagnosis (as defined above for this study)) with the 
reference standard of diagnostic US.  
Sensitivity (i.e. the probability that the index test is positive when US is positive), specificity (i.e. 
the probability that the index test is negative when US is negative), positive predictive value (PPV) 
(i.e. probability that US is positive when then index test is positive), negative predictive value 
(NPV) (i.e. the probability that US is negative when the index test is negative) and their 95% CIs 
were calculated for each index test and for the clinical diagnosis overall (i.e. tender on palpation 
plus one positive loading index test). 235 Positive likelihood ratios (LR+) (i.e. the ratio between the 
probability of a positive index test when US is positive and the probability of a positive index test 
when US is negative) and negative likelihood ratios (LR-) (i.e. the ratio between the probability of a 
negative test when US is positive and the probability of a negative test when US is negative) were 
calculated to provide an estimate of the shift in probability of the condition being present based on a 
positive or negative index test.236 Likelihood ratios between 0 and 1 decrease the probability of the 
reference standard being positive, likelihood ratios greater than 1 increase the probability and ratios 
close to 1 have little effect on the post-test probability. 95% CIs were calculated and the LR was 
considered statistically significant if the CIs did not contain 1. 236 
6.1.3 Results 
Participant features 
Fifty-two participants (42 (80.8%) females) with a mean (SD) age of 46.2 (12.3) years and worse 
medial foot/ankle pain over the previous week of 6.5/10 (2.2) were included in this study (Table 
6-1). There were no differences in sex, body mass index and pain levels between positive and 
negative clinical diagnosis or presence of TPT as per the reference standard. Interestingly, the 
positive US group was approximately a decade older than the negative US group (Table 6-1).  
Figure 6-2 outlines the flow of participants through the study and the results of the clinical and US 
assessments. Twenty-two participants (42.3%) had greyscale changes in the tibialis posterior tendon 
on US, and 28 (54%) had a positive clinical diagnosis (i.e. tenderness on palpation of the tibialis 
posterior tendon and one positive loading index test) (Table 6-1/Figure 6-2). There were no 
adverse events related to the clinical or US assessments. 
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Table 6-1 Participant demographics. All data are presented as mean (SD) or n (%). 
 
All  
(n = 52) 
Clinical +ve 
(n = 28) 
Clinical -ve 
(n = 24) 
p-
value 
US +ve 
(n = 22) 
US -ve 
(n = 30) 
p-value 
Women n 42 (80.8) 23 (82.1) 19 (79.2) 0.79 18 (81.8) 24 (80.0) 0.87 
Left study side, n 29 (55.8) 14 (50.0) 15 (62.5) 0.37 14 (63.6) 15 (50.0) 0.33 
Age, years 46.2 (12.3) 47.0 (13.7) 45.3 (10.9) 0.62 51.2 (12.1) 42.5 (11.4) 0.01 
Height, m  1.67 (0.09) 1.66 (0.08) 1.69 (0.10) 0.15 1.65 (0.09) 1.68 (0.09) 0.19 
Mass, kg 84.7 (22.0) 87.1 (25.0) 81.2 (17.7) 0.35 86.8 (21.5) 82.6 (22.4) 0.50 
Body mass index, kg/m2 30.1 (7.6) 30.4 (6.7) 29.7 (8.7) 0.74 31.5 (8.0) 29.1 (7.2) 0.26 
Average pain /10  4.4 (1.9) 4.4 (2.1) 4.3 (1.7) 0.96 4.3 (2.0) 4.4 (1.8) 0.93 
Worst pain /10 6.5 (2.2) 6.6 (2.4) 6.3 (2.0) 0.57 6.7 (2.4) 6.3 (2.1) 0.58 
Abbreviations: +ve; positive, -ve; negative, US; ultrasound 
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Figure 6-2 Participant flow through the study and results of the US and clinical examinations 
 
Reliability of index tests 
There were 4 participants for whom a second rater was not available to perform the index test 
examination, which leaves 48 participants in the reliability analysis. Pain or inability to perform a 
SLHR had the highest inter-rater agreement ( 0.74 (95% CI 0.54 to 0.93), with the two 
physiotherapists agreeing in 42 of 48 cases (87.5%) (Table 6-2). There was moderate inter-rater 
agreement for swelling of the tibialis posterior tendon (77.1% agreement,  0.54 (95% CI 0.30 to 
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0.78), pain/weakness with resisted PF/INV (72.9% agreement,  0.46 (95% CI 0.21 to 0.71) and 
tenderness on palpation (75.0% agreement,  0.44 (95% CI 0.18 to 0.69). 
Table 6-2 Inter-rater agreement for index tests (n = 48) 
Index test Kappa statistic Standard error 95% CI p-value 
Pain/inability to SLHR 0.74 0.099 0.54 0.93 <0.001 
Swelling along tendon course 0.54 0.121 0.30 0.78 <0.001 
Pain/weakness with resisted PF/INV 0.46 0.127 0.21 0.71 0.001 
Tenderness on palpation  0.44 0.129 0.18 0.69 0.002 
Abbreviations: CI; confidence interval, PF/INV; plantar flexion-inversion, SLHR; single leg heel raise 
 
Diagnostic utility of the index tests 
Of the individual index tests, the SLHR (pain or inability to perform) had the highest sensitivity 
(77.3%), identified 17 true cases of TPT (positive index test and positive US) and had the lowest 
number of false negatives (5 TPT on US not picked up by the index tests). Specificity was 63.3%, 
identifying 19 (over 80%) true negatives, and this index test had the highest accuracy rate (69.2%), 
PPV (60.7%) and NPV (79.2%) (Table 6-3). Pain or inability to perform a SLHR had the largest 
positive and negative LR and was the only individual index test for which the CIs did not include 1. 
This indicates that pain or inability to perform a SLHR is the single most useful index test for ruling 
TPT both in and out i.e. if SLHR is positive there is a greater likelihood that TPT is present on US, 
or if SLHR is negative there is a lower likelihood that TPT is present on US (approximately 20% 
shift in probability, see Table 6-4). 
For the combination of  palpation plus one positive loading index test, there were 16 true positives 
(positive clinical diagnosis and positive US), 18 true negatives (negative clinical diagnosis and 
negative US), 12 false positives (positive clinical diagnosis and negative US) and 6 false negatives 
(negative clinical diagnosis and positive US) (Table 6-3/Figure 6-2) The clinical examination had a 
reasonable sensitivity (72.7%), specificity (60.0 %) and accuracy rate (i.e. the overall probability 
that a participant was correctly classified using the clinical diagnosis was 65.4%) (Table 6-3/Figure 
6-2). The LR+ and LR- (95% CI) for the clinical diagnosis were 1.8 (1.1 to 3.0) and 0.5 (0.2 to 1.0) 
respectively. 
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Table 6-3 Index test results and indices of clinical utility in the diagnosis of tibialis posterior tendinopathy using US as the reference standard 
 
TP TN FP FN 
Sens (%) Spec (%) PPV (%) NPV (%) LR+ LR- 
Accuracy 
(%) 
Index test (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) 
Clinical diagnosis 
of TPT^ 
16 18 12 6 72.7 60.0 57.1 75.0 1.82 0.45 65.4 
    (49.8 to 
89.3) 
(40.6 to 
77.3) 
(44.5 to 
68.9) 
(58.8 to 
86.3) 
(1.09 to 
3.02) 
(0.22 to 
0.95) 
(50.9 to 
78.0)  
           
 
           
Tender on 
palpation 
15 14 16 7 68.2 46.7 48.4 66.7 1.3 0.7 55.8 
    (45.1 to 
86.1) 
(28.3 to 
65.7) 
(37.7 to 
59.3) 
(49.3 to 
80.5) 
(0.8 to 2.0) (0.3 to 1.4) 
(41.3 to 
69.5) 
Swelling along 
tendon course 
12 18 12 10 54.6 60.0 50.0 64.3 1.4 0.8 57.7 
    (32.2 to 
75.6) 
(40.6 to 
77.3) 
(35.9 to 
64.1) 
(51.1 to 
75.6) 
(0.8 to 
2.44) 
(0.4 to 1.3) 
(43.2 to 
71.3) 
Pain/weakness 
with resisted 
PF/INV 
10 19 11 12 45.5 63.3 47.6 61.3 1.2 0.9 55.8 
 
    (24.2 to 
67.8) 
(43.9 to 
80.1) 
(32.1 to 
63.7) 
(49.8 to 
71.7) 
(0.6 to 2.4) (0.5 to 1.4) 
(41.3 to 
69.5) 
Pain/inability to 
SLHR 
17 19 11 5 77.3 63.3 60.7 79.2 2.1 0.4 69.2 
 
    (54.6 to 
92.2) 
(43.9 to 
80.1) 
(47.8 to 
72.3) 
(62.6 to 
89.6) 
(1.25 to 
3.55) 
(0.2 to 0.8) 
(54.9 to 
81.3) 
Abbreviations: TP; true positive, TN; true negative, FP; false positive, FN; false negative, Sens; sensitivity, Spec, specificity, LR+; likelihood 
ratio positive, LR-; likelihood ratio negative. Key: ^ Positive clinical diagnosis of TPT = positive tender on palpation, and positive on at least 
one loading test 
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Table 6-4 Interpreting Likelihood Ratios (LR) of clinical (index) tests and clinical implications 
assuming pre-test probability of 42% based on reference standard (greyscale changes on US). 
Index Test Result LR Post-test 
Probability 
% 
Change 
% 
Implications 
Pain or 
inability to 
SLHR* 
+ve 2.1 60.3 18.3 If the patient experiences pain or 
cannot do a SLHR, probability of 
greyscale findings on US increases 
by 18% to 60%, if negative, 
probability of greyscale findings on 
US decreases by 20% to 23%. 
-ve 0.4 22.5 -19.5 
Clinical 
diagnosis^ 
+ve 1.8 56.6 14.6 If the patient is tender on palpation 
plus has pain/weakness with 
resisted PF/INV or pain/inability to 
SLHR, probability of greyscale 
findings on US increase by 15% to 
57% and reduce to 27% if negative. 
-ve 0.5 26.6 -15.4 
Palpation 
+ve 1.3 48.5 6.5 Almost no change in probability of 
greyscale findings on US with a 
positive or negative test 
-ve 0.7 33.6 -8.4 
Swelling along 
tendon 
+ve 1.4 50.3 8.3 Almost no change in probability of 
greyscale findings on US with a 
positive or negative test 
-ve 0.8 36.6 -5.4 
Pain or 
weakness with 
isometric 
PF/INV 
contraction  
+ve 1.2 46.5 4.5 
Almost no change in probability of 
greyscale findings on US with a 
positive or negative test 
-ve 0.9 39.5 -2.5 
Abbreviations: LR; likelihood ratio, +ve; positive, -ve; negative, PF/INV; plantar flexion/inversion, 
SLHR; single leg heel raise, US; ultrasound^ tender on palpation plus 1 of loading tests, * tests 
with LR CIs that did not contain 1. 
 
True and false positives and negatives for tenderness on palpation, swelling of the posterior tibial 
tendon sheath and pain or weakness with resisted PF/INV are provided in Table 6-3. For tenderness 
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on palpation, specificity and PPV were low (fewer true positives than false positives) indicating that 
isolated tenderness on palpation of the tibialis posterior tendon may have minimal clinical utility in 
ruling out TPT (i.e. identified on index test when there is no TPT on US). PPV for swelling was 
50.0%, indicating that the presence of swelling has no/minimal clinical utility in ruling out the 
presence of TPT (as many true positives as false positives). The PPV for pain or weakness with 
resisted PF/INV was 47.6%, indicating that less than half of those who tested positive had TPT on 
US. Twelve participants who tested negative to this index test were positive on US (highest number 
of false negatives of all index tests and lowest NPV (61.3%)).  
Measurements of tendon diameter 
We also compared tendon diameter as measured on US between true positives (positive clinical and 
US) and true negatives (negative clinical and US) and observed TPT to have greater diameter 
(Table 6-5). There was a large SMD (effect) for anteroposterior tendon diameter at the medial 
malleolus, moderate effect for greater transverse tendon diameter at the medial malleolus, and 
moderate effect for anteroposterior diameter at the midpoint between the medial malleolus and the 
navicular insertion of the tendon (Table 6-5).  
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Table 6-5 Ultrasound measurements of tendon diameter and hypoechoic regions for true positives compared to true negatives 
 
 
Positive on Clinical + US Negative Clinical + US Positive v Negative 
Measurement (mm) n Mean SD n Mean SD MD 95% CI p-value SMD 95% CI 
AP tendon at medial malleolus 16 5.21 1.26 18 3.92 0.69 1.29 0.56 2.02 0.00 1.26 0.53 2.00 
Transverse tendon at medial malleolus 16 9.62 1.85 18 8.09 2.17 1.53 0.11 2.95 0.04 0.74 0.04 1.43 
AP tendon at MP 16 4.91 1.90 18 3.39 0.51 1.52 0.49 2.56 0.01 1.10 0.38 1.82 
Transverse tendon at MP 16 9.89 2.90 18 8.36 2.21 1.53 -0.26 3.33 0.09 0.58 -0.10 1.27 
Hypoechoic region in longitudinal^ 5 5.84 2.60 0 - - - - - - - - - 
Hypoechoic region in transverse^ 5 3.88 1.97 0 - - - - - - - - - 
Key: ^; only measured if present, -; cannot be computed because at least one of the groups was 0 
Abbreviations: US; ultrasound (reference standard) SD; standard deviation, MD; mean difference, CI; confidence interval, AP; anteroposterior 
measurement, MP; midpoint between medial malleolus and navicular insertion  
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6.1.4 Discussion  
To our knowledge, this is the first study in patients with medial foot/ankle pain that investigates the 
diagnostic utility and reliability of commonly used clinical tests for TPT. 84 We used grey scale 
changes seen in the tibialis posterior tendon on US as the reference standard. Overall our findings 
indicate that commonly used clinical examination tests have low diagnostic utility in identifying 
those patients who have grey scale changes on US in the tibialis posterior tendon. This should be 
viewed in light of the reasonably low prevalence rate of US identified TPT in our sample (22/52, 
42%). 
SLHR found to have best clinical utility 
Of the 22 individuals presenting with US identified TPT, over 70% were correctly identified 
clinically by either having pain or an inability to perform a SLHR (17, 77%) or a clinical diagnosis 
that was a combination of positive findings on palpation and one of the active contraction tests of 
the tibialis posterior muscle (16, 73%). Considering both reliability and diagnostic utility of the 
individual index tests, SLHR appears the most useful index test when greyscale changes in the 
tibialis posterior tendon are present with US as the reference standard. SLHR had the highest inter-
rater agreement ( = 0.74) and largest effects across all indices of diagnostic utility (Table 6-3). 
Pain or inability to perform a SLHR appears to be slightly more useful in ruling out the presence of 
TPT on US, as it had highest sensitivity and negative likelihood ratios of all indices, including when 
combined with palpation in the clinical diagnosis test. Negative SLHR almost halved the 
probability of the patient having grey scale changes on US (see Table 6-4). 
Despite the SLHR index test having the greatest diagnostic utility of those examined in this study 
(the only test with CI not containing the null), there were still a significant proportion of 
participants who tested positive to the SLHR test that did not have signs of TPT on US (11 false 
positives). This suggests that a SLHR may also be painful in individuals presenting with other 
causes of medial foot/ankle pain, and may not help to differentially diagnose TPT from other medial 
ankle pathologies. For example, the lower limb in a SLHR experiences 100% of the body mass in 
load, which conceivably loads the mid-tarsal joints or other nearby tendons (e.g., flexor hallucis 
longus). Alternatively, the US examination evaluated only greyscale changes, which may not be 
sufficiently sensitive to detect earlier pathological changes in the tendon or paratendon that could 
conceivably be a source of pain in this area. 237 
Loading in clinical examination tests of tendinopathy  
Tendinopathies are characterised by pain localised to the tendon that increases with loading. 238 The 
SLHR test is frequently described as a key component of the examination for TPT, 51 due to the role 
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of the tibialis posterior muscle in plantar flexion, inversion and stabilising and lifting the medial 
longitudinal arch. 239 The forces acting on the lower limb during a SLHR (due to 100% body mass) 
plausibly places more load through the tibialis posterior tendon than those during a clinician’s 
manually resisted PF/INV isometric contraction. This may explain the greater sensitivity and 
accuracy of the SLHR index test than the resisted PF/INV test (i.e. fewer false negatives for SLHR 
than resisted PF/INV). In another lower limb tendinopathy (gluteal tendinopathy), we showed that a 
test that included weight bearing on a single limb had better clinical utility than manually resisted 
isometric contractions of the involved muscles. 240 Together with our data, this suggests that manual 
resistance may not provide sufficient load to elicit a positive response and that for lower limb 
tendinopathies, bodyweight loading is probably more useful in identifying when there are signs of 
tendinopathy on imaging.  
Our physiotherapists applied manual resistance to an isometric contraction of PF/INV muscles with 
the rearfoot in an anatomically neutral position. That is, we did not test in a position of dorsiflexion 
and eversion, which would additionally stress the tibialis posterior tendons where it passes from 
posterior the medial malleolus to its primary destination at the navicular bone. 107 In our study of 
gluteal tendinopathy, we found that manually resisted isometric contractions in positions of the hip 
that added compression load to the tendons were diagnostically more useful. 240 It is compelling to 
speculate that performing resisted PF/INV in a dorsiflexed and everted position, thereby adding 
compression and tensile stresses to the tendon, may increase the diagnostic utility of this manually 
limited isometric PF/INV test.  
Palpation  
Tenderness on palpation has historically been a key component of the clinical examination for 
differentiating lower limb musculoskeletal conditions. 241 In this study, sensitivity of palpation was 
moderate (68%) and specificity was low (50%). This indicates there were as many true negatives as 
false positives, limiting the utility of palpation for ruling out TPT. The inter-rater reliability for 
tenderness on palpation of the tibialis posterior tendon was moderate ( = 0.41), which is likely to 
have influenced the diagnostic utility of the test. The clinical utility of palpation for accurately 
predicting pathology in tendons as seen on imaging must be interpreted with consideration of the 
comparator group (i.e. asymptomatic or pain group) and the reliability of the test. For example, 
compared to an asymptomatic cohort, inter-rater reliability of palpation for Achilles tendinopathy 
was substantial to almost perfect ( = 0.72 to 0.86), specificity was high (85% (75 to 91)) and 
sensitivity was moderate (58% (39 to 75)). 242 Reliability of palpation is likely influenced by 
palpation skills/technique of the clinician and the specific area. That is, close proximity of other 
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anatomical structures that might be sensitized/painful (e.g., as in conditions such as tarsal tunnel 
syndrome or posterior impingement). 241 
Low specificity values indicate that tenderness on palpation may be present in tendons that do not 
have US-identified tendinopathy (i.e. high number of false positives; positive results when there is 
no tendinopathy on US). When all participants in diagnostic utility studies present with pain, the 
specificity of palpation for diagnosing tendinopathy on imaging is lower than compared to when the 
cohort includes asymptomatic participants (e.g., 47% in gluteal tendinopathy, 240 and between 6% 
243 and 70% 244 in patellar tendinopathy compared to 85% when the comparator is asymptomatic 
242). In our study, there were 16 false positives (47% specificity) which suggests that other 
structures in the area are responsible for the symptoms. Alternatively, it is possible that some 
tendons that do not have US changes are tender on palpation. 245  
Clinical implications 
Our data suggest that the index tests selected in this study may be more useful for ruling out TPT in 
patients presenting with medial foot/ankle pain. Table 4 provides a clinical example of this. The 
probability of a patient presenting with medial ankle pain being diagnosed as having TPT from this 
study is 42%. A positive SLHR index test would increase this probability to 60% (18% change), but 
if the test was negative, the post-test probability would decrease to 22% (19% change). These 
findings suggest that clinicians need to be cautious using palpation alone to make a diagnostic 
decision. While palpation forms an integral component of the physical examination and may be 
important to determine the location of pain, adding a loading test improves likelihood of correctly 
diagnosing when there is a TPT. Thus, adding a loading test to palpation improves the diagnostic 
utility of palpation alone. Of the two loading tests used in this study, loading with body weight has 
greater diagnostic utility. As such, clinicians should consider using the SLHR test in preference to 
manually resisted PF/INV for clinically diagnosing TPT.  
Clinical signs of tendinopathy, specifically localised tendon pain that increases with load, can be 
present in the absence of degenerative pathological changes in the tendon. 246-248 The association 
between clinical signs and symptoms of tendinopathy and structural abnormalities is poor, 249 with 
abnormal imaging signs present in up to 50% of asymptomatic tendons. 250-253 Additionally, 
improvements in pain and function in tendinopathy are not mediated by changes in pathologic 
tendon structure. 254 Considering this disconnect between tendon pathology and clinical symptoms, 
255 it is important for clinicians to consider imaging findings in conjunction with clinical signs of 
tendinopathy and presenting impairments to help guide management. 
Limitations 
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There are limitations to consider when interpreting the results of this study. The first potential 
limitation is using US as the reference standard. While this means the findings are dependent on the 
inherent accuracy of US, it has been shown to be accurate and reliable when compared to magnetic 
resonance imaging 182 225-227 and is correlated with surgical findings. 139 Another potential limitation 
is that a single examiner performed all US assessments, where two clinicians performed the index 
test assessment. We only had access to one sonographer for this study and previous studies have 
shown better intra- than inter-rater reliability. 229 Second, the sample size is small and the indices of 
diagnostic utility (LRs) are small, lack precision (i.e., large CI), and (except for SLHR) all CIs 
contained 1 (i.e., null). As such, we were unable to confidently report shifts in post-test probability 
for three of the four index tests. Stronger conclusions may have been possible with a larger sample 
size, however this is the first study to investigate the reliability and utility of clinical tests for TPT 
that were identified by a systematic review of all primary research on the condition. Further 
research should seek ways to increase sample size so that estimates of diagnostic utility are more 
precise and also so that clinical prediction rules might be developed. Third, it must be considered 
that PPV and NPV are influenced by the prevalence of the disease in the population being tested 
(i.e. 42% in this case), and as such, the values reported in this study are only applicable when 
considering those presenting with medial ankle pain, not the general population. That said, the 
omission of asymptomatic participants in this study ensures there was no overestimation of the 
accuracy and sensitivity of the clinical tests in detecting tendinopathy. 246 This study reflects the use 
of clinical tests to diagnose tendinopathy in the clinical setting (i.e. to differentiate TPT from 
another cause of medial ankle pain).  
6.1.5 Conclusion 
Overall, the selected clinical tests for TPT have low diagnostic utility. In individuals with medial 
foot/ankle pain, pain or inability to perform a SLHR is likely to have the greatest utility in assisting 
a clinician to make a diagnosis of TPT. Common clinical tests such as palpation, manually resisted 
PF/INV and observing swelling along the tendon when applied as single tests are not useful in 
determining if TPT is present on US. Combining palpation with either SLHR or manually resisted 
PF/IN marginally improves the diagnostic utility of palpation, but it is still inferior to SLHR alone. 
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 Distinguishing features of tibialis posterior 
tendinopathy 
 Pronated foot posture, foot mobility and single leg heel raise capacity are 
distinguishing features of tibialis posterior tendinopathy 
Chapter four investigated clinical impairments, pain and disability reported in the current TPT 
literature. The review highlighted that outcome measures were predominantly focussed on local 
tendon dysfunction and foot posture and that 9/10 studies had eligibility criteria relating to foot 
posture, which makes findings about altered foot posture in TPT difficult to interpret. The primary 
aim of this chapter was to determine if there were differences in a range of common clinical foot 
and ankle measures between individuals with medial foot/ankle pain that was attributed to TPT, 
those who had TPT plus concomitant pain, those with medial foot/ankle pain that was not attributed 
to TPT and pain-free controls.  
Ross MH, Smith MD, Mellor, R, Vicenzino B. Heel raise capacity plus foot mobility and pronated 
posture distinguish individuals with tibialis posterior tendinopathy from those with concomitant 
pain, medial foot/ankle pain and pain-free: a cross sectional study.  
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7.1.1 Introduction 
Lower arch height and altered foot posture are frequently reported as key features of tibialis 
posterior tendinopathy. 84 195 Due to the path of the tendon on the posteromedial aspect of the ankle 
joint and its tendinous insertions to the plantar aspect of the tarsals and metatarsals, 256 257 
dysfunction of the tibialis posterior is often implicated as the most common cause of an adult 
acquired flatfoot deformity. 46 258 
Literature suggests that tendinopathy is the early stage on a continuum of progressive failure of the 
tendon and osseoligamentous structures of the foot that maintain the medial longitudinal arch (e.g. 
the plantar calcaneonavicular ligament) which can progress to an acquired flatfoot deformity. 130 
Flatfoot, and acquired flatfoot deformities have several eitiologies other than tibialis posterior 
tendinopathy, including congenital, neurological and traumatic causes. 132  
A recent systematic review found large, significant effects for lower arch height index (AHI; the 
height of the dorsum of the foot at 50% total foot length, divided by truncated foot length) 259 in 
individuals with tibialis posterior tendinopathy compared to controls. 195 This finding should be 
interpreted with caution as eligibility criteria for 9 out of 10 included studies required participants to 
demonstrate signs of flatfoot deformity, and specified control participants demonstrate AHI 1 
standard deviation (SD) above normative values. 260 Subsequently, it is not currently clear whether 
flatfoot is a key feature of the presentation when there are clinical signs of tendinopathy of the 
tibialis posterior tendon.  
Literature suggests that tibialis posterior tendinopathy is often misdiagnosed, or not diagnosed until 
the later stages when there is associated ligamentous failure and significant deformity and disability 
is present. 70 Identifying clinical features of tibialis posterior tendinopathy that are distinct from 
medial foot pain that is not attributable to tibialis posterior tendinopathy may assist with earlier 
diagnosis and developing targeted interventions. Due to the dearth of high quality randomised 
clinical trials for conservative management of tibialis posterior tendinopathy, the literature suggests 
management should be guided by presenting impairments. 65 Management strategies for pain in the 
medial foot and ankle regions vary considerably and a greater understanding of any differences in 
presenting impairments between those attributable to tibialis posterior tendinopathy and others may 
assist with the development of tailored management approaches for tibialis posterior tendinopathy.  
The first aim of this cross sectional study was to determine if there were differences in a range of 
commonly used clinical foot and ankle measures between individuals who had medial foot/ankle 
pain that we attributed to tibialis posterior tendinopathy (TPT), those who had TPT plus 
concomitant pain (TPTplus), those with medial foot/ankle pain that is not attributable to TPT (non-
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TPTMFP) and controls. A secondary aim was to evaluate if there were differences between the 
symptomatic and asymptomatic sides of individuals with TPT, TPTplus and non-TPTMFP and the 
asymptomatic side compared to controls. The reasons for including this analysis were two-fold; 
first, unilateral musculoskeletal conditions often manifest with bilateral impairments or deficits, 261 
and side to side comparisons are common clinical practice in evaluating musculoskeletal conditions.  
7.1.2 Methods 
Participants 
Participants were recruited from the Brisbane area between July 2017 and March 2019 for this cross 
sectional study. Participants between 18 and 70 years of age, reporting pain on the medial aspect of 
the foot and/or ankle and no history of lower limb surgery in the preceding 12 months, responded to 
online and print advertisements and completed an online screening survey. Potential participants 
invited to undergo a physical screening and testing session at the University of Queensland, 
Brisbane, Australia.  
On physical examination, those volunteers who had medial foot/ankle pain were classified as TPT if 
they had pain on the medial aspect of the foot/ankle greater than 2/10 on a numerical rating scale 
(NRS) on most days for the preceding three months and pain or inability to perform a single leg 
heel raise (SLHR). These selection criteria were based on a diagnostic utility study of index tests for 
TPT (Study 5) and performed by two separate examiners to improve the confidence in the selection 
process. Of the participants meeting selection criteria for the TPT group, those who also had pain 
elsewhere in the lower limbs or back, including bilateral TPT symptoms, were further classified into 
the TPTplus group. Participants with medial foot/ankle pain greater than 2/10 on a NRS on most 
days for the preceding three months who tested negative to the SLHR test were classified as having 
non-TPTMFP. Where participants had bilateral TPT or non-TPTMFP, the most symptomatic side 
was considered the ‘study side’. Participants were excluded if pain was not greater than 2/10 on 
most days in the preceding three months, or if pain was not in the medial aspect of the foot/ankle on 
physical screening. Control participants responded to an online screening survey and were eligible 
if they had no history of lower limb or back pain in the last 12 months and no history of lower limb 
surgery. Participants with neurological or inflammatory arthritic diseases were excluded from all 
groups.  
Measures 
To characterise foot posture and mobility, a range of commonly used clinical outcome measures 
were collected for all participants. Static foot posture was quantified visually using the Foot Posture 
Index (FPI). This simple and reliable 262 tool contains six criterion-based observations of the 
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rearfoot and forefoot which are used to classify foot posture. Observations are graded on a scale 
from -2 to 2 with more supinated positions receiving a negative value, and more pronated positions 
receiving a positive value with final aggregate scores ranging between -12 to +12 (Figure 7-1). 263 
Arch height index (AHI) is another commonly reported measure of foot posture, and was calculated 
as the height of the arch at 50% of truncated foot length. 259 To measure foot mobility, the Foot 
Mobility Magnitude (FMM) was used to calculate change in midfoot height (DiffAH) and width 
(DiffMFW) between weight bearing (Figure 7-1) and non-weight bearing conditions. 264 Total foot 
length, midfoot height and width at 50% of total foot length and forefoot width were measured in 
standing and unsupported sitting and the FMM was calculated as √(DiffAH)2 + (DiffMFW)2  as 
previously described in the literature. 264  
 
Figure 7-1 Left: Position for visual observation of foot posture for FPI, right: measurement 
position for AHI and weight bearing arch height measurement of FMM.  
Weight bearing dorsiflexion (WBDF) was measured using a lunge ankle dorsiflexion measurement 
device previously shown to have high intra- and inter-rater reliability in clinical population. 265 
Linear measurement of the horizontal distance between the anterior knee and the fixed reference 
block at the longest toe was recorded (mm) (Figure 7-2) as well as the inclination (degrees) of the 
tibia using an inclinometer placed at the midpoint of the anterior border of the tibia at the end of 
WBDF range. Tibial inclination (degrees) during ankle dorsiflexion in knee extension was also 
measured with the central line on the lunge ankle dorsiflexion measurement device bisecting the 
foot between the second and third toe and centre of the calcaneus consistent with the positioning for 
the WBDF measurement. 265  
Ankle plantar flexor endurance was assessed using a single leg heel raise (SLHR) test in knee 
extension, which has been widely used for assessing people with tibialis posterior tendinopathy. 133 
Participants performed as many repetitions as possible at maximal SLHR height determined on a 
single repetition prior to beginning the test (Figure 7-2). The test was terminated when the knee 
flexed, the height of the heel raise diminished (i.e. participant was unable to reach the horizontal bar 
set at the maximal heel raise height determined on a single repetition prior to the test), excessive 
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weight was placed through the hands or the participant was unable to perform another repetition due 
to pain. Number of successful SLHRs and pain intensity during and following the test was recorded 
on a NRS. 
  
Figure 7-2 Left: Measurement position for WBDF, right: SLHR test position 
Five self-report measures were used to better understand the impact of medial foot/ankle pain on 
those with TPT, TPTplus and non-TPTMFP. Health-related foot function and foot-health related 
quality of life were assessed using the Foot Function Index-Revised. This is a valid and reliable 
self-report questionnaire consisting 68 questions in relation to pain, stiffness, difficulties, activity 
limitations, social restrictions. 266 267 Responses to each question were given on 5-point likert scales 
and summed to give scores for each subscale and an overall score, with higher values indicating 
poor foot health and poor foot-related quality of life. 268 Multi-dimensional health-related quality of 
life was assessed using the Assessment of Quality of Life (6 domains) (AQoL-6D). The self-report 
questionnaire has appropriate levels of construct, concurrent and convergent validity with other 
generic measures of health related quality of life 269 270 and consists of 20 questions pertaining to six 
domains (independent living, relationships, mental health, coping, pain and senses). 270 For each 
item there are 4-6 response options, with higher scores representing greater impairment in quality of 
life. 269 Catastrophic thinking related to pain was measured using the Pain Catastrophisation Scale 
(PCS), which has demonstrated adequate to excellent internal consistency, 271 and moderate 
reliability overall. 272 The PCS consists of 13 items scored on a 5-point scale from 0 (not at all) to 4 
(all the time), 271 and total score is calculated by summing the responses to all 13 items (ranges from 
0 to 52 where 52 represents a high level of catastrophizing). 271 Fear of movement or (re)-injury 
related to pain fear of movement was assessed using the Tampa Scale of Kinesiophobia (TSK). The 
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TSK is a self-administered questionnaire with 17 items scored on a 4-point Likert scale from 
‘strongly disagree’ (1 point) to ‘strongly agree’ (4 points). A final score is calculated by first 
inversing the scores from items 4, 8, 12 and 16 and then summing the total which ranges from 17 or 
68 with higher scores indicating greater levels of fear of movement. 273 The TSK has demonstrated 
high internal consistency and subsequently high reliability 274 in addition to good responsiveness, 
concurrent validity and predictive validity. 275 
Procedures 
Following physical screening, demographic and anthropometric data were collected for all 
participants prior to undergoing the physical testing session. Self-report measures were completed 
online following the physical testing session.  
Statistical analysis 
All data were examined for normality prior to analyses using SPSS version 25 (IMB, New York, 
NY). Continuous, normally distributed descriptive data were expressed as mean (SD) and compared 
between groups using an analysis of variance (ANOVA) with an alpha level of p = 0.05. 
Descriptive data that was not normally distributed was reported as median (interquartile range 
(IQR)) and compared using the Krustal-Wallis (>2 groups) or Mann Whitney-U (2 groups) tests. 
Descriptive categorical data was reported as n (%) for each group and compared using Pearson’s 
chi-square statistic (χ2). For outcomes with bilateral data, the left and right sides of control 
participants were pooled to give one average value. Where there were bilateral medial foot/ankle 
symptoms for the TPTplus and non-TPTMFP groups, as the most symptomatic side was considered 
the ‘study side’ and the other, less painful side, was excluded from analyses of the ‘asymptomatic 
side’. 
Multivariate analyses of variance and covariance (MANOVA and MANCOVA) were run to 
compare TPT, TPTplus and non-TPTMFP groups for foot measures on the symptomatic side (after 
controlling for body mass index (BMI) (MANCOVA) and self-report outcomes (MANOVA). A 
second MANOVA was run to compare foot measures between the symptomatic and asymptomatic 
side for the three pain groups (TPT, TPTplus and non-TPTMFP) and a second MANCOVA was run 
to compare the symptomatic and asymptomatic sides for each pain group to control participants 
after controlling for BMI. Pairwise comparisons were expressed as mean differences (MDs) and 
95% confidence intervals (CIs) for between group and side differences (for TPT and non-TPTMFP 
groups).  
Standardised mean differences (SMDs) were calculated as the difference between group means, 
divided by the pooled SD 197 and visualised on forest plots as SMDs and 95% CIs. SMDs were 
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interpreted based on Hopkins, as follows; < 0.2 trivial effect, 0.2 - 0.6 small effect, 0.61 – 1.2 
medium effect, and > 1.2 large effect. 88 
7.1.3 Results 
Participants 
Seventy-one participants with medial foot/ankle pain met eligibility criteria and were compared to 
27 age and sex matched controls (Figure 7-3). Of participants presenting with medial foot/ankle 
pain, a 15 (21.1%) cases were classified as TPT, 27 (38.0%) cases as TPTplus and 29 (40.8%) cases 
as non-TPTMFP. All groups were similar in terms of age, proportion of females, height, pain 
medication use (in the previous 48 hours), hormonal status, diabetes and physical activity (Table 
7-1).  
 
Figure 7-3 Participant flow through the study 
Excluded 
n = 358 
Not medial foot/ankle pain n 
= 142 
Unable to contact n = 127 
Declined to participate n = 
65 
Pain ≤ 2/10 n = 16 
Other pain condition (i.e. 
neurological) n = 4 
Surgical history n = 2 
Not 18-70 years n = 2 
Excluded 
n = 53 
Location of pain = 37 
Not symptomatic = 9 
Pain elsewhere = 6 
Duration < 3/12 = 1 
TPT 
n = 42 
Isolated 
n = 15 
Not 
isolated 
n = 31 
Pain free control 
n = 27 
Phone screening 
n = 478 
Physical screening 
n = 151 
Clinical examination 
n = 98 
Online screening 
survey 
n = 1629 
Excluded 
n = 1151 
Pain location n = 794 
Declined to participate n = 
144 
Surgical history n = 91 
Pain ≤ 2/10 n = 58 
Not 18-70 years n = 39 
Medial foot pain 
n = 29 
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All participants with medial foot/ankle pain regardless of tissue attribution had significantly higher 
body mass and body mass index (BMI) than control participants (p<0.01). Duration of symptoms 
and worst pain in the previous week were similar between participants with TPT, TPTplus and non-
TPTMFP (Table 7-1). A greater proportion of participants with TPT plus concomitant pain than 
isolated TPT and controls were taking regular prescription medication, but there was no difference 
compared to non-TPTMFP participants (p<0.01). There was a greater proportion of participants in 
the TPTplus and control groups who were post-menopausal compared to the TPT only group 
(Table 7-1). Physical activity in the previous week was not different between the four groups 
overall, however participants with isolated TPT reported a greater total time than participants with 
TPT plus concomitant pain, of whom a lesser proportion were sufficiently active compared to 
controls (Table 7-1). 
 
Table 7-1 Demographic characteristics of included participants (n=98). Data are number (%) of 
participants or mean (SD) unless otherwise specified. 
Characteristic TPT1 TPTplus2 non-
TPTMFP3 
Control4  
 n=15 n=27 n=29 n=27 p-
value 
Age, years  43.8 (11.6) 47.6 (14.6) 43.5 (11.1) 43.7 (15.6) 0.64 
Female 12 (80.0) 23 (85.2) 24 (82.8) 25 (92.6) 0.65 
Left study foot 3 (20.0)2,3 19 (70.4)1,4 16 (55.2)1 9 (33.3)2 <0.01 
Bilateral MFP - 9 (33.3) 6 (20.7) - 0.29~ 
Height, m 1.7 (0.1)2,3,4 1.6 (0.1) 1.7 (0.1) 1.7 (0.1) 0.08 
Mass, kg 83.4 (19.5) 86.0 (21.9) 79.3 (21.7) 63.7 (13.6)1,2,3 <0.01 
Body mass index kg/m2 28.2 (7.1) 31.4 (6.5) 28.8 (8.1) 23.0 (4.6)1,2,3 <0.01 
Symptom duration, months^ 13 (42, 3-60) 34 (54, 3-
240) 
30 (90, 3-
312)) 
- 0.37# 
3-6 2 (13.3) 5 (18.5) 3 (10.3) - 0.89 
6-12 4 (26.7) 5 (18.5) 6 (20.7) -  
>12 9 (60.0) 15 (63.0) 20 (69.) -  
Worst pain^ /10 7 (4, 4-9) 7 (3, 2-10) 6 (3, 2-10) - 0.44# 
Number of patients with pain 
elsewhere 
- 25 (92.6) 24 (82.8) - 0.27~ 
Number of additional pain 
locations^ 
- 1 (1, 0-7) 1 (1, 0-7) - 0.84~ 
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Superscript numbers denote groups that are different at the 0.05 level based on pairwise 
comparisons, ~ = Comparison between TPT+pain and non-TPTMFP groups only, ^ = median 
(IQR, range), # = comparison between 3 pain groups only 
 
Main outcomes 
A MANCOVA was conducted to determine if there were statistically significant differences 
between isolated TPT, TPT plus concomitant pain, non-TPTMFP and controls on foot posture and 
mobility measures on the symptomatic side after controlling for BMI (Table 7-2). 
.
Used pain medication in last 
48 hours 
1 (6.7) 7 (25.9) 8 (27.6) 3 (11.1) 0.19 
Regular medication use 4 (26.7)2 17 (63.0)1,4 14 (48.3)4 5 (18.5)2 <0.01 
Diabetes 1 (6.7) 0 (0.0) 0 (0.0) 0 (0.0) 0.13 
Hormonal status     0.24 
Premenopausal 5 (33.3) 9 (33.3) 11 (37.9) 14 (51.9)  
Perimenopausal 6 (40.0) 5 (18.5) 9 (31.0) 5 (18.5)  
Postmenopausal 0 (0.0)2,4 8 (29.6)1 4 (13.8) 6 (22.2)1  
Not applicable 4 (26.7) 5 (18.5) 5 (17.2) 2 (7.4)  
Total physical activity over the 
last week, hrs 
14.6 (9.7)2 7.2 (6.1)1 11.3 (9.6) 12.4 (8.1) 0.10 
Rating of physical activity^      0.20 
Inactive 0 (0.0) 2 (11.8) 1 (4.0) 0 (0.00)  
Insufficiently active 1 (6.7) 3 (17.6) 4 (16.0) 1 (3.70)  
Sufficiently active 14 (93.3) 12 (70.6)4 20 (80.0) 26 (96.30)2  
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Table 7-2 Foot posture and mobility data for participants with TPT, non-TPTMFP and controls. Data are mean (SD). 
  TPT TPTplus Non-TPTMFP Control 
  
Symptomatic 
(n=15) 
Asymptomatic 
(n=15) 
Symptomatic 
(n=26) 
Asymptomatic 
(n=18^) 
Symptomatic 
(n=28) 
Asymptomatic 
(n=22^) 
Average 
(n=27) 
Characteristic Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) 
Mean 
(SD) 
FPI (-12 to 12) 6.67 (3.13) 4.00 (3.03) 7.00 (3.37) 4.27 (3.46) 3.53 (2.69) 1.18 (2.66) 1.98 (3.19) 
AHI 0.31 (0.03) 0.31 (0.03) 0.30 (0.04) 0.31 (0.04) 0.32 (0.03) 0.32 (0.03) 0.32 (0.03) 
Foot mobility magnitude 17.89 (3.42) 19.07 (3.31) 17.77 (3.68) 17.37 (3.78) 15.83 (2.94) 16.10 (2.91) 
16.93 
(3.48) 
WBDF (mm) 87.04 (33.63) 111.24 (32.56) 86.01 (36.22) 97.14 (37.14) 93.29 (28.88) 107.3 (28.62) 
112.72 
(34.26) 
Tibial inclination in knee 
flexion (degrees) 37.98 (8.44) 42.84 (8.17) 35.01 (9.09) 39.42 (9.32) 38.57 (7.25) 42.15 (7.18) 42.77 (8.6) 
Tibial inclination in knee 
extension (degrees) 31.60 (5.70) 34.67 (5.51) 30.2 (6.13) 31.17 (6.29) 31.5 (4.89) 34.3 (4.85) 
35.26 
(5.80) 
SLHR height (cm) 8.73 (1.99) 8.96 (1.93) 7.18 (2.15) 8.48 (2.2) 8.55 (1.71) 9.15 (1.70) 9 (2.03) 
SLHR repetitions 9.48 (6.09) 14.28 (5.90) 8.41 (6.56) 12.84 (6.73) 12.21 (5.23) 15.76 (5.19) 
19.57 
(6.21) 
SLHR pain during /10 4.73 (2.33) 1.07 (2.26) 4.86 (2.51) 1.82 (2.58) 3.33 (2.00) 0.37 (1.99) 
-0.08 
(2.38) 
Evaluated with BMI as a covariate at 28.33, ^ = asymptomatic side excluded due to pain  
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Between groups 
There were no differences between participants with isolated TPT and TPTplus on the symptomatic 
side (Table 7-3). Participants with TPTplus fewer repetitions (~4 repetitions, p = 0.01) on the 
symptomatic side compared to those with non-TPTMFP (Table 7-3/Figure 7-4-c). Considering 
foot posture, there were significant differences between non-TPTMFP participants and TPT (TPT 
and TPTplus) for FPI with participants with TPT (TPT and TPTplus) having significantly more 
pronated foot posture than non-TPTMFP (Table 7-3/Figure 7-4-b,c). Participants with TPTplus 
also had significantly greater foot mobility (FMM) than the non-TPTMFP group (Table 7-3/Figure 
7-4-c). There were no differences in ankle dorsiflexion or AHI between any pain groups (Table 
7-3/Figure 7-4-a,b,c). 
Table 7-3 Symptomatic side comparisons between groups for foot posture and mobility outcomes. 
Data are mean (SD). 
Comparison TPT v TPTplus TPT v non-TPTMFP  TPTplus v non-TPTMFP 
Characteristic MD (95% CI), p MD (95% CI), p MD (95% CI), p 
FPI (-12 to 12) -0.33 (-2.29 to 1.62), 0.74 3.15 (1.23 to 5.06), <0.01* 3.48 (1.84 to 5.12), <0.01* 
AHI 0.01 (-0.01 to 0.03), 0.31 -0.01 (-0.03 to 0.01), 0.59 -0.02 (-0.03 to 0), 0.07 
Foot mobility 
magnitude 
-0.08 (-2.2 to 2.04), 0.94 1.94 (-0.11 to 3.99), 0.06 2.02 (0.2 to 3.84), 0.03* 
WBDF (mm) 3.55 (-17.3 to 24.4), 0.74 -4.77 (-24.95 to 15.41), 0.64 -8.32 (-26.19 to 9.55), 0.36 
Tibial 
inclination in 
knee flexion 
(degrees) 
3.99 (-1.22 to 9.21), 0.13 -0.06 (-5.1 to 4.99), 0.98 -4.05 (-8.52 to 0.42), 0.08 
Tibial 
inclination in 
knee extension 
(degrees) 
1.73 (-1.79 to 5.26), 0.33 0.26 (-3.15 to 3.68), 0.88 -1.47 (-4.5 to 1.55), 0.34 
SLHR 
repetitions 
2.11 (-1.66 to 5.88), 0.27 -2.13 (-5.78 to 1.51), 0.25 -4.25 (-7.47 to -1.02), 0.01* 
Evaluated with BMI as a covariate at 28.33, * = mean difference significant at 0.05 
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Figure 7-4 SMD (95% CI) for the symptomatic side between pain groups. Positive SMDs indicate 
greater values in a) TPT group, b) TPT group and c) TPTplus group. 
-3 -2 -1 0 1 2 3
SLHR repetitions
Tibial inclination (knee extension)
Tibial inclination
WBDF
Foot mobility magnitude
AHI
FPI
SMD (95% CI)
a) TPT v TPTplus
b) TPT v non-TPTMFP
c) TPTplus v non-TPTMFP
-3 -2 -1 0 1 2 3
SLHR repetitions
Tibial inclination (knee extension)
Tibial inclination
WBDF
Foot mobility magnitude
AHI
FPI
SMD (95% CI)
-3 -2 -1 0 1 2 3
SLHR repetitions
Tibial inclination (knee extension)
Tibial inclination
WBDF
Foot mobility magnitude
AHI
FPI
SMD (95% CI)
132 
 
Compared to controls, all participants with medial foot/ankle pain had significantly poorer foot-
related function and quality of life on the FFI-R (Table 7-4) poorer quality of life overall, and in 
relation to the independent living and pain subscales of the AQoL6D (Table 7-4). There were no 
differences between TPT, TPTplus or non-TPTMFP for self-reported foot function, quality of life, 
pain catastrophizing or kinesiophobia (Table 7-4). Only participants with TPTplus had significantly 
poorer quality of life compared to controls in relation to the relationships, mental health and coping 
subscales (Table 7-4).  
 
Table 7-4 Self report outcomes for isolated TPT and TPT with concomitant pain. Data are mean 
(SD) unless otherwise specified. 
  
TPT  
(n = 15) 1 
TPTplus  
(n = 17) 2 
non-TPTMFP  
(n = 25) 3 
Control  
(n=27) 4 
  
p-
value Characteristic Mean (SD) Mean (SD) Mean (SD) Mean (SD) 
Foot Function 
Index-Revised 
45.77 (14.03) 4 46.03 (11.75) 4 42.09 (9.08) 4 25.37 (1.2) 1, 2, 3 <0.01 
Pain  56.41 (13.5) 4 54.50 (14.48) 4 52.76 (10.71) 4 25.21 (1.07) 1, 2, 3 <0.01 
Stiffness 49.26 (18.86) 4 52.70 (17.15) 4 50.46 (14.51) 4 25.36 (1.36) 1, 2, 3 <0.01 
Difficulties 47.06 (14.86) 4 48.53 (15.83) 4 43.86 (14.15) 4 25 (0) 1, 2, 3 <0.01 
Activity 
limitations 
35.57 (13.82) 4 33.42 (10.28) 4 31.58 (8.31) 4 25 (0) 1, 2, 3 <0.01 
Social 
restrictions 
41.72 (17.44) 4 42.35 (14.16) 4 36.21 (11.36) 4 25.96 (3.6) 1, 2, 3 <0.01 
AQoL6D 36.60 (9.88) 4 38.94 (11.08) 4 36.36 (7.8) 4 27.89 (4.77) 1, 2, 3 <0.01 
Independent 
living 
6.47 (2.07) 4 6.94 (2.88) 4 6.60 (2.36) 4 4.15 (0.36) 1, 2, 3 <0.01 
Relationships 4.13 (1.64) 4.29 (1.9) 4 4.00 (1.35) 3.33 (0.56) 2 0.09 
Mental health 8.07 (2.74) 8.76 (3.27) 4 7.76 (1.79) 6.74 (2.23) 2 0.06 
Coping 5.93 (1.67) 7.12 (2.47) 4 6.28 (1.82) 5.70 (1.61) 2 0.11 
Pain 7.13 (2.23) 4 7.18 (2.24) 4 6.72 (1.79) 4 3.41 (0.75) 1, 2, 3 <0.01 
Senses 4.87 (1.6) 4.65 (1.32) 5.00 (1.29) 4.56 (1.22) 0.65 
Pain 
Catastrophizing 
Scale 
8.73 (11.38) 6.53 (7.33) 5.28 (4.77) 6.26 (11.13) 0.70 
Tampa Scale of 
Kinesiophobia# 
35.00 (6.57) 32.35 (10.51) 36.32 (4.88) - 0.24 
Superscript numbers denote groups that are different at the 0.05 level based on pairwise 
comparisons, # = comparison between 3 pain groups only. Abbreviations: AQoL6D; Assessment of 
Quality of Life (6 domains) 
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Between sides 
A MANOVA was conducted to see if there were statistically significant differences between the 
symptomatic and asymptomatic side for each of the three pain groups, excluding the asymptomatic 
side for those who had bilateral pain.  
 
Table 7-5 Foot posture and mobility outcomes between symptomatic and asymptomatic sides for 
pain groups 
  TPT between sides TPTplus between sides non-TPTMFP between sides 
Characteristic MD (95% CI), p MD (95% CI), p MD (95% CI), p 
FPI (-12 to 12) 2.67 (0.48 to 4.85), 0.02* 2.74 (0.91 to 4.58), <0.01* 2.35 (0.65 to 4.06), <0.01* 
Arch height 
index 
0.01 (-0.02 to 0.03), 0.59 -0.01 (-0.03 to 0.01), 0.18 0 (-0.02 to 0.02), 0.96 
Foot mobility 
magnitude 
-1.18 (-3.59 to 1.23), 0.34 0.44 (-1.58 to 2.47), 0.67 -0.24 (-2.12 to 1.64), 0.8 
WBDF (mm) -24.2 (-47.7 to -0.7), 0.04* -11.34 (-31.08 to 8.39), 0.26 -14.17 (-32.5 to 4.17), 0.13 
Tibial inclination 
in knee flexion 
(degrees) 
-4.87 (-10.85 to 1.11), 0.11 -4.53 (-9.55 to 0.5), 0.08 -3.67 (-8.34 to 0.99), 0.12 
Tibial inclination 
in knee extension 
(degrees) 
-3.07 (-7.03 to 0.9), 0.13 -0.97 (-4.3 to 2.37), 0.57 -2.79 (-5.89 to 0.3), 0.08 
SLHR height 
(cm) 
-0.23 (-1.73 to 1.26), 0.76 -1.36 (-2.62 to -0.11), 0.03* -0.65 (-1.81 to 0.52), 0.27 
SLHR repetitions -4.8 (-9.59 to -0.01), 0.05 -4.67 (-8.69 to -0.65), 0.02* -3.73 (-7.46 to 0.01), 0.05 
SLHR pain  3.67 (2.04 to 5.29), <0.01* 3.03 (1.66 to 4.4), <0.01* 2.96 (1.69 to 4.23), <0.01* 
* = mean difference significant at 0.05 
 
All participants with medial foot/ankle pain had significantly more pronated foot posture on the 
symptomatic side compared to the asymptomatic side with moderate to large effects (SMD 0.61 to 
>1.2) (Table 7-5/Figure 7-5). Only participants with isolated TPT had significantly less WBDF 
range of motion on the symptomatic side than the asymptomatic side (Table 7-5/Figure 7-5-b). In 
participants with non-TPTMFP, there was a moderate effect for restricted tibial inclination in knee 
extension (Figure 7-5-c), but this did not reach statistical significance (Table 7-5). All participants 
with medial foot/ankle pain reported significantly greater pain on the symptomatic side compared to 
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the asymptomatic side during the SLHR test, but only those with TPT plus concomitant pain 
performed significantly fewer repetitions on the symptomatic side (Table 7-5/Figure 7-5-a,b,c). 
There was also a difference between height of SLHR on the symptomatic compared to 
asymptomatic side for the TPTplus group, however the CIs for the effect contained 0 (Table 
7-5/Figure 7-5-a).  
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Figure 7-5 Between side differences for a) isolated TPT, b) TPTplus, c) non-TPTMFP. Positive 
SMDs indicate greater values on the symptomatic side.  
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Compared to controls 
Both TPT groups, but not those with non-TPTMFP had significantly more pronated foot posture 
compared to controls on both the symptomatic and asymptomatic side (Table 7-6/Figure 7-6). 
Participants with TPTplus, but not those with TPT or non-TPTMFP had significantly smaller AHI 
on the symptomatic side compared to controls (Table 7-6/Figure 7-6-a,c,e). There was 
significantly less WBDF range of motion on the symptomatic compared to controls for all groups 
(Table 7-6/Figure 7-6-a,c,e), tibial inclination in knee flexion and extension for the TPTplus group 
(Figure 7-6-c) and tibial inclination in knee extension only for the non-TPTMFP group (Figure 
7-6-e). Dorsiflexion in knee extension was also restricted on the asymptomatic side for the TPTplus 
group (Table 7-6/Figure 7-6-d) 
Single leg heel raise endurance was significantly poorer compared to controls for both the 
symptomatic and asymptomatic sides for all participants with medial foot/ankle pain (Table 
7-6/Figure 7-6), with a greater magnitude of deficit for the symptomatic side (moderate to large 
SMDs; Figure 7-6-a,c,e).  
There were no differences between non-TPTMFP participants and controls for foot posture or 
mobility outcomes on the symptomatic or asymptomatic sides (Table 7-6/Figure 7-6-e,f). There 
were no differences between the asymptomatic side for the non-TPTMFP group and controls except 
for SLHR endurance (Table 7-6/Figure 7-6-f).  
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Table 7-6 Foot posture and mobility outcomes for pain groups compared to controls for the symptomatic and asymptomatic side. Data are mean (SD).  
  Symptomatic v control 
  TPT TPTplus non-TPTMFP 
Characteristic MD (95% CI), p MD (95% CI), p MD (95% CI), p 
FPI (-12 to 12) 4.7 (2.73 to 6.66), <0.01* 5.03 (3.27 to 6.78), <0.01* 1.55 (-0.12 to 3.22), 0.07 
AHI -0.01 (-0.03 to 0.01), 0.2 -0.02 (-0.04 to -0.01), 0.01* -0.01 (-0.03 to 0.01), 0.39 
Foot mobility magnitude 0.85 (-1.252to 2.94), 0.43 0.92 (-1.02 to 2.87), 0.35 -1.1 (-2.92 to 0.73), 0.24 
WBDF (mm) -24.28 (-44.91 to -3.66), 0.02* -27.84 (-46.96 to -8.71), <0.01* -19.52 (-37.43 to -1.61), 0.03* 
Tibial inclination in knee flexion (degrees) -4.31 (-9.47 to 0.85), 0.1 -8.3 (-13.09 to -3.52), <0.01* -4.26 (-8.74 to 0.22), 0.06 
Tibial inclination in knee extension 
(degrees) -3.52 (-7.009 to -0.03), 0.05 -5.25 (-8.49 to -2.02), <0.01* -3.78 (-6.81 to -0.75), 0.01* 
SLHR repetitions -9.54 (-13.266 to -5.812), <0.01* -11.65 (-15.11 to -8.19), <0.01* -7.41 (-10.64 to -4.17), <0.01* 
  Asymptomatic v control 
  TPT TPTplus non-TPTMFP 
Characteristic MD (95% CI), p MD (95% CI), p MD (95% CI), p 
FPI (-12 to 12) 2.03 (0.06 to 3.99), 0.04* 2.30 (0.39 to 4.20), 0.02* -0.79 (-2.56 to 0.97), 0.37 
AHI -0.02 (-0.04 to 0), 0.07 -0.01 (-0.03 to 0.01), 0.33 -0.01 (-0.03 to 0.01), 0.46 
Foot mobility magnitude 2.14 (0 to 4.29), 0.05 0.44 (-1.64 to 2.53), 0.67 -0.83 (-2.75 to 1.1), 0.4 
WBDF (mm) -1.56 (-22.66 to 19.54), 0.88 -15.71 (-36.21 to 4.81), 0.13 -5.51 (-24.44 to 13.43), 0.57 
Tibial inclination in knee flexion (degrees) 0.02 (-5.25 to 5.3), 0.99 -3.43 (-8.56 to 1.7), 0.19 -0.67 (-5.41 to 4.06), 0.78 
Tibial inclination in knee extension 
(degrees) -0.61 (-4.18 to 2.96), 0.74 -4.12 (-7.59 to -0.65), 0.02* -0.98 (-4.18 to 2.22), 0.55 
SLHR repetitions -5.33 (-9.14 to -1.52), <0.01* -6.8 (-10.5 to -3.09), <0.01* -3.86 (-7.28 to -0.44), 0.03* 
Evaluated with BMI as a covariate at 28.33, * = mean difference significant at 0.05 
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Figure 7-6 SMD (95% CI) for the symptomatic and asymptomatic side for pain groups compared to controls. Positive SMDs indicate greater values in 
the TPT group compared to controls.  
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7.1.4 Discussion 
This cross-sectional study is the first to investigate and report differences in the clinical presentation 
of medial foot/ankle pain that is attributable to tibialis posterior tendinopathy based on pain location 
and pain or difficulties with raising the heel on one foot standing (TPT), when compared to TPT 
plus concomitant pain (TPTplus), medial foot/ankle pain that is not attributable to the tibialis 
posterior tendon (nonTPTMFP) and to controls. We classified medial foot/ankle pain being 
attributable to tibialis posterior by using the SLHR. We based this on a comprehensive systematic 
review 84 and diagnostic utility study (Study 5) that showed it to have the highest likelihood ratio 
(both positive and negative) of identifying US greyscale features of tibialis posterior tendinopathy. 
Of 71 participants with medial foot/ankle pain included in the present study, 39% (28) could not be 
attributed to the tibialis posterior on the classification criteria we used. Of the 41 (58%) participants 
who had a positive SLHR test, only 15 (37%, or 21% of the total sample of 71) did not have 
concomitant pains elsewhere in the lower body. 
Results suggest that there are some clinical features that distinguish between individuals with TPT, 
TPTplus, non-TPTMFP and controls. Participants with TPT and concomitant pain were more likely 
to be taking regular medications, be post-menopausal and participate in approximately 7 hours of 
moderate to vigorous physical activity less than those with isolated TPT. Considering foot posture, 
individuals with medial foot/ankle pain that was attributed to the tibialis posterior tendon had 
bilaterally pronated foot posture and in terms of SLHR capacity, those with TPTplus had greater 
deficits in height, endurance and pain compared to those with medial foot/ankle pain that was not 
attributed to the tibialis posterior tendon.  
The SLHR test was used to quantify evidence of impaired capacity of the tibialis posterior muscle. 
Findings from this study are comparable to previously published literature demonstrating impaired 
heel raise performance 66 67 in tibialis posterior tendinopathy compared to healthy controls. Unique 
to this study, individuals with TPTplus (i.e., additional pain sites) had greater deficits in SLHR 
endurance compared to MFP not attributable to tibialis posterior tendinopathy, and deficits in 
endurance were greater in, but not limited to, the symptomatic side in all pain groups compared to 
controls. Bilaterally impaired SLHR endurance has been demonstrated previously for TPT. 66 
Results from this study indicate that bilaterally impaired SLHR endurance is a clinical feature of 
tibialis posterior tendinopathy, despite unilateral symptoms. Interestingly, non-TPTMFP was 
associated with similar endurance deficits compared to controls on the symptomatic side only, 
although to a lesser magnitude than TPT. Together, these findings suggest that the SLHR test is a 
provocative test for individuals with medial foot/ankle pain (not just TPT) but is considerably more 
difficult for individuals with pain that was attributed to TPT on clinical testing, particularly when 
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there are concomitant pain sites (greatest magnitude of deficit). Clinically this suggests that 
individuals presenting with medial foot/ankle pain, regardless of differential diagnosis, may benefit 
from treatment directed at improving functional capacity of the ankle plantar flexors and may 
require management bilaterally. 
Research has consistently shown that individuals with TPT have altered foot posture compared to 
healthy, asymptomatic controls. 195 Flatfoot deformity has been implicated as both a risk factor for, 
276 277 and a sequelae of, tibialis posterior tendinopathy, 130 with lowering of the medial longitudinal 
arch, forefoot abduction and calcaneal eversion characteristic features of the deformity. 191 Results 
from this study are consistent with the previous research; individuals with medial foot/ankle pain 
that was attributed to the tibialis posterior tendon have pronated foot posture on both feet compared 
to controls, which is greater on the symptomatic than asymptomatic side. As this was a cross-
sectional study design no causal direction can be inferred and as such it is not known whether 
greater pronation on the symptomatic side preceded symptoms or is a result of osseoligamentous 
failure. 278 Pronated foot posture, quantified in this study using the FPI, may be useful however, in 
distinguishing TPT from other medial foot/ankle pain that is not attributable to TPT. Foot posture 
was not different between those with non-TPTMFP and controls on the symptomatic or 
asymptomatic side, and those with TPT (both isolated and with concomitant pain) had significantly 
more pronated foot posture on the symptomatic side compared to the non-TPTMFP group.  
Restrictions in range of motion at the ankle were also present in participants with medial foot/ankle 
pain compared to controls. On the symptomatic side, all pain participants had similar deficits in 
WBDF range of motion compared to pain free controls. Maximal dorsiflexion at the ankle increases 
compressive and tensile loads 107 on the tibialis posterior tendon as it runs posteriorly to the medial 
malleolus and is likely to be provocative for individuals with tibialis posterior tendinopathy. As 
dorsiflexion range of motion with the knee extended may be limited by the gastrocnemius-achilles 
complex before compression occurs, it is possible that participants with TPTplus and non-TPTMFP 
were limited by this rather than pain from compression. Previous research has suggested that 
Achilles tendon contracture may at times, occur concurrently with TPT. 192 193 Evidence of impaired 
dorsiflexion in knee flexion, and extension, may support this association, although further research 
is warranted.  
There are some limitations that need to be considered when interpreting the findings from this 
study. First is that classification criteria for TPT were based on clinical tests for TPT with moderate 
ability to identify when there were greyscale changes on ultrasound. The SLHR test had the best 
diagnostic utility and was chosen as the key selection criteria in this study (in addition to medial 
ankle pain). While selection into the TPT and non-TPTMFP groups was not based on imaging 
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findings, the criteria for TPT were based on a clinical diagnosis of tendinopathy (persistent tendon 
pain and pain with mechanical loading). 64 Second, sample size for each group is small, and the 
‘asymptomatic’ side was reduced where participants had bilateral pain, which may have further 
increased the potential for type two errors. 
Overall, this study has several clinical implications. Firstly, findings from this study suggest that 
considering local foot posture and mobility measures and self-report measures of pain, function and 
quality of life, a distinction may not need to be made between isolated cases of TPT and cases plus 
concomitant pain sites. This finding also has research implications. Isolated TPT is difficult to 
recruit; it is not clear from previous research whether small sample sizes have been limited by the 
presence of additional pain, 66 127 214 however the findings from this study may permit larger sample 
sizes to be recruited in the future, thus affording a greater understanding of the condition. This study 
did not investigate impairments proximal to the ankle. Future research should investigate potential 
differences between isolated TPT and TPT plus concomitant pain with regard to global function in 
order to determine whether these two groups can be considered together on the whole. The second 
clinical implication is that pronated foot posture, rather than lowered arch height, may be a 
distinguishing feature when there is tendinopathy of the TP, and that the FPI (a quick, simple and 
reliable tool) 263 may be useful in differentiating TPT from other causes of non-TPTMFP.  
7.1.5 Conclusion 
This is the first study to compare the presentation of isolated TPT, TPT plus concomitant pain, 
other causes of non-TPTMFP and controls. Pronated foot posture, and not lower arch height, 
appears to be a characteristic feature of TPT, that is not present with other causes of non-TPTMFP 
compared to pain free controls. Compared to other causes of medial foot/ankle pain, participants 
with TPT have significantly more pronated and mobile feet and have poorer SLHR capacity and 
participants with TPT plus concomitant pain have the greatest deficits in SLHR capacity.  
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 Considering tibialis posterior tendinopathy under the 
ICF framework 
 Considering tibialis posterior tendinopathy under the ICF framework: a 
cross-sectional study identifying bilateral hip extension muscle weakness 
and psychosocial components of the condition  
Chapter four investigated clinical impairments, pain and disability reported in the current TPT 
literature. The review highlighted that outcome measures were predominantly focussed on local 
impairments with some indication of changes in hip strength, walking, balance and function in TPT. 
In order to advance the current knowledge and address the gaps in the literature, this chapter 
explores a range of clinical measures (both locally and proximally) and self report outcome 
measures under each domain of the ICF framework in individuals clinically diagnosed with TPT 
compared to asymptomatic controls.  
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8.1.1 Introduction 
Tibialis posterior tendinopathy (TPT) is characterised by pain around the medial aspect of the foot 
and ankle, and difficulty with activities that load the tendon. 84 In some cases, these symptoms may 
be accompanied by an acquired flatfoot deformity. The prevalence of this progressive condition is 
unknown but estimated to reach up to 10% 70 and most frequently affects mid-late aged females. 47 
Studies of impairments associated with TPT have primarily focussed on structure and function at 
the foot and ankle, with reports of lower arch height, plantar flexion inversion strength and 
endurance, and heel raise height in individuals with TPT compared to controls (Study 4). 195 
The International Classification of Functioning, Disability and Health (ICF) framework is used to 
describe health and wellbeing in terms of body structure and function, activity, and participation. 7 
Considering body structure and function, in addition to impairments in strength and endurance of 
the tibialis posterior, kinematic analysis has shown greater rearfoot eversion,124-128 lower medial 
longitudinal arch 125 127 and more forefoot abduction 124 127 128 214 during walking in individuals with 
TPT compared to controls. There is minimal research investigating impairments in structure or 
function beyond the foot and ankle. Research suggests TPT is associated with overall reductions in 
function. Individuals with TPT have been shown to have  reduced walking speeds 128 214 and 
distances, 66 and report pain, 66 difficulties and social limitations due to foot problems. 195 
Considering the ICF, these issues are likely to have a negative effect on performance of activities of 
daily living, participation and overall quality of life for those affected. 
The aim of this study is to characterise TPT using the ICF framework; specifically, to compare 
impairments at the body structure and function level more broadly than the foot and ankle, activity 
limitations and participation restrictions between individuals with TPT and asymptomatic controls. 
It is hypothesised that participants with TPT will have impairments beyond the foot and ankle under 
all three domains of the ICF.  
8.1.2 Methods 
Participants 
Participants aged between 18 and 70 years were recruited from the community between July 2017 
and March 2019 in two groups: those who presented with clinical signs of TPT and asymptomatic 
age and sex matched controls. Participants were screened online and via phone prior to attending 
one physical screening and subsequent testing session at the University of Queensland, Brisbane, 
Australia. Participants were eligible for the TPT group if they presented with medial foot/ankle pain 
on most days for at least three months, with an average pain in the previous week greater than 2/10 
on a Numeric Rating Scale (NRS) anchored with “no pain” at 0 and “worst pain imaginable” at 10, 
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and pain or inability to perform a single leg heel raise (SLHR) on physical screening. Selection 
criteria were based on a clinical definition of tendinopathy 64 and the diagnostic utility of clinical 
tests for TPT (Study 5) where the SLHR test had the highest likelihood ratio (positive and negative) 
for predicting when there would be greyscale changes within the tendon on ultrasound imaging. 
Participants in the TPT group were permitted to have pain in other locations provided that their 
medial foot/ankle pain was their predominant pain.  
Asymptomatic control participants were eligible providing they had no lower extremity pain in the 
previous three months. Participants with a history of lower limb surgery in the previous year and 
systemic, neurological or arthritic diseases were excluded from both groups. The study was 
approved by the institutional Human Research Ethics Committee and each participant provided 
written informed consent prior to participation.  
Procedures 
Measures of body structure and function 
Foot Posture Index (FPI) was used as a simple and reliable method of visually classifying static foot 
postures.262 Arch height index (AHI) and the Foot Mobility Magnitude (FMM) (change in arch 
height and midfoot width between weight bearing and non-weight bearing positions) were measured 
and calculated in accordance with previously published protocols (as per Study 7). 259 260 264 Ankle 
dorsiflexion in weight bearing was measured using a Lunge Ankle Dorsiflexion device in 
accordance with a previously published protocol shown to have high intra- and inter-rater 
reliability. 265 Tibial inclination (°) was measured using an inclinometer in both knee flexion and 
extension to record the angle of the lower leg relative to the horizontal position in maximal 
dorsiflexion.  
Ankle plantar flexor endurance was assessed with a single leg heel raise (SLHR) with knee 
extended and light hand support on a horizontal rail for balance. This test has been widely used in 
individuals with TPT. 133 Participants performed as many repetitions as possible at 100% of 
maximal SLHR height (determined by a single repetition prior to beginning the test). The test was 
terminated if the knee flexed, the height of the heel raise diminished, excessive weight was placed 
through the hands, the participant was unable to lift the heel off the ground, or when they reached 
upper limit of 25 repetitions (selected based on population norms for females between 40 and 60 
years of age). 279 The number of complete SLHRs was recorded in one trial. Worst pain experienced 
before, during and after the test was recorded on a NRS. 
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Combined ankle plantar flexion-inversion muscle strength was measured with the participant lying 
supine in 90° hip and knee flexion (with the leg supported) and the ankle in 45° plantar flexion 
(Figure 8-1). The centre of the hand held dynamometer (HHD) (Nicholas, Lafayett, IN47903 USA) 
was secured to the medial side of the first metatarsal head. The participant was instructed to 
maintain plantar flexion and to push isometrically against the HHD into inversion/forefoot 
adduction. Participants were given one practice trial at 50% effort, followed by three experimental 
trials of maximal voluntary contraction, with the maximal force (N) value used for analysis.  
 
Figure 8-1 Test position for plantar flexion-inversion force with fixed hand held dynamometer 
 
Passive and active hip internal rotation (IR) and external rotation (ER) range of motion (ROM) 
were measured in 90° hip and knee flexion using a pleurometer (Figure 8-2). 280 281 Hip IR and ER 
lag was calculated as the difference between passive and active ROM for each direction. 
Figure 8-2 Test positions for passive and active hip rotation range  
a) Start position b) End position hip ER  c) End position hip IR 
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Maximal isometric muscle strength of the hip abductor, adductor, flexor, extensor and external and 
internal rotation muscle groups was measured using a HHD ( 
Figure 8-3). Dynamometry is reported to be a reliable and valid measure of muscle strength 282 in 
both older adults 283 and healthy strong populations. 284 A strap was placed around the dynamometer 
and the plinth during testing to stabilize the HHD and provide resistance to muscle contraction. 285 
Hip abductor and adductor muscle torque were measured with the participant lying supine, with 
both legs extended. The centre of the HHD was positioned above the lateral malleolus for abduction 
or the medial malleolus for adduction. The distance between the centre of the HHD and the anterior 
superior iliac spine (ASIS) was measured (m) as lever arm length.  
Hip extension and flexion were performed in side lying, with the test hip at 30° and the knee at 45° 
flexion. The HHD was placed on the posterior aspect of the thigh just proximal to the knee crease 
for extension, and 5cm above the patella on the anterior aspect for flexion. The lever length was 
measured as the distance between the ASIS and the point 5cm above the base of the patella.  
Hip external and internal rotation were measured with the participant lying supine, hips flexed to 
30° and the knees flexed to 90° over a wedge. The HHD was positioned 5cm proximal to the distal 
tip of the medial malleolus for ER and the lateral malleolus for IR. The lever arms were measured 
as the distance between the medial/lateral condyle of the femur to the point 5cm above the 
medial/lateral malleoli of the ankle, with the axis of rotation through the centre of the knee joint, 
along the length of the femur and perpendicular to the tibia. The examiners hand was placed lightly 
on the test thigh to discourage compensatory thigh movements. 
For all muscle groups, participants were given one practice trial at 50% effort, followed by three 
experimental trials of maximal voluntary contraction. Fifteen seconds rest was allowed between 
each contraction. The participants were asked to increase the force gradually, and then maintain a 
maximal contraction for 5 seconds. Peak force (N) was recorded for each contraction, and the 
maximal value achieved over the three repetitions was used for analysis. Torque (Nm) was 
calculated by the equation Torque (Nm) = Force (N) x Lever arm length (m), and then standardized 
to body mass (Nm/kg).  
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Figure 8-3 Test positions for hip muscle torque measurements  
 
To characterise catastrophic thinking related to pain, the Pain Catastrophization Scale (PCS) was 
administered to both groups. The PCS consists of 13 items pertaining to three domains; rumination, 
magnification and helplessness. 271 Total scores range from 0 to 52 where 52 represents a high level 
of catastrophizing. 271 The Tampa Scale of Kinesiophobia (TSK) was used to measure fear of 
a) Hip abduction b) Hip adduction 
c) Hip flexion d) Hip extension 
e) Hip external rotation f) Hip internal rotation 
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movement or (re)-injury related to pain in the TPT group only. Total scores range between 17 and 
68. Higher scores indicate greater levels of fear of movement.273 A total score >37 indicates 
significant fear of movement.273 
Measures of activity  
Participants descended and then ascended a flight of 20 stairs (not assisted by placing hands on the 
railing) and time taken to complete the test was recorded. The intensity of pain before, during and 
after the test (using the NRS) was recorded.  
The Active Australia Survey (AAS) was used to measure total number of minutes of physical 
activity in the preceding week, and to classify participants as inactive (0 minutes) or participating in 
insufficient (<150 minutes) or sufficient (>150 minutes) amounts of moderate to vigorous physical 
activity. 286 
Measures of participation  
The Foot Function Index-Revised (FFI-R) questionnaire was used to measure health-related foot 
function and foot-related quality of life. An overall index (percentage score) and indices for each 
sub-scale (pain, stiffness, difficulties, activity limitations, social issues) were calculated by 
summing responses and dividing by the maximum possible scores. Scores range from 0-100% with 
higher scores indicating worse foot health and poorer foot-related quality of life. The questionnaire 
has been shown to be valid and reliable in assessment of patients with foot problems. 266 267 Scores 
for subscales of the FFI-R falling under the body structure and function and activity domains of the 
ICF are reported in the relevant section in the results. 
The Assessment of Quality of Life (AQoL) was used to obtain health-related quality of life 
information under six domains; independent living, relationships, mental health, coping, pain and 
senses. Domains are scored separately and combined for an overall ‘utility’ score with higher scores 
representing greater impairment in quality of life. 269 270 Scores for the domains of the AQoL falling 
under the body structure and function and activity domains of the ICF are reported in the relevant 
section in the results.  
Statistical analysis 
Statistical Package for the Social Sciences (SPSS) version 25 (IMB, New York, NY) was used for 
data analysis. All data were examined for normality. Continuous descriptive data were expressed as 
mean (SD) or median (IQR) and group differences examined using independent t-tests or Mann-
Whitney U tests for normally and nonnormally distributed data respectively. Categorical descriptive 
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data were expressed as n (%), with between group differences examined using Pearsons Chi-square 
(χ2). 
For outcomes with data from both limbs, a multivariate analysis of variance (MANOVA) with three 
groups (TPT symptomatic, TPT asymptomatic and control) was used to test for differences between 
sides in the TPT group and between the TPT group and controls. Where TPT participants had 
bilateral pain, only the most symptomatic side was used in the analysis. For control participants, a 
mean of the two sides was used in the analysis. For self-report data and the stairs task, group 
differences were examined using MANOVA with two groups (TPT and control). In the presence of 
group main effects, pairwise comparisons were completed and reported as mean differences (MD) 
and 95% confidence intervals (CIs). Standardised mean differences (SMDs) were calculated as the 
difference between TPT and control group means divided by the pooled SD. 197 SMDs and 95% CIs 
were visualised on forest plots and interpreted as follows; < 0.2 trivial effect, 0.2 - 0.6 small effect, 
0.61 – 1.2 medium effect, and > 1.2 large effect. 88 
A two-way analysis of variance (ANOVA) was used to analyse differences in pain during the 
functional tasks for the TPT group. The two factors were task (two levels: SLHR and stairs) and 
time (three levels: before, during and after) and pairwise comparisons were completed to explore 
main effects.  
8.1.3 Results 
Participants  
Twenty-two participants (19 (86%) females) met selection criteria for TPT and were compared to 
27 (25 (93%) females) asymptomatic controls (Figure 8-4/Table 8-1).  
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Figure 8-4 Participant flow through the study 
 
Participants were similar in age and sex, but weight and BMI were significantly higher in the TPT 
group compared to controls (p<0.01) (Table 8-1). Participants in the TPT group had a median 
(IQR) symptom duration of 13 (45) months and an average and worst pain over the last week of 4 
(3) and 7 (3) out of 10 respectively on the NRS. Five participants (23%) with TPT had pain in 
another location (which was not their predominant pain) and 3 participants (13%) had bilateral 
medial ankle pain. There were no differences between groups with regards to pain medication use in 
the previous 48 hours, regular medication use, diabetes or hormonal status (p > 0.1).  
 
Excluded  
n = 352 
Not TPT n = 139 
Unable to contact n = 127 
Declined to participate n = 63 
Pain ≤ 2/10 n = 15 
Other pain condition (i.e. 
neurological) n = 4 
Surgical history n = 2 
Not 18-70 years n = 2 
Excluded  
n = 101 
Location of pain = 59 
Pain elsewhere = 32 
Not symptomatic = 9 
Duration < 3/12 = 1 
Neurological condition n = 1 
Phone screening 
n = 503 
Physical screening 
n = 151 
Clinical examination 
n = 49 
TPT  
n = 22 
Pain free control 
n = 27 
Online screening 
survey 
n = 1629 
Excluded  
n = 1126 
Pain location n = 794 
Declined to participate n = 144 
Surgical history n = 91 
Pain ≤ 2/10 n = 58 
Not 18-70 years n = 39 
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Table 8-1 Demographic characteristics of participants by group. Data are number of participants 
(%) or mean (SD) unless otherwise specified. 
Characteristic 
TPT 
(n = 22) 
Control  
(n = 27) p 
Age, years  43.3 (12.7) 43.7 (15.6) 0.91 
Sex, female 19 (86.4) 25 (92.6) 0.47 
Study foot, left 5 (22.7) 9 (33.3) 0.41 
Height, m 1.70 (0.1) 1.66 (0.1) 0.19 
Mass, kg 80.6 (20.5)* 63.7 (13.6) <0.01 
Body mass index, kg/m2 27.9 (6.9)* 23.0 (4.6) <0.01 
Symptom duration, months^ 13 (45) - - 
3-6 3 (13.6) - - 
6-12 7 (31.8) - - 
>12 12 (54.5) - - 
Average pain^ 4 (3) - - 
Worst pain ^ 7 (3) - - 
Used pain medication in last 48 hours 3 (13.6) 3 (11.1) 0.80 
Regular medication use 7 (31.8) 5 (18.5) 0.28 
Diabetes 1 (4.5) 0 (0.0) 0.26 
Hormonal status   0.19 
Premenopausal 10 (45.5) 14 (51.9)  
Perimenopausal 7 (31.8) 5 (18.5)  
Postmenopausal 1 (4.5) 6 (22.2)  
Not applicable 4 (18.2) 2 (7.4)  
*; p <0.05, ^; median (IQR) 
 
Measures of body structure and function 
Foot and ankle 
Participants with TPT had a significantly more pronated foot posture on the symptomatic compared 
to asymptomatic side (p = 0.01) and on both sides compared to controls (p = 0.01) (Table 
8-2/Figure 8-5). Weight-bearing ankle dorsiflexion was significantly lower on the symptomatic 
compared to the asymptomatic side for TPT (p = 0.04) and compared to controls (p = 0.01). 
Compared to controls, individuals with TPT produced significantly less plantar flexion inversion 
force on the symptomatic side (p<0.01) and performed significantly fewer SLHR repetitions on 
both sides (p < 0.01) (Figure 8-5). 
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Table 8-2 Body structure and function impairment measures by side and group. Data are presented as mean (SD). 
Foot / ankle  
        
TPT symptomatic v 
asymptomatic 
TPT symptomatic v control 
TPT asymptomatic v 
control 
Characteristic 
Symptomatic 
(n = 22) 
Asymptomatic 
(n = 19)~ 
Control 
(n = 27) 
p 
Mean difference (95% 
CI), p 
Mean difference (95% CI), 
p 
Mean difference (95% 
CI), p 
Foot Posture 
Index  
6.64 (2.36) 4.16 (4.15) 1.85 (1.97) <0.01 2.48 (0.70 to 4.6)*, 
<0.01 
4.79 (3.15 to 6.42)*, <0.01 2.30 (0.60 to 4.01)*, 
<0.01 
Arch Height 
Index 
0.31 (0.03) 0.30 (0.03) 0.32 (0.03) 0.20 0.01 (-0.01 to 0.02), 
0.61 
-0.01 (-0.03 to 0.01), 0.22 -0.02 (-0.03 to 0.00), 
0.09 
Difference in 
arch height 
13.73 (2.93) 14.79 (2.64) 13.38 (1.90) 0.16 -1.07 (-2.62 to 0.49), 
0.18 
0.35 (-1.08 to 1.77), 0.63 1.42 (-0.07 to 2.90), 
0.06 
Difference in 
midfoot width 
10.78 (3.46) 10.74 (4.20) 9.25 (3.60) 0.27 0.04 (-2.30 to 2.40), 
0.98 
1.53 (-0.61 to 3.67), 0.16 1.50 (-0.74 to 3.73), 
0.19 
Foot Mobility 
Magnitude 
17.70 (3.36) 18.54 (3.79) 16.55 (3.01) 0.14 -0.84 (-2.94 to 1.26), 
0.43 
1.15 (-0.77 to 3.01), 0.24 1.99 (-0.01 to 4.00), 
0.05 
Ankle 
dorsiflexion 
(mm) 
89.74 (26.85) 109.47 (29.40) 114.79 
(31.91) 
0.01 -19.73 (-38.28 to -
1.18)*, 0.04 
-25.01 (-42.06 to -8.03)*, 
<0.01 
-5.32 (-23.05 to 12.42), 
0.55 
Tibial inclination 
(°) 
38.59 (5.50) 42.37 (6.34) 43.93 (6.53) 0.01 -3.78 (-7.63 to -0.07), 
0.06 
-5.34 (-8.87to -1.80)*, 
<0.00 
-1.56 (-5.24 to 2.13), 
0.40 
Dorsiflexion 
range of motion 
(°) 
32.27 (4.78) 34.37 (6.01) 35.17 (4.54) 0.14 -2.10 (-5.26 to 1.07), 
0.19 
-2.89 (-5.80 to 0.01), 0.05 -0.80 (-3.83 to 2.23), 
0.60 
Plantar flexion 
inversion force 
(N) 
47.28 (21.48) 62.21 (24.31) 66.91 (27.34) 0.02 -14.93 (-30.40 to 0.54), 
0.06 
-19.63 (-33.82 to -5.45)*, 
<0.01 
-4.70 (-19.49 to 10.09), 
0.53 
SLHR height 8.74 (1.88) 8.97 (1.70) 9.59 (1.39) 0.18 -0.24 (-1.27 to 0.79), 
0.65 
-0.85 (-1.80 to 0.09), 0.08 -0.61 (-1.60 to 0.37), 
0.22 
SLHR 
repetitions  
10.46 (7.12) 14.00 (6.50) 21.89 (4.18) <0.01 -3.55 (-7.25 to 0.16), 
0.06 
-11.43 (-14.83 to -8.04)*, 
<0.01 
-7.89 (-11.43 to -4.35)*, 
<0.01 
Hip         
TPT symptomatic v 
asymptomatic 
TPT symptomatic v control 
TPT asymptomatic v 
control 
Characteristic 
Symptomatic 
(n = 21)^ 
Asymptomatic 
(n = 18)^~ 
Control 
(n = 27) 
p 
Mean difference (95% 
CI), p 
Mean difference (95% CI), 
p 
Mean difference (95% 
CI), p 
Passive External 
Rotation (°) 
44.53 (7.53) 42.79 (4.61) 45.97 (5.54) 0.21 1.15 (-2.67 to 4.97), 
0.55 
-1.99 (-5.45 to 1.48), 0.26 -3.14 (-6.76 to 0.48), 
0.09 
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Passive Internal 
Rotation (°) 
35.76 (9.34) 36.67 (10.41) 40.78 (7.38) 0.09 -0.39 (-6.08 to 5.31), 
0.89 
-5.13 (-10.29 to 0.02), 0.05 -4.75 (-10.14 to 0.65) 
Active External 
Rotation (°) 
37.17 (7.71) 33.70 (8.83) 37.42 (4.18) 0.23 3.07 (-1.42 to 7.55), 
0.18 
-0.49 (-4.55 to 3.57), 0.81 -3.55 (-7.80 to 0.69) 
Active Internal 
Rotation (°) 
34.20 (8.40) 34.77 (6.12) 35.85 (7.53) 0.79 -0.56 (-5.42 to 4.30), 
0.82 
-1.48 (-5.88 to 2.92), 0.50 -0.92 (-5.52 to 3.68) 
External 
Rotation Lag (°) 
7.36 (6.40) 8.02 (4.80) 12.15 (5.74) 0.01 -0.86 (-4.55 to 2.83), 
0.64 
-5.11 (-8.45 to -1.76)*, 
<0.01 
-4.25 (-7.74 to -0.75)* 
Internal Rotation 
Lag (°) 
1.56 (6.33) 1.26 (4.93) 4.94 (4.55) 0.02 0.29 (-3.11 to 3.68), 
0.87 
-3.65 (-6.73 to -0.58)*, 0.02 -3.94 (-7.15 to -0.73)* 
Adduction 
(Nm/kg) 
1.06 (0.46) 1.07 (0.36) 1.14 (0.37) 0.69 -0.01 (-0.27 to 0.24), 
0.96 
-0.09 (-0.33 to 0.14), 0.44 -0.08 (-0.33 to 0.16) 
Abduction 
(Nm/kg) 
1.09 (0.46) 1.12 (0.47) 1.15 (0.44) 0.86 -0.02 (-0.31 to 0.27), 
0.88 
-0.07 (-0.34 to 0.19), 0.59 -0.05 (-0.33 to 0.23) 
Flexion (Nm/kg) 0.99 (0.50) 0.98 (0.50) 1.14 (0.54) 0.42 0.02 (-0.31 to 0.36), 
0.89 
-0.16 (-0.47 to 0.14), 0.29 -0.19 (-0.50 to 0.13) 
Extension 
(Nm/kg) 
0.75 (0.46) 0.80 (0.46) 1.16 (0.68) 0.01 -0.05 (-0.40 to 0.30), 
0.79 
-0.46 (-0.77 to -0.14)*, 0.01 -0.41 (-0.74 to -0.08)* 
External 
Rotation 
(Nm/kg) 
0.38 (0.15) 0.40 (0.14) 0.45 (0.17) 0.17 -0.03 (-0.13 to 0.07), 
0.61 
-0.08 (-0.18 to 0.01), 0.07 -0.06 (-0.15 to 0.04) 
Internal Rotation 
(Nm/kg) 
0.55 (0.18) 0.59 (0.22) 0.58 (0.23) 0.71 -0.04 (-0.17 to 0.10), 
0.59 
-0.05 (-0.17 to 0.07), 0.42 -0.01 (-0.14 to 0.11) 
Self-report measures       TPT v control     
Characteristic 
TPT 
(n = 22) 
 
Control  
(n = 27)   
Mean difference (95% 
CI), p 
    
FFI-R - Pain  54.28 (12.37)  25.21 (1.07) 
 
29.08 (23.89 to 34.26)*, 
<0.01   
FFI-R - Stiffness 49.92 (16.86)  25.36 (1.36) 
 
24.56 (12.02 to 31.09)*, 
<0.01   
AQoL - Pain  6.91 (2.20)  3.41 (0.75) 
 
3.50 (2.59 to 4.41)*, 
<0.01   
AQoL - Senses 4.64 (1.47)  4.56 (1.22) 
 
0.08 (-0.69 to 0.85), 
0.83   
Pain 
catastrophizing 
scale 
6.45 (8.55)  6.26 (11.13) 
 
0.20 (-5.62 to 6.01), 
0.95 
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Tampa scale of 
kinesiophobia# 
8 (36.4)  - 
 
- 
 
  
~; 3 participants with bilateral pain were excluded from 'asymptomatic', *; p<0.05, ^; one TPT participant was excluded from the hip torque due to 
missing data (testing caused pain which limited maximal voluntary contraction), #; n (%) greater than 37. Abbreviations: SLHR; single leg heel raise, 
FFI-R; Foot function index - revised, AQoL; Australian Quality of Life 
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Figure 8-5 SMD (95%) CI for body structure and function outcomes relating to the foot and ankle 
for the symptomatic and asymptomatic sides compared to controls. Positive SMDs indicate greater 
values in TPT compared to controls for the symptomatic (red square) and asymptomatic (blue 
triangle) sides. 
 
Individuals with TPT had a median (IQR) pain severity of 2 (4) out of 10 during the first SLHR (to 
maximal height) on the symptomatic side. During the SLHR endurance test (maximal number of 
repetitions) participants reported a median (IQR) pain severity of 4 (4) out of 10 and following the 
endurance test pain returned to pre-test severity (2 (4)). Table 8-3 shows the reasons for stopping 
the maximal SLHR test for the TPT (symptomatic and asymptomatic sides) and control groups. 
Significantly more controls participants reached 25 repetitions, more TPT participants reported pain 
as the reason for stopping on the symptomatic compared to both asymptomatic side and controls, 
and significantly more TPT participants reported calf fatigue as the reason for stopping on the 
asymptomatic side compared to the symptomatic side and controls (p < 0.05) (Table 8-3).  
Table 8-3 Reasons for stopping the SLHR test, n (%) 
Reason 
TPT 
symptomatic 
(n = 22) 
Control 
(n = 27) 
TPT 
asymptomatic 
(n = 19) 
-3 -2 -1 0 1 2 3 4
SMD (95% CI)
Foot posture index
Arch height index
Difference in arch height
Difference in midfoot width
Foot mobility magnitude
Weight bearing dorsiflexion (mm)
Ankle dorsiflexion (knee flexed)
Ankle dorsiflexion (knee extended)
Single leg heel raise height (cm)
Single leg heel raise repetitions
Plantarflexion inversion force (N)
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Completed 25 repetitions 0 (0.0) 
14 
(51.9)^ 2 (10.5) 
Pain tibialis posterior 
tendon 9 (40.9)^ 0 (0.0) 0 (0.0) 
Unable to reach bar 5 (22.7) 3 (11.1) 3 (15.8) 
Knee flexion 3 (13.6) 2 (7.4) 1 (5.3) 
Calf fatigue 4 (18.2) 8 (29.6) 12 (63.2)^ 
Weakness 1 (4.5) 0 (0.0) 0 (0.0) 
Balance 0 (0.0) 0 (0.0) 1 (5.0) 
^; denotes group proportion differs significantly from the others at the 
0.05 level 
Hip  
Individuals with TPT generated significantly less peak normalised hip extension torque on both 
sides compared to controls (p < 0.04) (Table 8-2/Figure 8-6). There were no between group 
differences in torque production for any other muscle groups and there were no between side 
differences in the TPT group (Table 8-2/Figure 8-6). There were no differences for active or 
passive hip ROM between sides or between groups. The difference between active and passive 
ROM (lag) in ER and IR was significantly less on both sides in TPT compared to controls (p < 
0.04) (Table 8-2/Figure 8-6).  
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Figure 8-6 SMD (95%) CI for body structure and function outcomes relating to the hip for the 
symptomatic and asymptomatic sides compared to controls. Positive SMDs indicate greater values 
in TPT compared to controls for the symptomatic (red square) and asymptomatic (blue triangle) 
sides. 
Self-report/questionnaire  
Individuals with TPT had significantly greater pain scores than controls on both the FFI-R and 
AQoL and greater self-reported stiffness (p<0.01) (Table 8-2). There were no differences between 
groups for the senses domain of the AQoL (p = 0.83) or the PCS (p = 0.95). Eight participants 
(36.4%) in the TPT group exhibited a high degree of fear of movement or (re)-injury (> 37 on the 
TSK).  
Measures of activity  
Compared to controls, individuals with TPT took significantly longer to complete the stair 
descent/ascent task (~4.5 seconds, p<0.01) (Table 8-4/Figure 8-7). Individuals with TPT had a 
median (IQR) pain severity of 1 (2) out of 10 prior to performing the stairs task, 3 (2.1) during the 
task and 1.75 (2.3) following completion of the test.  
Table 8-4 Activity limitations and participation restriction measures 
Activity limitations TPT (n = 22) Control (n = 27) Mean difference (SD) 
p-
value 
Clinical      
Stairs - time 27.91 (4.39) 23.43 (3.23) 4.47 (2.28 to 6.67)* <0.01 
     
Questionnaire     
FFI-R - Difficulties 45.19 (13.54) 25 (0.00) 20.19 (14.96 to 25.42)* <0.01 
FFI-R - Activity 
limitations 33.68 (12.02) 25 (0.00) 8.68 (4.03 to 13.32)* <0.01 
AQoL - Independent 
living  6.36 (1.89) 4.15 (0.36) 2.22 (1.47 to 2.96)* <0.01 
AAS - Total time  759.36 (554.94) 744.85 (485.82) 
14.51 (-284.70 to 
313.72) 0.92 
AAS - Rating     0.43 
Inactive 0 (0) 0 (0)   
Insufficiently active 2 (9.1) 1 (3.7)   
Sufficiently active 20 (90.9) 26 (96.3)   
Participation restrictions TPT (n = 22) Control (n = 27) Mean difference (SD) 
p-
value 
Questionnaire     
FFI-R - Total 43.98 (12.05) 25.37 (1.20) 12.61 (13.93 to 23.29)* <0.01 
FFI-R - Social 
restrictions 39.47 (14.15) 25.96 (3.60) 13.51 (7.83 to 19.20)* <0.01 
158 
AQoL - Total 36.55 (8.67) 27.89 (4.77) 8.66 (4.73 to 12.58)* <0.01 
AQoL - Relationships 3.95 (1.43) 3.33 (0.56) 0.62 (0.02 to 1.22)* 0.04 
AQoL - Mental health 8.32 (2.75) 6.74 (2.23) 1.58 (0.15 to 3.01)* 0.03 
AQoL - Coping 6.36 (1.87) 5.70 (1.61) 0.66 (-0.34 to 1.66) 0.19 
*; p<0.05, Abbreviations: FFI-R; Foot function index - revised, AQoL; Assessment of Quality of 
Life, AAS; Active Australia Survey 
 
Figure 8-7 SMD (95%) CI for body structure and function self-report outcomes and activity and 
participation outcomes. Positive SMDs indicate greater values in TPT compared to controls. 
There were large effects (SMD > 1.2) for greater foot-related functional difficulties (p<0.01) and 
difficulties with independent living (p<0.01) in TPT compared to controls (Table 8-4/Figure 8-7). 
There was a moderate effect (SMD 0.61-1.2) for greater activity limitations on the FFI-R in TPT 
(p<0.01), but there were no differences between groups in physical activity over the previous week 
or proportion of participants who were sufficiently active (Table 8-4). 
Pain experienced before, during and after two functional activities (SLHR and stairs) was compared 
for the TPT group (Figure 8) using a repeated measures ANOVA. There were significant main 
effects for time (F (2, 20) = 18.93, p <0.01) and task (F (1, 21) = 8.21, p = 0.01), with no interaction 
(p = 0.08). Pain with the SLHR task was significantly greater than pain during the stairs task (MD 
(95% CI) 1.1 (0.3 to 1.9), p = 0.01) (Figure 8-8). For both tasks, pain during the task was 
significantly greater than pain before (MD (95% CI) 1.9 (1.3 to 2.6), p < 0.01) and after (MD (95% 
-3 -2 -1 0 1 2 3 4
Coping
Mental health
Relationships
AQoL Total
Social restrictions
FFI-R Total
Physical activity
Independent living
Activity limitations
Difficulties
Stairs
Pain catastrophising
Senses
AQoL Pain
Stiffness
FFI-R PainBoody structure and function
Activity limitations
Participation restrictions
SMD (95% CI)
159 
CI) 1.5 (0.9 to 2.1), p < 0.01) and pain after the task was significantly greater than before, although 
to a lesser extent (MD (95% CI) 0.4 (0.1 to 0.8), p = 0.03).  
 
Figure 8-8 Pain before, during and after SLHR and stairs tasks for TPT group 
 
Measures of participation  
There were large effects for poorer self-reported foot function overall, greater social restrictions due 
to foot problems, and poorer quality of life overall in TPT compared to controls (p < 0.01) (Table 
8-4/Figure 8-7). There were small to moderate effects (SMD 0.2-0.6) for poorer scores on the 
relationships (p = 0.04) and mental health (p = 0.03) domains of the AQoL (Table 8-4/Figure 8-7).  
8.1.4 Discussion 
Few studies have investigated impairments in body structure beyond the foot and ankle, function, 
activities and participation in individuals with TPT. This is the first study to report hip muscle 
torque in all directions and quality of life in individuals with clinically diagnosed TPT. The results 
of this study demonstrate significant bilateral deficits in hip extension torque production compared 
to healthy controls and significantly poorer quality of life, particularly in relation to independent 
living and pain. Individuals with TPT also took significantly longer to ascend and descend stairs 
and reported greater functional difficulties and activity limitations than controls. Consistent with 
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other studies, we also found differences in body structure and function at the foot and ankle 
including more pronated foot posture and local muscle deficits. 195 
Heel raise performance is a common clinical test used to assess the functional capacity of the 
tibialis posterior and is often reported in terms of maximal height and number of repetitions. A 
recent systematic review indicated large effects for poorer SLHR endurance in individuals with 
TPT compared to controls. 195 In addition to finding impaired endurance on the symptomatic side 
(~11 repetitions fewer than controls), participants with unilateral symptoms also performed fewer 
repetitions on the asymptomatic side compared to controls (~8 repetitions fewer). Relatively fewer 
individuals with TPT were able to reach the normative range for number of repetitions completed 
by healthy adults of the same age (n = 21 to 25 repetitions) 279 on their asymptomatic side than 
controls (2 v 14), which suggests that while pain and symptoms may be unilateral, there are bilateral 
deficits in plantar flexor endurance. Clinically, this suggests that a SLHR test should be completed 
on both the symptomatic and asymptomatic sides and compared to normative values rather than 
between sides. Interestingly, while there were bilateral impairments in overall plantar flexor 
endurance, only the symptomatic side demonstrated poorer isolated plantar flexion inversion force. 
It is possible that although overall calf muscle endurance (that has contributions from the 
gastrocnemius soleus complex) was poorer, the isolated tibialis posterior force production capacity 
on the asymptomatic side was not impaired.  
Global functional impairments were identified in TPT. We found it took significantly longer for 
individuals with TPT to complete the stairs task (almost 5 seconds slower) which is similar to 
previously published work that shows women with TPT walk a significantly shorter distance in 6 
minutes than controls. 66 Adequate ankle dorsiflexion ROM is required for walking and navigating 
stairs, and restrictions in dorsiflexion have been associated with shorter step length and slower 
walking speed. 287 Results from this study suggest ankle dorsiflexion ROM is significantly 
restricted compared to the asymptomatic side and controls. This must be interpreted with caution, as 
group means all fell within normative values for ankle dorsiflexion ROM. 288 However, the 
asymmetry between sides in the TPT group was greater than minimal detectable change, 288 and 
also the value at which clinically relevant impairments have been demonstrated. 289 290 Ankle plantar 
flexor power and hip extension torque have also been identified as predictors for walking speed, 
stride length and cadence in older adults. 291 292 We found bilaterally impaired hip extension torque 
in individuals with TPT. This is similar to findings from the only other study to investigate muscle 
function at the hip in women with TPT, where bilateral deficits in hip abduction and extension 
torque and endurance were found. 66 Clinically, assessing for ankle dorsiflexion ROM, plantar 
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flexor and hip extensor muscle torque may assist with identifying impairments to target in 
management of this population. 
Impairments in muscle function, including strength, have been associated with limited participation 
in physical activity. 293 294 While individuals with TPT reported significantly greater foot-related 
activity limitations, participation in overall physical activity was not different between groups. 
Considering this and the findings of bilaterally impaired plantar flexor endurance and hip extension 
strength, it is possible there are direction specific (sagittal plane) impairments in muscle function, 
rather than widespread activity-related declines. 295 It is possible that despite experiencing pain and 
difficulties with activities that specifically load the affected tendon, individuals with TPT are still 
able to participate in physical activity required to limit activity-related declines in strength. 295 
Despite 91.3% of individuals with TPT participating in sufficient levels of physical activity for 
health, 296 over a third displayed signs of fear of movement (TSK). Considered within the 
biopsychosocial model of health, 297 participants with TPT also had significantly poorer overall 
quality of life compared to controls, particularly in regard to pain and independent living, and to a 
lesser extent, relationships and mental health. This suggests a there may be a psychosocial 
component of TPT that has not previously been considered beyond foot-related function and foot-
health related quality of life.  
Lower arch height is often reported as a feature of TPT. 195 In contrast to previous studies, 
eligibility for the TPT group in this study was based exclusively on a clinical definition of 
tendinopathy of the tibialis posterior tendon 64 and as such there were no criteria requiring specific 
foot postures for either group. This may explain the conflict between the findings for arch height in 
the present study and the results of a recently published systematic review and meta-analysis that 
found large, significant effects for lower arch height in individuals with TPT compared to controls. 
195 Most studies included in the meta-analysis required control participants to have a ‘normal arch’ 
(AHI 0.33 to 0.38) which may have over-estimated the between group difference. While we found 
no difference in arch height, there were significant differences in the overall foot posture (FPI). 
Further research is required to investigate if other components of the FPI better characterise foot 
position in TPT than the AHI.  
There are some limitations that need to be considered when interpreting the findings of this study. 
First, due to the cross-sectional design, it cannot be ascertained whether the impairments are a 
consequence or predisposing factor for the development of TPT. Second, eligibility criteria did not 
limit sex or age, despite TPT reportedly being more prevalent in mid-late aged females. This 
resulted in a large age range and a small proportion of male participants included in the study. To 
address this, groups were matched for age and sex. Finally, participants included in the TPT group 
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in this study did not have imaging-confirmed signs of tendinopathy. To address this, decisions 
regarding eligibility for the TPT group were based on persistent tibialis posterior tendon pain and 
the clinical index test with the best diagnostic utility (SLHR) and was examined and agreed upon by 
two physiotherapists. Despite this, it is possible that participants who met eligibility criteria for this 
study did not have imaging-confirmed TPT and this should be considered when interpreting the 
findings.  
8.1.5 Conclusion 
Individuals with TPT have impairments beyond the symptomatic foot and ankle. We found bilateral 
deficits in hip extensor torque and SLHR endurance, unilateral deficits in plantar flexion-inversion 
muscle force production and activity limitations with a functional stairs task. These clinical 
impairments were accompanied by poorer self-reported function and quality of life, particularly 
relating to independent living and pain. These findings suggest management of TPT should involve 
assessment of both sides, consideration of proximal as well as local muscle function, and addressing 
psychosocial aspects of the condition across all domains of the ICF.  
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PART C:  
Overall discussion and conclusions 
 
This section integrates the major findings of the thesis, discusses the clinical implications of these 
findings in relation to the ICF, limitations of the thesis, and provides directions for future research. 
This thesis provides a comprehensive synthesis of available literature investigating a condition that 
is poorly understood and poorly managed and further characterises the clinical presentation of 
TPT with regard to terminology, diagnosis, impairments in body structure and function, activity 
limitations and participation restrictions. 
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 Overall discussion and conclusions 
The early stages of the condition referred to in the literature as PTTD or AAFD are characterised by 
signs and symptoms of tendinopathy of the TP tendon. 84 Debilitating and progressive, 
PTTD/AAFD often goes undiagnosed until substantial pain and limitations affect individuals’ daily 
functioning. 47 Ligament failure associated with a dysfunctional TP tendon 130 results in a 
characteristic flatfoot deformity, for which surgical intervention is considered the only option. 
Surgical procedures for PTTD/AAFD are invasive and costly, with no high-level evidence to 
support their efficacy. With the overarching objective of informing the future development of 
targeted interventions for TPT, the aims of this thesis were to systematically synthesise the current 
evidence in relation to terminology, clinical presentation and management of TPT, to address 
current gaps in the literature in relation to diagnosis, and to explore the clinical presentation of TPT 
using the ICF framework.  
 Summary of main findings 
9.1.1 Part A  
Part A consisted of four systematic reviews of the current literature for TPT. This section began 
with a systematic review of RCTs of local strengthening exercises for TPT (Study 1). It highlighted 
the paucity of high-quality research and demonstrated significant inadequacies in current 
conservative management. 65 Prescription parameters were poorly reported, interventions and 
outcomes were exclusively related to the foot and ankle, and the treatment effects of local 
strengthening exercises were small.  
Chapter three (Study 2) was a systematic review of selection criteria used in all primary research 
papers investigating PTTD and/or AAFD. The terminology PTTD and AAFD were used in this 
chapter to reflect what is most often reported in academic literature. We made the recommendation 
that PTTD is used when key signs and symptoms relate to tendon pathology, leaving AAFD to be 
used as an umbrella term for which there are several aetiologies. 84 This chapter found that the 
selection criteria for stage I and II PTTD were specific to tendon pathology (pain and/or swelling 
along the tendon, difficulty with foot inversion or a SLHR) and thus guided the development of the 
clinical tests used in Chapter six and the eligibility criteria for Chapters 7 and 8 for TPT. 
Chapter four (Study 3) was a systematic review of the literature that compared clinical measures of 
impairment, pain and disability between individuals with TPT and control participants. Meta-
analyses revealed significantly flatter foot posture and local strength deficits in individuals with 
TPT compared to controls. 195 These local impairments were also accompanied by deficits in foot-
related function, greater pain and activity limitations compared to controls. There was preliminary 
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evidence for reductions in global functioning and altered hip muscle function, however, 
investigation of impairments beyond the foot and ankle were limited.  
Chapter five (Study 4) further characterised the presentation of TPT by systematically synthesising 
the literature exploring foot and ankle kinematics during gait. Meta-analyses revealed greater ankle 
plantar flexion and hindfoot eversion across all phases of stance and greater forefoot abduction 
during initial contact, loading response, midstance and pre-swing. Medial longitudinal arch angle 
was also lower in TPT compared to controls across all phases of stance with moderate to large 
effects. No studies included kinematic data for proximal lower limb segments. 
9.1.2 Part B  
The findings from Part A identified gaps in the existing literature and current knowledge of TPT 
that warranted further investigation. Part B consisted of three clinical studies designed to investigate 
the clinical presentation of TPT with consideration of the whole ICF framework. Chapter six (Study 
5) investigated the diagnostic utility of clinical tests (identified in Chapter three) in determining 
when there is US-identified TPT. Pain or inability to perform a SLHR was the test most likely to 
identify TPT. Common clinical tests such as palpation, contraction against manual resistance and 
observing swelling were not useful in conclusively identifying whether or not TPT was present on 
US.  
Chapter seven (Study 6) and eight (Study 7) contribute to what is currently known about the clinical 
presentation of TPT. Chapter seven investigated foot and ankle impairments and self-reported 
function and quality of life of people with isolated TPT compared to those with TPT plus 
concomitant pain sites, other causes of MFP that was not attributable to TPT, and healthy controls. 
Differences between isolated TPT and TPT plus pain elsewhere were minimal, with only SLHR 
height significantly lower in those with TPT and concomitant pain. Both TPT groups had a 
significantly more pronated foot posture and greater deficits in SLHR capacity compared to MFP 
that was not attributable to TPT. Self-reported function and quality of life were not different 
between the three pain groups. This suggests that pronated foot posture, rather than arch height, 
appears to be characteristic of TPT and that individuals with TPT and concomitant lower extremity 
pain have the greatest deficits in local muscle function.  
The final study in this thesis (Study 7) explored the global impact of TPT on the individual by 
considering outcomes under each domain of the ICF compared to pain-free controls. In addition to 
impairments in local body structure and function (e.g. pronated foot posture and SLHR endurance), 
individuals with TPT demonstrated bilaterally impaired hip extension torque. Large effects were 
found for activity limitations including greater time to complete stairs descent/ascent and 
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difficulties with independent living. Considering participation, overall foot-related function and 
quality of life is poorer in individuals with TPT compared to controls, particularly in relation to 
social restrictions, relationships and mental health.  
 Integration of main findings in relation to the ICF framework; looking 
beyond body structure and function  
Effective management of chronic musculoskeletal conditions requires consideration of factors 
beyond the biomedical model of health care, that is, beyond impairments in body structure and 
function. 298 299 The ICF framework is based on a biopsychosocial approach to overall functioning 
and disability, 16 by describing impairments in body structure and function, activity limitations and 
participation restrictions with consideration of personal and environmental factors. 7 The following 
section will discuss the integration of the findings of impairments in body structure and function, 
and the associated implications for activity and participation.  
9.2.1 Foot posture and TPT 
A review of the literature in Study 3 found large effects for altered foot posture in TPT compared to 
controls, but this must be interpreted with caution as most studies had requirements for certain foot 
posture in the control or TPT groups (i.e. within 1 SD of normative values). Without such 
requirements, Studies 6 and 7 also demonstrated large effects for more pronated foot posture in TPT 
compared to medial foot/ankle pain that was not attributable to the TP tendon, and controls. 
Pronated foot posture has been implicated as a risk factor for the development of lower limb 
overuse injuries and pain. 300-302 Considering the development of TPT specifically, a pre-existing 
flat- or pronated-foot posture is the most commonly proposed aetiologic risk factor, 132 276 277 303 but 
there is a lack of rigorous, prospective studies to support this notion. Notwithstanding, the 
association between pronated foot posture and TPT could potentially be bi-directional, particularly 
when considered from an anatomical and tendon loading perspective, and each will be discussed 
briefly below. 
9.2.1.1 Foot posture as a potential contributor to the development of TPT 
Abnormal kinematics have been implicated as a risk factor for developing lower limb 
tendinopathies. A recent systematic review of observational studies found that peak rearfoot 
eversion is a significant factor in development of lower limb tendinopathies in runners. 304 
Repetitive microtrauma associated with subtalar and mid-tarsal joint pronation may contribute to 
the development of tendinopathy, due to the role the TP muscle and tendon play in stabilising and 
supporting the medial longitudinal arch. 256 Literature suggests that excessive or repeated pronation 
at the subtalar joint associated with flat foot posture may increase the eccentric load on the TP 
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tendon, 277 305 which may result in mechanical overload and subsequent development of 
tendinopathy.  
A recent study found that despite significant relationships between TP tendon strain, energy 
absorption at the subtalar joint and subtalar joint pronation, there were no associations between 
tendon strain and TP muscle force. 306 This suggests that the TP tendon may be predisposed to 
strain-related injury due to its role in absorption of energy at the subtalar joint. Greater subtalar joint 
moments during increased walking velocities drive increases in tendon stress, 307 which may further 
contribute to micro-damage and tendon degeneration due to resultant increases in tendon strain, 306 
which is the biggest predictor of tendon failure during cyclic loading. 308  
9.2.1.2 Foot posture as a potential consequence of TPT 
A flat foot deformity that develops as a consequence of TP tendon failure is often reported in the 
literature. 46 130 258 Increased loading through the soft tissue structures of the posteromedial foot and 
ankle, due to progressive loss of TP function, 309 has been implicated in the development of AAFD. 
The association between the loss of TP tendon function and concomitant ligament failure has been 
discussed in several publications with in vivo studies demonstrating the most frequently and 
severely involved capsuloligamentous structure is the spring ligament. 130 204 278 310-314 One cross-
sectional study also found that while the spring ligament complex (superomedial and inferomedial 
calcaneonavicular ligaments) was the most severely and frequently involved, there were high 
frequencies of talocalcaneal interosseous ligament, anterior component of superficial deltoid 
ligament, plantar metatarsal ligament and plantar naviculocuneiform ligament involvement. 130 
While significant associations have been demonstrated, causation (i.e. the direction of the 
relationship between insufficiency of the TP and ligament failure) cannot be determined without 
prospective study designs, which to date are lacking.  
9.2.2 Foot posture and potential relationships with pain and disability 
Findings of flat- or pronated-foot posture, with or without ligament involvement, in the presentation 
of TPT need to be considered in terms of the global impact of altered foot posture on the individual, 
specifically in relation to activity limitations and participation restrictions. While findings from this 
thesis demonstrate altered foot posture and activity limitations and participation restrictions in TPT, 
relationships between foot posture and measures of disability and quality of life were not calculated 
as sample size was not large enough to properly or validly explore relationships.  
Relationships between foot posture and measures of activity and participation have not been 
specifically investigated in TPT elsewhere. Some insight can be gained from examining literature 
investigating foot posture in the general population. Although limited, there are two studies 
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exploring the impact of foot posture on functional outcomes and quality of life. For example, in a 
random population sample, one study has demonstrated that foot health-related quality of life and 
foot function were lower in participants with asymptomatic flat foot posture than those with normal 
foot posture (on the Foot Health Status Questionnaire and the FFI), but found no difference between 
groups on the generic quality of life outcome (Short Form Health Survey (SF-36)). 315 Another 
cross-sectional study also found no differences in general, nor specific foot health-related quality of 
life, between participants with low, normal or high arches. 316 While this does not provide 
conclusive evidence that foot posture is not associated with quality of life, it highlights that further 
research is required to explore the impact of foot posture on disability, including quality of life, 
particularly in those with TPT.  
9.2.3 Tendon structure and the associations with pain and disability 
In Study 5 of this thesis, the frequency of greyscale changes within the TP tendon on US in those 
presenting with medial foot/ankle pain was 42.3% (22 of 52 participants). This was lower than the 
frequency of those who were given a clinical diagnosis of TPT based on tests commonly used by 
clinicians to diagnose tendinopathy (i.e. pain on palpation and pain or inability to load the tendon). 
This suggests some disconnect between the clinical presentation of TPT (i.e. reporting of persistent 
tendon pain in the area of the TP tendon and pain or inability to perform a SLHR) and structural 
changes within the tendon and imaging. This relationship, or lack of relationship, between imaging 
findings and the clinical presentation of tendinopathy (i.e. pain) is often debated in the tendinopathy 
literature. 255 It is accepted that imaging in tendinopathy is able to identify the presence and extent 
of intra-tendinous structural changes, when changes are substantially advanced. Imaging may miss 
substructural changes (i.e. histopathological changes). Notwithstanding, interpretation of structural 
changes within a tendon needs to occur in conjunction with the clinical features of tendinopathy 
(i.e. presence of persistent tendon pain, aggravated by mechanical loading). 64 246  
Tendinosis is the term used for histological or imaging signs of degeneration within the tendon, 
independent of clinical features of tendinopathy. 247 As in other tendinopathies, 317 there is evidence 
of degenerative tendinosis within the TP tendon, 318 319 and several histopathological studies have 
demonstrated increased mucin content, fibroblast hypercellularity, neovascularisation and 
disruption of the linear orientation of collagen fibres. 318 320 321 Some participants in Study 5 whose 
presentation did not fit the clinical picture for TPT (i.e. pain in the medial foot/ankle area but did 
not have pain on tendon loading) were found to have greyscale changes (i.e. tendinosis) on US 
imaging. Abnormal structure on imaging can be present in up to 50% of asymptomatic tendons, 250-
253 and is frequently found in other tendons such as the patellar tendon, 252 Achilles tendon, 322 323 
rotator cuff tendons 324 and lateral epicondylalgia. 325 Conversely, some participants who did fit the 
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clinical picture for TPT (i.e. localised tendon pain and pain with loading) did not demonstrate 
degenerative changes in the TP tendon on US. Current literature indicates that a tendon can still be a 
source of pain and dysfunction, despite relatively normal structure on imaging. 246 It may be useful 
to consider TPT using the model proposed by Coombes et al 326 which integrates local tendon 
pathology with motor and pain system changes. Investigating potential interactions between the 
peripheral and central nervous systems and local tendon changes, as in other tendinopathies, 327 may 
provide a greater understanding of TPT. 238 
9.2.4 Potential for changes in pain processing in TPT  
Pain system changes have been implicated in the persistence of tendon pain and may be useful to 
consider when interpreting the findings of this thesis. A significant proportion of participants with 
medial foot/ankle pain (with and without meeting selection criteria for TPT) had concomitant pain 
sites (bilateral pain and pain in sites remote to the medial foot/ankle). The concepts of physiological 
and pathophysiological pain may underpin these findings. ‘Nociceptive’ (physiological) pain is pain 
that occurs in the presence of actual or anticipated tissue damage or inflammation, whereas 
pathophysiological pain occurs when there is altered processing and/or output from the central 
and/or peripheral nervous systems. 238 328 329 The persistence of localised, and widespread pain, in 
chronic musculoskeletal conditions has been proposed to be a result of peripheral or central 
sensitisation. 329 330  
The International Association for the Study of Pain (IASP) defines sensitisation as an “increased 
receptiveness of nociceptive neurons to their normal input, and/or recruitment of a response to 
normally subthreshold inputs.” 331 Peripheral sensitisation involves increased receptiveness and 
decreased thresholds of peripheral nociceptive neurons, whereas central sensitisation involves 
increased receptiveness of nociceptive neurons in the central nervous system. 331 Allodynia (“pain 
due to a stimulus that does not normally provoke pain”) and hyperalgesia (“increased pain from a 
stimulus that normally provokes pain”) are the clinical manifestations of peripheral or central 
sensitisation, or both. 331  
Assessment of these clinical manifestations has allowed the relationship between persistent 
tendinopathies and altered pain processing to be explored. Quantitative sensory testing (QST) 
enables objective assessment of the response to noxious and non-noxious stimuli and is a means by 
which the presence and extent of hyperalgesia and allodynia can be inferred. 332 Systematic reviews 
and QST studies suggest that peripheral and/or central sensitisation may play a role in persistent 
tendinopathies, 333 334 and in the lower limb, the presence of local hyperalgesia appears to 
predominate. 335 336  To date, the presence (or absence) of peripheral and/or central sensitisation has 
not been investigated in TPT.  
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Bilateral pain and pain in sites remote to the medial foot/ankle were observed in this thesis. While 
developing bilateral symptoms in lower limb tendinopathy is common, 337 and the development of 
concomitant lower limb pain in remote sites is often attributed to altered biomechanics and loading 
(i.e. during ambulation), central sensitisation may provide an alternative explanation for the 
development of bilateral pain, 338 and warrants investigation in TPT. Evaluating pain associated 
with TPT with consideration of potentially altered central and peripheral pain processing and 
modulated neural output, may help to better understand the clinical manifestation of the condition 
and assist with developing management strategies that address potential pathophysiological pain 
presentations.  
9.2.5 Potential for motor system changes in TPT 
Just as the integration of local tendon pathology and pain system changes may underpin the findings 
of this thesis, it is also important to consider potential motor system changes in the presentation of 
TPT. Systematic synthesis of existing literature (Studies 3 and 4) revealed that consideration of 
impairments beyond the affected foot and ankle in TPT was largely omitted. To address this gap in 
the literature, not only were foot and ankle outcomes evaluated for both the symptomatic and 
asymptomatic sides in Study 6 and 7, impairments in hip muscle function and activities were 
evaluated in individuals with TPT in Study 7 and compared to pain-free controls. Results indicated 
that individuals with TPT (with and without concomitant pain sites) have bilateral impairments in 
muscle function both locally and proximally, with Study 7 identifying that, compared to controls, 
participants with TPT have unilaterally impaired plantar flexion/inversion force production and 
bilateral deficits in plantar flexor endurance and hip extensor torque production. 
Impaired muscle function (i.e. force production, endurance) can result from changes within the 
contractile components of the muscles themselves (i.e. sarcopenia, atrophy) or nervous system 
changes (i.e. motor control) and are influenced by lifestyle (i.e. physical activity), biological (i.e. 
hormones) and psychosocial factors (i.e. fear of movement). 339 It stands to reason then, that just as 
the development of bilateral symptoms is common, so too is the presentation of bilateral 
impairments in unilateral musculoskeletal conditions. 333  
Aberrant motor control has been demonstrated in tendinopathy. The direction of the relationship 
between altered motor control and tendinopathy is still unclear, with the majority of research in the 
area consisting of case-control or cross-sectional studies. Some evidence suggests that altered motor 
control may contribute to the development of tendinopathy, 340 while other studies suggest changes 
in motor system function occur after symptom development. While it was not possible to establish 
whether impairments in hip extension torque preceded or were an adaptation to the onset of TPT, 
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considering these impairments from a biomechanical perspective may help develop hypotheses that 
can be tested in future research.  
Systematic synthesis of the literature investigating kinematic characteristics during gait (Study 4) 
highlighted that individuals with TPT have significantly greater hindfoot plantar flexion and 
eversion, forefoot abduction and lowering of the medial longitudinal arch during the stance phase 
(i.e. dynamic pronation). Greater subtalar joint pronation (a combination of rearfoot eversion, 
forefoot abduction and ankle dorsiflexion) has been associated with hip internal rotation and pelvic 
alignment in individuals with asymptomatic flatfoot postures. 341 This alteration in biomechanics 
and positioning has been proposed to contribute to overload of lower limb structures resulting in 
overuse injuries due to micro-trauma. 342 When applied to TPT, increased loading through the 
medial portion of the foot due to altered proximal movement patterns is a potential mechanism for 
mechanical overload of the TP tendon.  
The ‘mechanical overload’ theory implicates the hip external rotators and abductors as potential 
contributors to the development of TPT (i.e., due to altered biomechanics and/or posture), yet 
Studies 3 and 7 of this thesis demonstrated no differences in hip abductor or external rotator torque 
in individuals with TPT compared to controls. Further research is required to establish whether, 
despite normal hip abduction and external rotation torque, hip muscle activity or adduction and/or 
internal rotation moments are altered in those with TPT. It is possible that hip muscle activity is not 
a contributing factor to the development and persistence of TPT, but rather a consequence.  
Considering the sagittal plane findings of Study 4 and 7 together may provide an explanation for hip 
extension deficits in TPT. Individuals with TPT demonstrated shorter stride length, restricted DF 
range of motion, greater ankle PF throughout stance, impaired plantar flexor force production and 
impaired hip extension torque. As DF increases compression of the TP tendon posteriorly to the 
medial malleolus, 343 individuals with TPT may instinctively avoid end range DF, and with poorer 
PF power 214 may be required to shorten their stride, initiating hip flexion before the hip extensors 
activate. While further research is required to investigate proximal muscle activity and kinematics 
during gait (particularly in the sagittal plane), it is possible that proximal impairments may be an 
adaptation to reduce medial foot/ankle symptoms.  
9.2.6 The implications of psychological factors in TPT 
The perception of pain is influenced by behavioural, social, emotional and cognitive factors. 344 345 
A number of psychological features have been implicated in the development and persistence of 
chronic musculoskeletal pain and disability including fear, anxiety, depression and 
catastrophisation. 346-349 In Study 6, individuals with TPT and concomitant pain, but not those with 
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isolated TPT or medial foot/ankle pain that was not attributed to TPT, had significantly poorer 
quality of life in regard to relationships, mental health and coping compared to controls, and fewer 
participants with TPT and concomitant pain were participating in sufficient physical activity for 
health. A large, prospective cohort study found a bidirectional influence of pain on mental health, 
and mental health on pain. 350 Participation in physical activity has positive effects across a range of 
psychological symptoms, including depression, anxiety and self reported health status. 351 While 
relationships between pain, physical activity and psychological factors were not able to be 
investigated in this thesis due to small sample size, being aware of psychological factors that may 
be associated with TPT may assist in optimising management. 349 352 Previous research in females 
with metabolic syndrome has demonstrated strong relationships between physical activity and 
mental health. 353 This relationship might be important to consider when interpreting the findings of 
this thesis, as individuals with medial foot/ankle pain (TPT or other) were predominantly female 
and had significantly higher BMI than control participants. While similar proportions of control and 
TPTplus participants were post-menopausal, the proportion of TPTplus participants meeting 
physical activity guidelines 286 296 was significantly less than controls (71% in TPTplus compared to 
96% of controls) and BMI was significantly higher. There is some evidence for higher prevalence 
of tendon conditions in post-menopausal women, which appears to be associated with metabolic 
factors including BMI. 354  
 Limitations  
There are limitations that need to be considered when interpreting the findings of this thesis. First, 
the sample of participants recruited for Chapters 6 to 8 (Studies 5-7) were predominantly female, 
with a broad age range (18 to 70 years). While this reflects what has previously been reported in the 
literature in terms of a predominance of females with ‘PTTD/AAFD’, age range was not limited to 
mid-late (40+) as it was unclear from the previous literature whether the demographic is the same 
for those with a clinical diagnosis of tendinopathy. It is possible that there may be differences in the 
clinical presentation of younger individuals with TPT compared to older adults (i.e., duration of 
symptoms, severity). Future research should consider exploring potential subgroups within the TPT 
population.  
Second, limitations of cross-sectional study design should be considered when interpreting the 
findings of Studies 6 and 7. All variables were measured on participants presenting with pain in the 
medial foot/ankle region for at least three months duration, and as such it is not able to be 
determined whether observed findings were a cause or result of TPT. That is, causality cannot be 
inferred. Despite this, cross-sectional study designs are useful as a first step in describing population 
characteristics and are well suited to exploring the presentation of a condition such as TPT where 
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there are significant gaps in the current evidence base. As the aim of this thesis was to explore the 
clinical presentation of TPT and informing future research and development of targeted 
interventions, cross-sectional design (Studies 6 and 7) was appropriate as it allowed for a vast array 
of clinically relevant outcome measures spanning each domain of the ICF to be assessed in 
participants presenting with medial foot/ankle pain and enabled comparisons to be made with 
controls.  
Third, the recruitment rate from the general population was unknown prior to conducting this body 
of research. This thesis significantly contributes to a currently under-researched condition and 
provides preliminary findings not only in relation to the clinical presentation and impact of TPT but 
on the prevalence of TPT. Between July 2017 and March 2019, >1600 potential participants were 
screened online, >500 by phone and >150 underwent physical screening. Of those, 42 received a 
clinical diagnosis of TPT (with and without other pain locations). A main finding from this thesis is 
the relatively infrequent presentation of isolated cases of TPT (15 in this body of work), compared 
to those with TPT and other areas of lower limb pain (n=27), and those with medial foot/ankle pain 
that does not present clinically as TPT (n=29). As such, the participants included in Studies 5-7 
were not unique samples and there was considerable overlap across studies (see Appendix 7). As 
well as overlap of participants between studies, some outcomes were presented in both Study 6 and 
7. This was because in Study 7, outcomes were chosen under each domain of the ICF to represent 
those that may be impaired based on previous studies, and the sample was a group of participants 
likely to present clinically (i.e. meeting selection criteria for TPT but permitted to have pain 
elsewhere, provided TPT was their predominant complaint).  
Fourth, findings from this thesis are based on small sample sizes and this should be taken into 
account when interpreting results.  As this thesis was primarily exploratory (i.e. the aim was to 
explore the presentation of TPT under each of the ICF domains), we were unable to conduct power 
analyses for Studies 5-7. This is because we were not confident in estimating effect sizes used in 
power analyses. Results are presented as SMDs, that is, we have provided point estimates of effect 
in this thesis so that readers are able to interpret whether effects are real or not. The limitations of 
relatively small sample sizes and the power to detect significant differences should be considered 
when interpreting results. Furthermore, small sample size may contribute to type II errors (i.e., 
incorrectly accepting the null hypothesis, or finding no difference when a difference is actually 
present).  
Finally, there is current debate around whether imaging is required for the diagnosis of 
tendinopathy. In this study, participants were allocated to the TPT or non-TPTMFP based on the 
findings of the diagnostic utility study presented in the fifth chapter of this thesis. TPT participants 
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included in Chapters 6 to 8 met the selection criteria for TPT based on persistent tendon pain and 
pain with mechanical loading. 64 The mechanical loading test chosen was the SLHR, as this had the 
highest positive and negative likelihood ratios in the diagnostic utility study (Study 5). Overall the 
ability of the clinical index tests to accurately detect when there is US-identified TPT (i.e. greyscale 
changes on the reference standard) was low. Despite having the highest likelihood ratios (positive 
and negative), post-test shifts in probability for the SLHR test were small (18% if positive and 19% 
if negative). As such, it is possible that participants included in the TPT groups across all studies, 
may not have had greyscale changes on US, despite meeting the selection criteria for TPT. 
Conversely, it is also possible that participants included in the non-TPTMFP group in Chapter 
seven did in fact have imaging signs of TPT. 
 Clinical implications of thesis findings  
This thesis has several important clinical implications. Data suggest that just over half (53%) of 
patients presenting with medial foot/ankle pain would receive a clinical diagnosis of TPT based on 
the criteria of persistent pain in the area of the TP tendon, and pain on or inability to perform a 
SLHR, and if US was used to diagnose the presence of greyscale changes within the tendon, this 
would decrease to 2 in 5 (40%). This suggests that symptomatic TPT may present without signs of 
tendinopathy on US imaging, and that clinicians should consider results from index tests together 
with presenting impairments when diagnosing TPT.  When patients presenting with medial 
foot/ankle pain have pain with or inability to perform a SLHR, impaired heel raise capacity and 
bilateral pronated foot posture (quantified using the FPI, a quick and easy clinical assessment tool), 
clinicians should consider TPT.  
When a clinician is managing a patient presenting with medial foot/ankle pain, findings from this 
thesis suggest the importance of considering the relatively infrequent presentation of isolated TPT 
(21% of those presenting with medial foot/ankle pain). TPT often presents with concomitant knee 
and/or hip pain, or other foot pain, indicating that clinicians should be assessing for concomitant 
pain areas and managing accordingly. Furthermore, participants with TPT demonstrated 
impairments in hip muscle function, which indicates that assessment and management should 
include evaluation of the proximal lower limb.  
Mental health, relationships and coping strategies may be important to consider in the management 
of TPT. This suggests that clinically, a biopsychosocial approach should be taken in the 
management of all individuals presenting with medial foot/ankle pain, but particularly those with 
TPT and pain elsewhere who may present with greater psychosocial concerns compared to the 
normal population. 
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As clinical recommendations about the most efficacious local strengthening exercise for TPT could 
not be made in Study 1 of this thesis, clinicians should be encouraged to use their assessment of 
presenting impairments to guide management. Assessment and management should not only 
include local body structure and function impairments, but proximal muscle function in addition to 
taking a biopsychosocial approach by evaluating limitations in activity and restrictions in 
participation, including quality of life.  
 Implications and directions for future research 
This thesis provides a comprehensive summary of the clinical presentation of TPT, a condition 
which is poorly understood and often poorly managed. Findings of the thesis highlight several 
different, but related implications for future research. The first is the difficulty in recruiting 
individuals with the condition. Considering this limitation, future research may need to involve 
multi-site collaborations and consider the expansion of selection criteria to include those who have 
concomitant pain sites, as this is commonly how individuals with TPT present.  
All future research should include clear reporting of the selection criteria used to include 
participants in TPT groups, the presence (or not) of concomitant pain sites and use the terminology 
recommended in this thesis. That is, that TPT is the preferred terminology when medial foot/ankle 
pain symptoms can be attributed to the TP tendon (i.e. persistent tendon pain that is worse with 
loading activities), and that AAFD should be reserved as an umbrella term for the condition of an 
adult-acquired flat foot, with the aetiology specified. This will ensure that future research is 
consistent, allowing for both clinical application of research findings and synthesis and/or 
comparison of findings between studies.  
The diagnostic utility of evidence-informed clinical tests for the condition, as evaluated in Study 5, 
is relatively poor. While it may be useful to conduct a larger diagnostic utility study to establish the 
ideal clinical diagnostic criteria, issues with recruitment (as discussed in relation to this thesis) may 
impede this line of future research. An alternative direction for future research takes into 
consideration the findings of Study 6, which demonstrated that those presenting with medial 
foot/ankle pain, with or without a clinical diagnosis of TPT, exhibit similar functional (both clinical 
and self-reported) impairments and psychosocial features. As the population characteristics of the 
participants included in this thesis are known to influence somatosensory profiles (i.e. primarily 
female, overweight, middle aged), 355 356 future research investigating whether pain processing 
(central or peripheral) is altered in individuals with TPT, and if so, to what extent, is warranted.  
Second is the need for research that explores potential correlations between significant impairments 
in TPT and pain, function and quality of life. For example, exploring the relationships between 
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pronated foot posture and SLHR capacity and measures of activity and participation, and 
considering the impact of these impairments on overall global functioning for those with TPT will 
help to guide future management of the condition. Of particular importance is identifying features 
of the condition affecting activity and participation that are modifiable and can be targeted with 
non-surgical management. Future research may also benefit from recruitment of participants with 
isolated and concomitant pain sites, and those who present with medial foot/ankle pain that is not 
attributed to TPT (as was done in Study 6 in this thesis), to explore any differences in relationships 
between these presentations, and to inform whether these presentations can be considered together 
in terms of the impact of impairments on pain and disability.  
Third is the investigation of kinematic characteristics and muscle activity of the proximal lower 
limb. Considering the findings of hip extension torque deficits (Study 7), the presence of altered 
foot and ankle kinematic characteristics during gait (Study 4) and the lack of research investigating 
kinematics more proximally than the foot and ankle, this is an area that warrants future research.  
There is still a significant gap in the literature regarding the efficacy of exercise management for 
TPT using rigorous, high-quality methodologies with thoroughly described exercise prescriptions 
targeted for tendinopathy. Further research is warranted to investigate the effects of non-surgical 
intervention on pain and functional outcomes demonstrated in this thesis in individuals presenting 
with TPT. The findings of this thesis lend themselves to proposing a novel approach to conservative 
management of TPT and/or medial foot/ankle pain, by targeting the impairments identified in 
previous chapters and considering the current state of research in lower limb tendinopathy. 
Interventions should be targeted towards not only specific impairments but take into consideration a 
biopsychosocial approach to the management of the condition. A feasibility study, to inform a 
larger clinical trial, should be the first step of future research into the management of medial 
foot/ankle pain. The feasibility study would ideally take into consideration the eligibility criteria 
proposed within this thesis, the findings of this thesis, the development of an intervention 
addressing all impairments (i.e. global impairments as demonstrated in Study 7) and evaluate 
outcomes across all domains of the ICF (i.e. quality of life, as per Study 7).  
 Conclusions 
This thesis has improved our understanding of the clinical presentation of TPT by systematically 
synthesising the existing literature and evaluating the diagnostic utility of clinical tests for TPT, 
investigating gaps in the literature identified by the systematic reviews and providing directions for 
future research. The results of this thesis indicate that the overall diagnostic utility of clinical tests 
to identify US defined TPT is poor, but that pain or inability to perform a SLHR is the best 
predictor of greyscale changes within the TP tendon on US. TPT is characterised by not only local 
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impairments in foot posture and SLHR capacity but also hip extension weakness, difficulties with 
stairs and has an impact on global functioning and quality of life. In order to develop targeted and 
effective management approaches for TPT that consider the biopsychosocial aspects of the 
condition, further research should investigate relationships between modifiable impairments and 
pain and disability.  
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Appendix 5 Studies reporting kinematic data by segment, plane and phase of gait cycle  
Segment Plane 
Gait 
cycle Houck* 124 Ness* 128 Neville 125 Rabbito 126 Ringleb 214 Tome 127 Van de Velde^ 215 Total 
Hindfoot 
(Ankle)(Shank-Cal) 
Coronal (INV/EV) 2. LR 1 1 1 0 1 1 1 6 
Hindfoot 
(Ankle)(Shank-Cal) 
Coronal (INV/EV) 5. PreSw 1 1 1 0 1 1 1 6 
Hindfoot 
(Ankle)(Shank-Cal) 
Coronal (INV/EV) 3. MS 0 1 1 0 1 1 1 5 
Forefoot (Cal-Met) Transverse 
(IR/ER)(ABD/ADD) 
2. LR 0 1 1 0 1 1 1 5 
Forefoot (Cal-Met) Transverse 
(IR/ER)(ABD/ADD) 
3. MS 0 1 1 0 1 1 1 5 
Forefoot (Cal-Met) Transverse 
(IR/ER)(ABD/ADD) 
5. PreSw 0 1 1 0 1 1 1 5 
Hindfoot 
(Ankle)(Shank-Cal) 
Sagittal (PF/DF) 2. LR 1 1 0 0 1 0 1 4 
Hindfoot 
(Ankle)(Shank-Cal) 
Sagittal (PF/DF) 5. PreSw 1 1 0 0 1 0 1 4 
Hindfoot 
(Ankle)(Shank-Cal) 
Coronal (INV/EV) 4. TS 1 1 1 0 0 1 0 4 
Forefoot (Cal-Met) Sagittal (PF/DF) 2. LR 1 1 0 0 1 0 1 4 
Forefoot (Cal-Met) Sagittal (PF/DF) 5. PreSw 1 1 0 0 1 0 1 4 
Hindfoot 
(Ankle)(Shank-Cal) 
Sagittal (PF/DF) 3. MS 0 1 0 0 1 0 1 3 
Hindfoot 
(Ankle)(Shank-Cal) 
Transverse 
(IR/ER)(ABD/ADD) 
2. LR 0 1 0 0 1 0 1 3 
Hindfoot 
(Ankle)(Shank-Cal) 
Transverse 
(IR/ER)(ABD/ADD) 
3. MS 0 1 0 0 1 0 1 3 
Hindfoot 
(Ankle)(Shank-Cal) 
Transverse 
(IR/ER)(ABD/ADD) 
5. PreSw 0 1 0 0 1 0 1 3 
Forefoot (Cal-Met) Sagittal (PF/DF) 3. MS 0 1 0 0 1 0 1 3 
Forefoot (Cal-Met) Coronal 
(INV/EV)(VAL/VA
R) 
2. LR 0 1 0 0 1 0 1 3 
Forefoot (Cal-Met) Coronal 
(INV/EV)(VAL/VA
R) 
3. MS 0 1 0 0 1 0 1 3 
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Forefoot (Cal-Met) Coronal 
(INV/EV)(VAL/VA
R) 
5. PreSw 0 1 0 0 1 0 1 3 
Forefoot (Cal-Met) Transverse 
(IR/ER)(ABD/ADD) 
4. TS 0 1 1 0 0 1 0 3 
Medial longitudinal 
arch 
Medial longitudinal 
arch 
2. LR 0 0 1 0 0 1 1 3 
Medial longitudinal 
arch 
Medial longitudinal 
arch 
3. MS 0 0 1 0 0 1 1 3 
Medial longitudinal 
arch 
Medial longitudinal 
arch 
5. PreSw 0 0 1 0 0 1 1 3 
Hindfoot 
(Ankle)(Shank-Cal) 
Sagittal (PF/DF) 1. IC 1 1 0 0 0 0 0 2 
Hindfoot 
(Ankle)(Shank-Cal) 
Sagittal (PF/DF) 4. TS 1 1 0 0 0 0 0 2 
Hindfoot 
(Ankle)(Shank-Cal) 
Coronal (INV/EV) 1. IC 1 1 0 0 0 0 0 2 
Forefoot (Cal-Met) Sagittal (PF/DF) 1. IC 1 1 0 0 0 0 0 2 
Forefoot (Cal-Met) Sagittal (PF/DF) 4. TS 1 1 0 0 0 0 0 2 
Hallux Sagittal (PF/DF) 2. LR 0 1 0 0 0 0 1 2 
Hallux Sagittal (PF/DF) 3. MS 0 1 0 0 0 0 1 2 
Hallux Sagittal (PF/DF) 5. PreSw 0 1 0 0 0 0 1 2 
Medial longitudinal 
arch 
Medial longitudinal 
arch 
4. TS 0 0 1 0 0 1 0 2 
Tibia Sagittal (Fwd/Bwd) 1. IC 0 1 0 0 0 0 0 1 
Tibia Sagittal (Fwd/Bwd) 2. LR 0 1 0 0 0 0 0 1 
Tibia Sagittal (Fwd/Bwd) 3. MS 0 1 0 0 0 0 0 1 
Tibia Sagittal (Fwd/Bwd) 4. TS 0 1 0 0 0 0 0 1 
Tibia Sagittal (Fwd/Bwd) 5. PreSw 0 1 0 0 0 0 0 1 
Tibia Coronal (ABD/ADD) 1. IC 0 1 0 0 0 0 0 1 
Tibia Coronal (ABD/ADD) 2. LR 0 1 0 0 0 0 0 1 
Tibia Coronal (ABD/ADD) 3. MS 0 1 0 0 0 0 0 1 
Tibia Coronal (ABD/ADD) 4. TS 0 1 0 0 0 0 0 1 
Tibia Coronal (ABD/ADD) 5. PreSw 0 1 0 0 0 0 0 1 
Tibia Transverse (IR/ER) 1. IC 0 1 0 0 0 0 0 1 
Tibia Transverse (IR/ER) 2. LR 0 1 0 0 0 0 0 1 
204 
Tibia Transverse (IR/ER) 3. MS 0 1 0 0 0 0 0 1 
Tibia Transverse (IR/ER) 4. TS 0 1 0 0 0 0 0 1 
Tibia Transverse (IR/ER) 5. PreSw 0 1 0 0 0 0 0 1 
Hindfoot 
(Ankle)(Shank-Cal) 
Transverse 
(IR/ER)(ABD/ADD) 
1. IC 0 1 0 0 0 0 0 1 
Hindfoot 
(Ankle)(Shank-Cal) 
Transverse 
(IR/ER)(ABD/ADD) 
4. TS 0 1 0 0 0 0 0 1 
Midfoot (Cal-Mid, 
Mid-Met) 
Sagittal (PF/DF) 2. LR 0 0 0 0 0 0 1 1 
Midfoot (Cal-Mid, 
Mid-Met) 
Sagittal (PF/DF) 3. MS 0 0 0 0 0 0 1 1 
Midfoot (Cal-Mid, 
Mid-Met) 
Sagittal (PF/DF) 5. PreSw 0 0 0 0 0 0 1 1 
Midfoot (Cal-Mid, 
Mid-Met) 
Coronal (INV/EV) 2. LR 0 0 0 0 0 0 1 1 
Midfoot (Cal-Mid, 
Mid-Met) 
Coronal (INV/EV) 3. MS 0 0 0 0 0 0 1 1 
Midfoot (Cal-Mid, 
Mid-Met) 
Coronal (INV/EV) 5. PreSw 0 0 0 0 0 0 1 1 
Midfoot (Cal-Mid, 
Mid-Met) 
Transverse 
(IR/ER)(ABD/ADD) 
2. LR 0 0 0 0 0 0 1 1 
Midfoot (Cal-Mid, 
Mid-Met) 
Transverse 
(IR/ER)(ABD/ADD) 
3. MS 0 0 0 0 0 0 1 1 
Midfoot (Cal-Mid, 
Mid-Met) 
Transverse 
(IR/ER)(ABD/ADD) 
5. PreSw 0 0 0 0 0 0 1 1 
Forefoot (Cal-Met) Coronal 
(INV/EV)(VAL/VA
R) 
1. IC 0 1 0 0 0 0 0 1 
Forefoot (Cal-Met) Coronal 
(INV/EV)(VAL/VA
R) 
4. TS 0 1 0 0 0 0 0 1 
Forefoot (Cal-Met) Transverse 
(IR/ER)(ABD/ADD) 
1. IC 0 1 0 0 0 0 0 1 
Hallux Sagittal (PF/DF) 1. IC 0 1 0 0 0 0 0 1 
Hallux Sagittal (PF/DF) 4. TS 0 1 0 0 0 0 0 1 
Hallux Coronal 
(INV/EV)(PRON/SU
P) 
1. IC 0 1 0 0 0 0 0 1 
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Hallux Coronal 
(INV/EV)(PRON/SU
P) 
2. LR 0 1 0 0 0 0 0 1 
Hallux Coronal 
(INV/EV)(PRON/SU
P) 
3. MS 0 1 0 0 0 0 0 1 
Hallux Coronal 
(INV/EV)(PRON/SU
P) 
4. TS 0 1 0 0 0 0 0 1 
Hallux Coronal 
(INV/EV)(PRON/SU
P) 
5. PreSw 0 1 0 0 0 0 0 1 
Hallux Transverse 
(IR/ER)(VAL/VAR) 
1. IC 0 1 0 0 0 0 0 1 
Hallux Transverse 
(IR/ER)(VAL/VAR) 
2. LR 0 1 0 0 0 0 0 1 
Hallux Transverse 
(IR/ER)(VAL/VAR) 
3. MS 0 1 0 0 0 0 0 1 
Hallux Transverse 
(IR/ER)(VAL/VAR) 
4. TS 0 1 0 0 0 0 0 1 
Hallux Transverse 
(IR/ER)(VAL/VAR) 
5. PreSw 0 1 0 0 0 0 0 1 
Midfoot (Cal-Mid, 
Mid-Met) 
Sagittal (PF/DF) 1. IC 0 0 0 0 0 0 0 0 
Midfoot (Cal-Mid, 
Mid-Met) 
Sagittal (PF/DF) 4. TS 0 0 0 0 0 0 0 0 
Midfoot (Cal-Mid, 
Mid-Met) 
Coronal (INV/EV) 1. IC 0 0 0 0 0 0 0 0 
Midfoot (Cal-Mid, 
Mid-Met) 
Coronal (INV/EV) 4. TS 0 0 0 0 0 0 0 0 
Midfoot (Cal-Mid, 
Mid-Met) 
Transverse 
(IR/ER)(ABD/ADD) 
1. IC 0 0 0 0 0 0 0 0 
Midfoot (Cal-Mid, 
Mid-Met) 
Transverse 
(IR/ER)(ABD/ADD) 
4. TS 0 0 0 0 0 0 0 0 
Medial longitudinal 
arch 
Medial longitudinal 
arch 
1. IC 0 0 0 0 0 0 0 0 
* reported peak and excursion, ^ reported excursion only, Abbreviations: 
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Appendix 6 Online survey of clinicians regarding the use of ultrasound in the diagnosis of tibialis 
posterior tendinopathy 
The following survey was circulated on social media between the 18th and 25th of February, 2019.  
ID# Profession 
Number 
of TPT 
patients 
per 
month 
Frequency of 
US for 
diagnosis 
Elements of US important for reference 
standard for TPT in order of importance (1 
most important, 4 least important) 
Greyscale 
changes 
in tendon 
Greyscale 
changes in 
peritendon 
Fluid in 
peritendon Doppler 
1 Podiatrist 11-15 Always 4 3 1 2 
2 Surgeon 11-15 Rarely 1 3 2 4 
3 Sports physician 6-10 Usually 2 4 1 3 
4 Radiologist 6-10 Always 1 4 3 2 
5 Radiologist 6-10 Always 1 4 2 3 
6 Podiatrist 6-10 Always 1 4 2 3 
7 Podiatrist 6-10 Rarely 1 3 2 4 
8 Podiatrist 6-10 Rarely 3 4 1 2 
9 Podiatrist 6-10 Sometimes 4 3 1 2 
10 Podiatrist 6-10 Rarely 1 4 3 2 
11 Sports physician 6-10 Never 4 1 3 2 
12 Podiatrist 6-10 Sometimes 1 2 3 4 
13 Physiotherapist 6-10 Never 1 4 2 3 
14 Podiatrist 6-10 Rarely 3 4 1 2 
15 Sonographer <5 Usually 1 2 4 3 
16 Sports physician <5 Usually 2 4 1 3 
17 Podiatrist <5 Rarely 3 2 1 4 
18 Sports physician <5 Always 1 3 2 4 
19 Physiotherapist <5 Always 2 4 3 1 
20 Physiotherapist <5 Never 3 4 2 1 
21 Physiotherapist <5 Never 1 3 2 4 
22 Physiotherapist <5 Sometimes 1 4 3 2 
23 Sports physician <5 Usually 1 3 2 4 
24 Physiotherapist <5 Usually 1 3 2 4 
25 Physiotherapist <5 Usually 1 4 2 3 
26 Physiotherapist <5 Rarely 3 2 1 4 
27 Physiotherapist <5 Never 1 3 4 2 
28 Physiotherapist <5 Never 3 1 2 4 
29 Podiatrist <5 Usually 2 4 3 1 
30 Podiatrist <5 Rarely 3 4 2 1 
31 Sports physician <5 Usually 1 3 2 4 
32 Physiotherapist <5 Never 3 2 1 4 
33 Physiotherapist <5 Rarely 2 1 3 4 
34 Physiotherapist <5 Sometimes 1 2 3 4 
35 Physiotherapist <5 Rarely 4 3 2 1 
36 Physiotherapist <5 Rarely 1 4 3 2 
37 Sonographer >15 Always 1 3 2 4 
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38 Podiatrist None Sometimes 1 4 3 2 
Total 38 Most important 21 3 9 5 
Physiotherapist 15 Second most 5 6 16 11 
Podiatrist 12 Second least 8 12 11 7 
Sports Physician 6 Least important 4 17 2 15 
Radiologist 2  
    
Sonographer 2 Most important 55.3% 7.9% 23.7% 13.2% 
Surgeon 1 Second most 13.2% 15.8% 42.1% 28.9% 
  
 Second least 21.1% 31.6% 28.9% 18.4% 
  
 Least important 10.5% 44.7% 5.3% 39.5% 
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Appendix 7 Results for index tests, clinical diagnoses and break down of participants included in each study  
ID 
Clinical index test findings 
Studies included in thesis 
All Study 5 Study 6 
Study 
7 
Group 
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Q
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1 TPT Yes Yes Yes Yes Yes Yes Yes Yes No No Yes Yes Yes 
2 TPT Yes Yes Yes Yes Yes Yes Yes Yes No No Yes Yes Yes 
3 TPT Yes Yes No Yes Yes Yes Yes Yes No No Yes Yes Yes 
4 TPT Yes Yes No Yes Yes Yes Yes Yes No No Yes Yes Yes 
5 TPT Yes Yes No Yes Yes Yes Yes Yes No No Yes Yes Yes 
6 Control No No No No No Yes No Yes No No Yes Yes Yes 
7 TPT Yes Yes No Yes Yes Yes Yes Yes No No Yes Yes Yes 
8 TPT Yes Yes No No Yes Yes Yes Yes Yes No Yes Yes Yes 
9 TPT Yes Yes No No Yes Yes Yes Yes Yes Yes Yes Yes Yes 
10 TPTplus Yes Yes No Yes Yes Yes Yes Yes Yes No Yes No No 
11 TPTplus Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes No 
12 TPTplus Yes No No No Yes Yes Yes Yes Yes Yes Yes Yes No 
13 TPT Yes No No Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes 
14 Control No No No No No Yes No Yes No No Yes Yes Yes 
15 TPT Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes 
16 non-TPTMFP No No No No No Yes Yes Yes Yes No Yes No No 
17 TPTplus Yes Yes No Yes Yes Yes Yes Yes Yes Yes Yes No No 
18 TPT Yes Yes Yes No Yes Yes Yes Yes Yes Yes Yes Yes Yes 
19 TPT Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes 
20 TPTplus Yes Yes Yes Yes Yes Yes Yes Yes Yes No Yes No No 
21 non-TPTMFP Yes Yes No No No Yes Yes Yes Yes Yes Yes No No 
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22 TPT Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes 
23 non-TPTMFP Yes Yes No Yes No Yes Yes Yes Yes Yes Yes Yes No 
24 TPTplus Yes Yes Yes No Yes Yes Yes Yes Yes No Yes No No 
25 non-TPTMFP No Yes No Yes Yes Yes Yes Yes Yes Yes Yes Yes No 
26 Control No No No No No Yes No Yes No No Yes Yes Yes 
27 Control No No No No No Yes No Yes No No Yes Yes Yes 
28 Control No No No No No Yes No Yes No No Yes Yes Yes 
29 Control No No No No No Yes No Yes No No Yes Yes Yes 
30 Control No No No No No Yes No Yes No No Yes Yes Yes 
31 non-TPTMFP No No No No No Yes Yes Yes Yes Yes Yes Yes No 
32 Control No No No No No Yes No Yes No No Yes Yes Yes 
33 Control No No No No No Yes No Yes No No Yes Yes Yes 
34 Control No No No No No Yes No Yes No No Yes Yes Yes 
35 Control No No No No No Yes No Yes No No Yes Yes Yes 
36 Control No No No No No Yes No Yes No No Yes Yes Yes 
37 Control No No No No No Yes No Yes No No Yes Yes Yes 
38 Control No No No No No Yes No Yes No No Yes Yes Yes 
39 Control No No No No No Yes No Yes No No Yes Yes Yes 
40 Control No No No No No Yes No Yes No No Yes Yes Yes 
41 Control No No No No No Yes No Yes No No Yes Yes Yes 
42 Control No No No No No Yes No Yes No No Yes Yes Yes 
43 Control No No No No No Yes No Yes No No Yes Yes Yes 
44 Control No No No No No Yes No Yes No No Yes Yes Yes 
45 Control No No No No No Yes No Yes No No Yes Yes Yes 
46 Control No No No No No Yes No Yes No No Yes Yes Yes 
47 Control No No No No No Yes No Yes No No Yes Yes Yes 
48 non-TPTMFP No No No No Yes Yes Yes Yes Yes Yes Yes Yes No 
49 Control No No No No No Yes No Yes No No Yes Yes Yes 
50 non-TPTMFP Yes No No No No Yes Yes Yes Yes Yes Yes Yes No 
51 TPT Yes Yes No No Yes Yes Yes Yes Yes Yes Yes Yes Yes 
52 non-TPTMFP No No No No No Yes Yes Yes Yes Yes Yes Yes No 
53 non-TPTMFP Yes No No No No Yes Yes Yes Yes Yes Yes No No 
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54 TPT Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes 
55 TPTplus Yes Yes Yes No Yes Yes Yes Yes Yes Yes Yes No No 
56 Control No No No No No Yes No Yes No No Yes Yes Yes 
57 Control No No No No No Yes No Yes No No Yes Yes Yes 
58 TPTplus Yes Yes No No Yes Yes Yes Yes Yes No Yes Yes No 
59 non-TPTMFP Yes Yes Yes No No Yes Yes Yes Yes Yes Yes Yes No 
60 non-TPTMFP No No No No Yes Yes Yes Yes Yes Yes Yes Yes No 
61 TPTplus Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes No No 
62 TPTplus Yes Yes Yes No Yes Yes Yes Yes Yes Yes Yes Yes No 
63 TPTplus Yes Yes Yes Yes Yes Yes Yes Yes Yes No Yes No No 
64 TPT Yes No Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes 
65 TPT Yes Yes Yes No Yes Yes Yes Yes Yes Yes Yes Yes Yes 
66 TPTplus Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes No 
67 TPTplus Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes No No 
68 non-TPTMFP Yes Yes Yes No No Yes Yes Yes Yes No Yes No No 
69 TPTplus Yes Yes Yes Yes Yes Yes Yes Yes Yes No Yes No No 
70 non-TPTMFP Yes No No No No Yes Yes Yes Yes Yes Yes Yes No 
71 non-TPTMFP Yes No No No No Yes Yes Yes Yes Yes Yes Yes No 
72 non-TPTMFP Yes No No No No Yes Yes Yes Yes Yes Yes Yes No 
73 non-TPTMFP Yes No No No No Yes Yes Yes No Yes Yes Yes No 
74 TPTplus Yes Yes Yes No Yes Yes Yes Yes Yes No Yes Yes No 
75 non-TPTMFP Yes No No No No Yes Yes Yes Yes Yes Yes Yes No 
76 non-TPTMFP Yes No No No No Yes Yes Yes Yes Yes Yes Yes No 
77 TPT Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes 
78 non-TPTMFP Yes No No Yes No Yes Yes Yes Yes Yes Yes Yes No 
79 non-TPTMFP Yes No No No No Yes Yes Yes No No Yes Yes No 
80 TPTplus Yes Yes Yes Yes Yes Yes Yes Yes No Yes Yes Yes No 
81 TPTplus Yes Yes Yes Yes Yes Yes Yes Yes Yes No Yes Yes No 
82 TPT Yes Yes No No Yes Yes Yes Yes Yes Yes Yes Yes Yes 
83 non-TPTMFP Yes No No No No Yes Yes Yes No Yes Yes Yes No 
84 non-TPTMFP Yes No No No No Yes Yes Yes Yes Yes Yes Yes No 
85 non-TPTMFP Yes No No No No Yes Yes Yes Yes Yes Yes Yes No 
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86 non-TPTMFP Yes No No No No Yes Yes Yes Yes Yes Yes Yes No 
87 TPTplus Yes Yes No Yes Yes Yes Yes Yes Yes Yes Yes Yes No 
88 non-TPTMFP Yes Yes No No No Yes Yes Yes No Yes Yes Yes No 
89 non-TPTMFP Yes Yes No No No Yes Yes Yes Yes Yes Yes Yes No 
90 non-TPTMFP Yes Yes No Yes No Yes Yes Yes No Yes Yes Yes No 
91 non-TPTMFP Yes No No No No Yes Yes Yes Yes Yes Yes Yes No 
92 TPTplus Yes Yes Yes No Yes Yes Yes Yes Yes Yes Yes Yes No 
93 TPT Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes 
94 TPT Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes 
95 TPT Yes Yes No Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes 
96 TPTplus Yes No No No Yes Yes Yes Yes Yes No Yes Yes No 
97 non-TPTMFP Yes No No No No Yes Yes Yes Yes Yes Yes Yes No 
98 Control No No No No No Yes No Yes No No Yes Yes Yes 
Control 27 0 0 0 0 0 27 0 27 0 0 27 27 27 
TPT 22 22 20 12 16 22 22 22 22 16 15 22 22 22 
non-
TPTMFP 
29 23 8 2 4 3 29 29 29 24 26 29 25 0 
TPTplus 20 20 18 14 12 20 20 20 20 19 11 20 11 0 
TOTAL 98 65 46 28 32 45 98 71 98 59 52 98 85 49 
 
  
